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ABSTRACT 
 
The causative agent of human tuberculosis, Mycobacterium tuberculosis, is an intracellular 
pathogen that secretes virulence factors, namely ESAT-6 and CFP-10, as substrates of the 
ESX-1 secretion system. It is hypothesised that these substrates interact with host proteins in a 
targeted manner in order to elicit a required immune response, and they have been shown to 
be involved in processes related to pro-inflammatory responses, necrosis, apoptosis, 
membrane lysis and cytolysis. However, the biological function of ESX-1 substrates during 
host-pathogen interactions remains poorly and incompletely understood. Therefore, the 
present study was designed to gain insight into the role of the ESX-1 secretion system 
substrates in host-pathogen interactions and to identify how M. tuberculosis mediates the 
response of the human host. 
 
In this study, a cDNA yeast two-hybrid library was constructed from human lung mRNA, to 
identify mycobacterial-host protein-protein interactions that occur within the lung alveoli. The 
ESX-1 secretion system substrates, ESAT-6 and CFP-10, were cloned in-frame into the 
pGBKT7 vector, which was used in the yeast two-hybrid system to screen the lung cDNA 
library in Saccharomyces cerevisiae. The ESAT-6 and CFP-10 screens identified 79 and 19 
positive colonies, respectively. Of the total number of clones characterised, only two in-frame 
inserts were identified with the ESAT-6 screen, corresponding to the human proteins filamin 
A and complement component 1, q subcomponent, A chain (C1QA). In addition, the screen 
with CFP-10 also identified C1QA as binding partner. 
 
Subsequent in vitro and in vivo experiments were unable to confirm the putative interactions 
of C1QA with ESAT-6 and CFP-10. However, the interaction between filamin A and ESAT-6 
was demonstrated and confirmed by both in vivo co-localisation and co-immunoprecipitation. 
Furthermore, the degradation of filamin A in the presence of ESAT-6 was shown to be 
reflective of cytoskeleton remodelling and the induction of cell death. The work presented 
here suggests that as ESAT-6 gains access to the cytosol, it initiates cell death by inducing 
destabilisation of the cytoskeleton cell structure.  This may possibly be driven by the 
interaction of ESAT-6 and filamin A.  
 
Finally, we also initiated an investigation of the identified putative binding partners (filamin A 
and C1QA) as possible genetic markers for genetic susceptibility studies to tuberculosis. A 
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case-control analysis was performed involving 604 cases, of which 109 were Tuberculous 
Meningitis (TBM), and 486 were controls from the South African Coloured (SAC) population 
within the Ravensmead-Uitsig catchment area. The results of this analysis demonstrated a 
novel association of a regulatory variant (rs587585) located upstream of the C1QA gene and 
demonstrated an increasing trend towards increased values in tuberculosis patients with the 
associated genotype. 
 
This study has contributed significantly to our understanding of human-mycobacterial host-
pathogen protein-protein interactions and has opened the way for future studies further 
exploring the consequences and function of the identified ESAT-6-filamin A interaction.  It 
has also led to the identification of a novel genetic association with tuberculosis. Finally, it 
demonstrates the usefulness of the yeast two-hybrid system to identify potential protein-
protein (host-pathogen) interactions that can lead to additional important and exciting research 
questions. 
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OPSOMMING 
 
 
Die organisme wat tuberkulose veroorsaak, Mycobacterium tuberculosis, is `n intrasellulȇre 
patogeen wat virulensie faktore afskei, naamlik ESAT-6 en CFP-10, as substrate van die 
ESX-1 sekresiesisteem. Daar word vermoed dat hierdie substrate met gasheerproteïene in „n 
teiken wyse interaksie het om `n vereiste immuunreaksie voort te bring. Hierdie substrate is 
betrokke by prosesse soos pro-inflammatoriese reaksies, nekrose, apoptose, membraanlise en 
sitolise. Die biologiese funksie van die ESX-1 substrate tydens gasheer-patogeen interaksies 
word egter tans swak en onvolledig verstaan. Daarom was die huidige studie ontwerp om 
insig te bekom oor die rol hiervan in gasheer-patogeen interaksies en om te identifiseer hoe M. 
tuberculosis die reaksie teenoor die gasheer bemiddel. 
 
In hierdie studie was `n komplementȇre deoksiribonukleïensuur (kDNS) gis twee-hibried 
biblioteek gemaak vanaf long boodskapper ribonukleïensuur (bRNS) om proteïen-proteïen 
interaksies wat in die long plaasvind, te identifiseer. Die substrate van die ESX-1 
sekresiesisteem, ESAT-6 en CFP-10, is in volgorde gekloneer in die pGBKT7 vektor en is 
gebruik om die long kDNS biblioteek in Saccharomyces cerevisiae te ondersoek. In die soeke 
na interaksies met ESAT-6 and CFP-10, was 79 en 19 positiewe kolonies onderskeidelik 
geïdentifiseer. Van die aantal klone, was slegs twee volgordes in-leesraam geïdentifiseer met 
ESAT-6. Hierdie proteïene het ooreengestem met filamin A en “complement component 1, q 
subcomponent, A chain” (C1QA). Bykomend hiertoe, is C1QA ook geïdentifiseer as „n 
bindende vennoot met CFP-10. 
 
Daaropvolgende in vitro and in vivo eksperimente kon nie die vermeende interaksie van 
C1QA met ESAT-6 en CFP-10 bevestig nie. Maar die interaksie tussen filamin A en ESAT-6 
kon wel gedemonstreer word deur die gebruik van mede-lokalisering en mede-
imunopresipitasie. Die afbreek van filamin A in die teenwoordigheid van ESAT-6 is ook 
aangetoon en blyk „n weerspieëling te wees van sitoskelet hermodellering en die induksie van 
seldood. Die werk wat hier aangebied word, dui daarop dat soos ESAT-6 toegang kry tot die 
sitosol, inisieër dit seldood deur die destabilisaisie van die sitoskelet selstruktuur. Dit word 
moontlik aangedryf deur die interaksie van ESAT-6 met filamin A. 
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Laastens het ons `n ondersoek van die geïdentifiseerde bindingsvennote (filamin A and 
C1QA) as moontlike genetiese merkers vir genetiese vatbaarheidsstudies vir tuberkulose 
uitgevoer. `n Pasiënt-kontrole studie is gedoen waarby 604 individue ingesluit is, waarvan 109 
gediagnoseer is met Tuberculosis Meningitis (TBM), en die ander 486 kontrole individue was 
van die Suid Afrikaanse Kleurling (SAC) bevolking binne die Ravenmead-Uitsig 
opvanggebied. Die resultate het „n nuwe assosiasie van „n regulerende variant (rs587585) wat 
stroomop van die C1QA geen gelokaliseer is, getoon. Hierdie variant het `n verhoogde 
neiging in tuberkulose pasiënte met die geassosieërde genotipe getoon. 
 
Hierdie studie het `n beduidende bydrae gemaak tot ons begrip van menslike-mikobakteriese 
gasheer-patogeen proteïen-proteïen interaksies. Hierdie resultate het die weg oopgemaak om 
die gevolge en funksie van die geïdentifiseerde ESAT-6-filamin A interaksie verder te 
ondersoek.  Dit het ook aanleiding gegee tot die identifikasie van `n genetiese assosiasie met 
tuberkulose. Om saam te vat, hierdie werk bewys die bruikbaarheid van die gis twee-hibriede 
sisteem, om potensiële proteïen-proteïen interaksies te ontdek wat die moontlikheid het om 
aanleiding te gee tot addisionele navorsingsvrae.  
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“We dance round in a ring and suppose, 
But the secret sits in the middle and knows.” 
Robert Frost  
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1 Introduction 
 
1.1 The varied lifestyles of intracellular pathogens 
 
Intracellular pathogens replicate either in the cytosol or in specialised phagosomal compartments 
to establish an infection niche. In doing so, microbes need to develop mechanisms to gain entry 
into host cells, as well as to escape the unfavorable effects of host immunity. Among the first 
lines of defense are the skin and mucosal epithelial cells of the respiratory, alimentary and 
urogenital tract. Once pathogens cross these physical barriers, the innate immune response is 
activated, to eliminate or contain infection (Kapetanovic and Cavaillon, 2007). Cellular 
components that mediate innate immunity includes epithelial cells, goblet cells, dendritic cells, 
airway macrophages, neutrophils, pneumocytes and secreted products such as antimicrobial 
peptides, inflammatory mediators, mucin and secretory immunoglobulin‘s (Sethi and Murphy, 
2008). Of these cell types, macrophages are more permissive to intracellular pathogens due to 
their inherent function of engulfing foreign particles and initiating an immune response. 
 
Macrophages, also known as professional phagocytes, regulate body homeostasis by engulfing 
necrotic and apoptotic cellular debris, in a silent non-inflammatory action, to aid in tissue 
development and maintenance. In a similar way, these cells act as alert signals for the innate 
immune response by recognising and engulfing invading pathogens and regulating activation of 
the acquired immune response (Yates et al., 2005). Beyond question, activated macrophages 
provide the most hostile niche for pathogen replication. 
 
Once inside the phagosome, pathogens need to adapt to the hostile environment but it also offers 
most micro-organisms the ability to escape humoral recognition by circulating antibodies and 
complement. Some pathogens reside in the phagosome and maintain features of either early-
endosomes or late-endosomes by diverting the endocytic pathway, normally targeted by 
lysosomal compartments (Cossart and Roy, 2010). A few pathogens, like Brucella abortus and 
Legionella pneumophila, avoid lysosomal vesicles by using an alternative route through the 
endoplasmic reticulum (ER) to disguise the phagosomal membrane as an ER membrane (Kumar 
and Valdivia, 2009).  
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A selected number of bacteria succeeds in escaping from the phagosome and replicate within the 
cytosol. This is true for Listeria monocytogenes, Shigella flexneri, Rickettsia conorii and 
Francisella tularensis. Once entry into the cytosol has been established, pathogens need to 
circumvent autophagy. Autophagy is a conserved event in which double layers of cellular 
membrane encapsulate unwanted cytosolic particles and degrade them by fusion with lysosomal 
vesicles (Cossart and Roy, 2010). In escaping autophagy, pathogens rapidly replicate, and employ 
actin polymerisation to establish intra- and inter-cellular distribution. Actin motility is employed 
by Listeria and Shigella, which hijack host protein complexes to produce actin comet tails for 
escape. These host protein complexes, which are considered uniquely for actin motility, have also 
been connected to autophagy recognition (Mostowy and Cossart, 2011).  
 
However, pathogens within the phagosome are challenged by phagolysosome fusion, which is 
designated to dispose of microbial invaders. Several intracellular pathogens like Salmonella, 
Chlamydia and Mycobacterium have developed various strategies for inhibiting phagolysosome 
fusion (Duclos and Desjardins, 2000; Deretic et al., 2006). Whether pathogens truly inhibit 
phagolysosome fusion, is open for debate, since authors suggest that it is rather a continual 
communication with the endocytic pathway delaying the event (Drecktrah et al., 2007; Pryor and 
Raines, 2010). However, it is clear that proteins and lipids involved in the regulation of lysosomal 
trafficking are targeted by secretory products of the pathogen (Pryor and Raines, 2010). 
Mycobacteria seem to be more proficient in this survival mechanism (Nguyen and Pieters, 2005).  
 
Macrophages are long-lived compared to neutrophils (which live for a much shorter lifespan and 
are also professional phagocytes) (Allen, 2003). Therefore, inhabiting macrophages provides a 
much more stable timeframe for intracellular replication. In the final step of replication and 
spread, pathogens need to be released from their replication niche in order to transmit to other 
cells. Examples of cell-to-cell spread have been observed with Listeria, malaria plasmodia and 
Toxoplasma gondii (Mounier et al., 1990; Sibley, 2004). Malaria and T. gondii strictly require 
being within host cells compared to Listeria, Mycobacterium tuberculosis, Brucella spp. and 
Salmonella enterica, which have developed the capacity to exist in the extracellular environment 
prior to entering new host cells. Microbes like these can even live in an abiotic milieu for longer 
periods of time. Despite the fact that M. tuberculosis is ultimately seen as an intracellular 
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bacterium, it flourishes in the extracellular debris of granulomas, reaching up to 10
13 
bacilli 
(Kaufmann, 2011) and can persist asymptomatically in the human host for years.  
 
1.2 Mycobacterium tuberculosis 
 
1.2.1 A brief history 
 
Robert Koch (1843-1910) had variable research interests and studied multiple organisms 
responsible for anthrax, plague, cholera, malaria, sleeping sickness and numerous animal diseases 
such as rinderpest and surra of cattle and horses. Regardless of this wide range of interests, his 
name is usually associated with the development of staining and culture methods for bacteria and 
for the isolation of the slow-growing agent of tuberculosis – Mycobacterium tuberculosis (Taylor 
et al., 2003). His work on M. tuberculosis was presented to the Physiological Society of Berlin in 
March 1882 (Ligon, 2002).  
 
A few years later, in 1895, Wilhelm Konrad Röntgen discovered X-rays and together these two 
scientific achievements were applied to clinical medicine. From 1905, doctors could start making 
a precise diagnosis by demonstrating abnormalities in a patient‘s chest radiograph and isolating 
tubercle bacilli from sputum (Murray, 2004). During the 1880s, Louis Pasteur developed a 
method to intentionally attenuate the virulence of a living microbe to generate a successful 
vaccine; the first was against fowl cholera and later against rabies and anthrax (Pasteur et al., 
2002). In 1908, Albert Calmette and Camile Guérin applied Pasteur‘s technique to generate a 
vaccine against tuberculosis. By a fortunate discovery, they learned that growth in ox bile 
diminished virulence of M. bovis and by performing 230 serial passages they isolated a single 
colony unable to cause fatal tuberculosis in a number of animals – among these were guinea pigs, 
rabbits, cows, horses, monkeys and chimpanzees (Dubos, 1986). The vaccine was called Bacille 
Bilié Calmette et Guérin, shortened to Bacille Calmette Guérin (BCG). In 1921, BCG vaccination 
was given to a number of babies and young children and by 1924 the vaccine demonstrated 
apparent protection with fewer side effects. It has been commonly observed that BCG 
immunisation is helpful in infants, providing protection against severe forms of tuberculosis, 
particularly miliary and meningeal disease (Dubos, 1986; Murray, 2004).  
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Much hope was placed on mass vaccination; but this was quickly shattered by the lack of BCG‘s 
protective effects. There has been no consensus about the usefulness of BCG vaccination, as 
BCG-induced immunity does not prevent subsequent development of infection; it only retards the 
spread (Gomes et al., 2004). Anti-tuberculous drugs was introduced in the 1940s (streptomycin) 
and 1950s (isoniazid), these and several other antibiotics were used as a clinical regimen 
(Lönnroth et al., 2009). Today, many countries document increases in multidrug resistant strains 
and in some cases now resistance to all available drugs (Velayati et al., 2009). Furthermore, no 
new drugs have been licensed since the identification of ethambutol in the 1960s (Comas and 
Gagneux, 2011). With the increasing prevalence of drug resistance and TB-human 
immunodeficiency virus (HIV) co-infections, there is an urgent need for new control strategies, 
improved diagnostics, effective drugs, shorter treatments and better vaccines (Kaufmann and 
Parida, 2007). 
 
1.2.2 TB incidence 
 
The World Health Organisation (WHO) – Global Tuberculosis Control 2011 Report – estimated 
that during 2010 there were an estimated 8.8 million incident cases (range, 8.5 – 9.2 million). The 
greatest proportion of incident cases occurred in Asia (59%) and Africa (26%), with smaller rates 
occurring in regions of the Eastern Mediterranean (7%), Europe (5%) and America (3%) (Figure 
1.1). The five countries that had the largest TB incidence in 2010 were India (range, 2.0-2.5 
million), China (range, 0.9-1.2 million), South Africa (range, 0.4-0.59 million), Indonesia (range, 
0.35-0.52 million) and Pakistan (range, 0.33-0.48 million). Of the reported 8.8 million cases in 
2010, the best fit estimate of people living with TB-HIV co-infection was 1.1 million (13%). 
Strikingly, approximately 82% of the HIV-positive individuals were from the African Region 
(Global Tuberculosis Control 2011 Report). 
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Figure 1.1: Estimated TB incidence rates, by country, in 2010 (WHO report 2011). 
 
Global TB control programs primarily focus on understanding transmission through early 
detection and effective treatment. Although control measures such as BCG vaccination and the 
WHO Directly Observed Treatment Short-Course (DOTS) strategy have been implemented, the 
rise in HIV transmission and the emergence of drug resistant phenotypes are still troublesome. 
However, since the addition of DOTS into the Stop TB strategy, the approach led to the treatment 
of 36 million patients between 1995 and 2008 and prevention of up to 8 million deaths (Ahmad, 
2011). A combination of disease surveillance and computational modeling predicts that the 1990 
targets of prevalence and mortality could be halved by 2015. The probability is, that if these 
targets are reached and maintained, the rate of disease will decrease, which will require a set of 
effective interventions that are both cost-effective and capable of producing effects on larger 
scale (Dye and Floyd, 2006). In 2005, the African Health Ministers at the 55
th
 Session of the 
WHO Regional Committee for Africa in Maputo declared tuberculosis as an ―Emergency‖, 
ensuring immediate and determined efforts to combat the disease (Chaisson and Martinson, 
2008). 
  
1.2.3 Bacteriology  
 
Tuberculosis is caused by a number of closely related Gram-positive bacilli in the genus of 
Mycobacterium, known as the Mycobacterium tuberculosis complex (MTBC). The MTBC 
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consists of a number of species and subspecies that include M. tuberculosis, M. africanum, M. 
bovis, M. canetti, M. caprae, M. microti, M. pinnipedi and recently discovered M. mungi 
(Alexander et al., 2010).  
 
M. tuberculosis is a non-motile rod shaped bacterium (Figure 1.2A). The rods are 2-4 
micrometers (µm) in length and 0.2-0.5 µm in width. M. tuberculosis is an obligate aerobe. For 
this reason, it is classically found within well-aerated upper lobes of the lungs, where it functions 
as an intracellular facultative pathogen. The tubercle bacilli has extremely slow doubling times of 
~20 hours (Todar, 2011), compared to the closely related M. marinum that doubles every ~ 4 
hours (Ramakrishnan and Falkow, 1994). As a result, M. tuberculosis can establish its niche 
within the host before recognition by host immunity. 
 
 
Figure 1.2: Microbial characteristics of M. tuberculosis – (A) Acid-fast staining of rod shaped M. tuberculosis 
recovered from glass culture tubes (Taylor et al., 2003). (B) Colonies of M. tuberculosis are rough, waxy, thick, 
wrinkled, have an irregular margin, and are faintly buff-coloured (Ojha et al., 2008). 
 
Traditionally, M. tuberculosis is grown on Lowenstein Jensen (LJ) culture media requiring 
several weeks before the bacilli can be isolated, resulting in delay of treatment. A faster result is 
nowadays obtained using Middlebrook medium or the BACTEC™ MGIT™ 960 System. 
Colonies of M. tuberculosis have an unusual, waxy coat on the cell surface that primarily consists 
of mycolic acids (Figure 1.2B) (Todar, 2011). This distinct feature highlights the large number of 
enzymes involved in lipid metabolism (Guo et al., 2010). It is also the dense lipid cell wall that 
makes the cells impermeable to gram staining, hence the use of acid fast staining techniques for 
identification (Figure 1.2A) (Misawa, 1952).  
 
The majority of the cell wall components consist of peptidoglycans and lipids. The lipid 
component primarily consists of hydrophobic mycolic acids, which are α-branched lipids and 
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makes up 50% of the dry weight of the mycobacterium (Figure 1.3). As a result, mycobacteria are 
slow growers due to the impaired entry of nutrients through the thick layer of mycolic acids, but 
it also provides resistance to cellular degradation processes within the human host (Brennan and 
Nikaido, 1995). Mycolic acids are dispersed mostly at the external portions of the cell wall, while 
the internal portions mostly consist of arabinogalactan, phosphatidyl-myo-inositol mannosides 
(PIMs) and peptidoglycans. Adjacent to the mycolic acids are other composites such as mannose-
capped lipoarabinomannan (ManLAM), the related lipomannan (LM) and mannosylated 
glycoproteins. The outer capsule and surface of the bacilli presents with mannan and 
arabinomannan caps (Torrelles and Schlesinger, 2010).  
 
 
Figure 1.3: Representation of the mycobacterial cell wall. The cell wall consists primarily of a large cell-wall 
complex that comprises of three covalently linked structures i.e. mycolic acids (green), arabinogalactan (blue) and 
peptidoglycan (grey). The mycolic acids are covalently linked and results in a hydrophobic layer of low fluidity, 
referred to as the mycomembrane (Abdallah et al., 2007).  
 
1.2.4 The course of M. tuberculosis infection 
 
The first stage of tuberculosis begins with the inhalation of M. tuberculosis containing aerosols 
into the respiratory tract. Once in the lung, the bacilli are phagocytized by alveolar macrophages 
resident in the lung airways (Cooper, 2009). During this stage, the destruction of the 
Stellenbosch University  http://scholar.sun.ac.za
   
9 
 
mycobacteria depends on the intrinsic bactericidal capacity of alveolar phagocytes and the 
virulence spectrum of the inhaled M. tuberculosis strain. During the initial infection, the bacillus 
multiplies in the lung, causing limited inflammation. Infection is established by employing 
multiple survival strategies within macrophages (Fatty et al., 2003), as well as the initial 
interactions with host cells. These survival mechanisms include triggering anti-inflammatory 
responses, blocking reactive oxygen and nitrogen production, and reducing acidification of M. 
tuberculosis-containing phagosomes (Flynn and Chan, 2001; Cooper, 2009). 
 
During the persistent phase of infection, the bacilli escape bactericidal properties and multiply, 
resulting in the destruction of alveolar macrophages. This prompts a localised inflammatory 
response that results in the supply of neighbouring mononuclear cells from blood vessels, 
providing new host cells for the bacterial growth (Russell et al., 2010). The monocytes mature 
into either antigen presenting cells, alveolar macrophages or dendritic cells. Alveolar 
macrophages ingest, but do not kill the bacteria, allowing them to effectively grow with limited 
tissue damage. T lymphocytes are activated and recruited 2-3 weeks post infection via antigen 
presenting dendritic cells travelling from the site of infection (Kleinnijenhuis et al., 2011).. The 
recruited T cells form the building blocks of the early granuloma, where macrophages become 
activated to kill intracellular M. tuberculosis (Ulrichs and Kaufmann, 2006; Sasindran and 
Torrelles, 2011). Continued activation of T cells leads to the formation of granulomas, which are 
the pathological signature of this disease, and subsequently to the emergence of cell-mediated 
immunity. This marks the latent stage of infection, where growth and spread to additional tissue 
sites are limited. The third and final stage is when latent and controlled infection is activated. The 
two main reasons for activation of disease is marked by (1) a decline in the host‘s immunity due 
to genetic, environmental or biological causes and (2) failure to maintain and develop immune 
signals, resulting in lung cavitation and development of disease (Sasindran and Torrelles, 2011). 
 
1.3 Genome of Mycobacterium tuberculosis  
 
Tuberculosis research has made great advances since the publication of the M. tuberculosis 
H37Rv genome in 1998 (Cole et al., 1998). Since then, sequences from M. bovis, M. bovis BCG, 
M. microtti, M. africanum and a large number of other strains have either been finished or are in 
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the process of completion. The genome of the laboratory strain, H37Rv, was revealed to possess a 
sequence length of 4, 411, 529 bp (Cole et al., 1998). Comparative genomics have revealed a 
number of polymorphisms across various members of the MTBC that adds to the phenotypic 
diversity observed across the various strains. Larger polymorphic regions, those greater than 0.5 
kb, have also been identified between strains and are termed regions of difference (RD loci). 
  
Mahairas and colleagues applied subtractive hybridisation to identify regions of difference that 
accounted for the avirulent phenotype observed in M. bovis BCG (Mahairas et al., 1996). Their 
studies showed three regions of difference in the genome of H37Rv that were absent from M. 
bovis BCG. Of these regions, RD3 corresponded to one (PhiRv1) of the two prophages elements 
(PhiRv1 and PhiRv2), and were found to be varied among M. tuberculosis clinical and laboratory 
strains. RD2 was only deleted from isolates of M. bovis BCG that was re-cultured from 1925. 
Lastly, and most importantly, RD1 was found to be deleted from all M. bovis BCG strains and 
were only present in the ancestral pathogenic strains, leading to the hypothesis that this deletion 
caused the attenuation of BCG. However, complementation assays with RD1 into modern BCG 
strains did not reconstitute the full virulent phenotype of M. bovis BCG (Mahairas et al., 1996).  
 
With the completion of the genome, other differences were found in BCG-duplicated regions 
(Brosch et al., 2000), and lineage specific deletions and point mutations (Behr et al., 1999) that all 
appeared to contribute to the attenuation of BCG (Brosch et al., 2007). However, many 
mechanisms are specific to M. tuberculosis, one of which is dependent on a fully functional RD1 
locus together with an effective two-component regulatory system (Frigui et al., 2008).  The RD1 
locus is situated in a cluster of genes that are part of a specialised secretion system named the 
ESX-1 secretion system (Hsu et al., 2003; Pym et al., 2003; Stanley et al., 2003; Brodin et al., 
2004; Guinn et al., 2004). The individual genes encoded by this locus have been shown by 
several groups to participate in virulence (Hsu et al., 2003; Pym et al., 2003; Sassetti and Rubin, 
2003; Stanley et al., 2003; Guinn et al., 2004). 
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Figure 1.4: Schematic representation of the genomic organisation of the five ESAT-6 gene cluster regions of M. 
tuberculosis (ESX-1 to - 5) (Gey van Pittius et al., 2001). 
 
1.3.1 ESX-1 secretion system 
 
M. tuberculosis has five specialised ESX secretion systems (ESX-1 to ESX-5, Figure 1.4), which 
have been dubbed Type VII secretion systems (Abdallah et al., 2007). The ESX systems are 
named after the first known secretion product of the ESX systems, the 6kDa early secreted 
antigenic target (ESAT-6). The trademark of these systems is that they secrete products with 
homology to ESAT-6 (Feltcher et al., 2010).  
 
The proteins associated with the ESX-1 secretion system can broadly be classified into three 
groups, namely – (1) secreted, (2) regulatory and (3) structural proteins. Combining 
computational results with those known from literature, Das and colleagues proposed a model for 
secretion of proteins through the ESX-1 secretion machinery. The model is depicted in Figure 1.5 
(Das et al., 2011). 
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Figure 1.5: Proposed model for secretion of substrates (CFP-10, ESAT-6, EspA, EspC, EspB) using Type VII 
secretion system. The various steps involved are indicated by numbers and are described below: (1) Initial activation 
by WhiB6; (2) Transcriptional regulation of the secretory proteins by Rv3866 and PhoP; (3) Multimeric assembly of 
secretory proteins by Rv3868; (4) Pairing up of secretory protein EspB with Rv3879c; (5a) Recruitment of CFP-
10/ESAT-6/EspA/EspC multimer by Rv3870 and Rv3871 to the inner membrane pore (Rv3877); (5b) Recruitment 
of EspB/Rv3879c pair by Rv3870 and Rv3871 to the inner membrane pore (Rv3877); (6) Interaction of MycP1 with 
Rv3877; (7) Inner membrane translocation of secretory proteins; (8) Cleavage of EspB by MycP1; (9) 
Mycomembrane translocation of secretory proteins. The dashed arrows show interaction between the components 
connected by the arrow (Das et al., 2011). 
 
The ESX-1 system functions to secrete effector proteins, including the 10kDa culture filtrate 
protein (CFP-10 also known as esxB) directly into the host phagosome or cytosol (Stanley et al., 
2007; Lewinsohn et al., 2006). In addition to ESAT-6 and CFP-10, four other substrates are 
secreted by the ESX-1 system: EspR, EspA, EspB and EspC (Gao et al., 2004; Fortune et al., 
2005; MacGurn et al., 2005; McLaughlin et al., 2007; Xu et al., 2007). EspR is a transcriptional 
activator that regulates the secretion of the system and are found to influence the expression of 
the espACD loci, which in turn regulates export of the ESAT-6·CFP-10 complex. The secretion 
of EspR is dependent on activation of the ESX-1 system that results in reduced expression of 
espACD genes (Blasco et al., 2011).  So, when the pathway is inactive, the cytosolic 
concentration of EspR increases, causing expression of the espACD loci (Raghavan et al., 2008). 
Stellenbosch University  http://scholar.sun.ac.za
   
13 
 
Additionally, EspA secretion is dependent on the secretion of the ESAT-6·CFP-10 complex and 
vice versa (Fortune et al., 2005).  
 
The ESX-1 locus contains two cytoplasmic AAA ATPases, EccA1 and EccCb1, that probably 
supply energy for the secretion process and are involved in targeting products for secretion 
(Stanley et al., 2003; Luthra et al., 2008). Eccb1 binds the C-terminal signal peptide of CFP-10 
and EccA1 binds the C-terminal region of EspC, these binding abilities are required for secretion 
of both the ESAT-6·CFP-10 complex and EspC (Champion et al., 2006; DiGiuseppe Champion 
et al., 2009).  
 
EccD1 is a multi-transmembrane protein that is proposed to be involved in the formation of the 
transmembrane pore for the translocation of mycobacterial proteins and virulence factors (Brodin 
et al., 2005). The integral membrane protein, EccCa1, interacts with ATPase EccCb1 (Stanley et 
al., 2003). EccB1 and EccE1 are predicted to be transmembrane proteins located in the periplasm 
of the cell wall (Krogh et al., 2001). EspD has been shown to interact with EccE1 and is required 
for the secretion of the ESAT-6·CFP-10 complex (MacGurn et al., 2005). Mycosin-1 (MycP1) is 
a transmembrane protein and is located in the cytoplasmic membrane of the cell wall. MycP1 is a 
serine protease that has been shown to cleave EspB after translocation and has been shown to be 
essential for ESX-1 secretion (Ohol et al., 2010). 
 
The ESX-1 secretion apparatus is a unique system, in that secretion of substrates is mutually 
dependent on all substrates of the system (Fortune et al., 2005; Abdallah et al., 2007) and deletion 
of any part of the system causes attenuation of the organism (Hsu et al., 2003; Stanley et al., 
2003; Guinn et al., 2004; Wards et al., 2000). 
 
1.3.2 Structural characteristics of CFP-10 and ESAT-6 
 
The open reading frames encoding for ESAT-6 and CFP-10 lie in an operon and are co-
transcribed. The protein products form a tight 1:1 complex (Renshaw et al., 2002; Lightbody et 
al., 2004). Renshaw and colleagues determined the structure of the ESAT-6·CFP-10 complex 
(Figure 1.6) and revealed that the inner core had a well-defined complex of two similar helix-
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turn-helix hairpin structures for each individual protein, which lie parallel to each other, forming 
a four helix bundle. The contact surface between CFP-10 and ESAT-6 is hydrophobic in nature 
(Renshaw et al., 2005) and the complex formation stabilises the protein, which is important for 
secretion, as CFP-10 contains a C-terminal signal peptide that targets the whole complex for 
secretion. 
 
 
Figure 1.6: Solution structure of the ESAT-6·CFP-10 protein complex. (A) A best-fit superposition of the protein 
backbone, with CFP-10 shown in red and ESAT-6 in blue. (B) A ribbon representation of the backbone topology of 
the ESAT-6·CFP-10 complex based on the converged structure closest to the mean, which illustrates the two helix–
turn–helix hairpin structures formed by the individual proteins (Renshaw et al., 2005). 
 
It has been demonstrated that once ESAT-6 and CFP-10 associate as a complex; it is the C-
terminus of CFP-10 that is responsible for the binding to host cells. This was illustrated by 
truncation of CFP-10 (residues 1-86) bound to full length ESAT-6 and full length CFP-10 bound 
to ESAT-6 with residues 1-84 being deleted. The deletion of CFP-10 residues impaired the 
binding of the complex to macrophage host cells, while the deletion of ESAT-6 showed no 
distinguishable difference when compared to the wild-type complex (Renshaw et al., 2005). 
Thermodynamic analyses revealed that binding between ESAT-6 and CFP-10 can take place 
below any melting temperature (Tm) of the complex, which is 53.4°C. An interesting observation 
was the loss of binding capacity to phospholipid membranes upon complex formation. Moreover, 
ESAT-6 adopted a more helical structure and enhanced thermal stability compare to CFP-10 or 
the complex, in the presence of phospholipid membranes. The processes that govern this 
observation and whether these features of ESAT-6 are observed on the surface of macrophages 
remain unknown. With respect to biochemical stability, the complex was found to be more 
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resistant to proteolytic cleavage by trypsin. The work presented by Meher et al., demonstrates 
overall structural change, enhanced thermodynamic and biochemical stability upon complex 
formation and highlight features involved in the physiological role of ESAT-6, CFP-10 and/or the 
complex in host cells (Meher et al., 2006). 
 
1.3.3 Role of the ESX-1 secretion system and virulence 
 
The ESX-1 secretion system is a major virulence determinant of M. tuberculosis. Described ESX-
1 effects are related to suppression of pro-inflammatory responses, necrosis, apoptosis, membrane 
lysis and cytolysis (Simeone et al., 2009). It has long been thought that ESAT-6 and CFP-10 are 
the effector molecules of the system, but additional proteins are also secreted and may serve as 
effector substrates of the ESX-1 machinery.   
 
The most documented function of ESAT-6 in literature is linked to lysis of cell membranes. It has 
been demonstrated that deletion mutants of ESAT-6 did indeed multiply in macrophages but were 
unable to spread to uninfected macrophages (Guinn et al., 2004). In addition, deletion mutants 
displayed reduced invasiveness due to the lack of cytolytic ability. The interaction of ESAT-6 and 
CFP-10 is dependent on pH and conversion to a more acidic environment leads to dissociation of 
the complex (de Jonge et al., 2007). Moreover, ESAT-6 has a greater ability to disrupt and lyse 
liposomes, whereas CFP-10 does not. Therefore, it is thought that the biological function of 
ESAT-6 is dependent on the acid environment within the phagosome (de Jonge et al., 2007). In 
contrast, Lightbody et al., demonstrated that the complex between ESAT-6 and CFP-10 showed 
no decrease in stability and appeared to be more stable at lower pH (Lightbody et al., 2008). 
These observed inconsistencies could be explained by the fact that Guinn et al., used acetylated 
ESAT-6 from culture filtrates (Guinn et al., 2004), whereas the latter study used non-acetylated 
ESAT-6 expressed from Escherichia coli (Lightbody et al., 2008). Furthermore, blot overlay 
assays demonstrated that CFP-10 primarily interacted with non-acetylated ESAT-6, with less 
binding affinity to acetylated ESAT-6 (Okkels et al., 2004). 
 
Literature suggests that M. tuberculosis remains in the phagosome, inhibiting maturation and 
phagosomal acidification, but escape from the phagosome remains to be elucidated.  Lee and 
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colleagues showed that the metabolic status of M. tuberculosis correlates with the degree of 
phagosomal maturation. They demonstrated that compartments occupying mycobacteria differ 
markedly from fully matured phagolysosomes. They showed that metabolically active M. 
tuberculosis is less fusiogenic with lysosomes than metabolically inactive M. tuberculosis. In 
addition, they also observed that 5 days post infection, 25% of M. tuberculosis was found in the 
cytosol of macrophages without phagosomal membranes (Lee et al., 2008). This confirms the 
finding of van der Wel and coworkers who proposed translocation of M. tuberculosis from the 
phagosome to the cytosol (van der Wel et al., 2007). 
 
In summary, the ESX-1 secretion system is clearly involved in pathogenicity and host-cell 
interactions, but there are still many details outstanding on the biology of these secretion systems 
and the function of the secreted products thereof. The elucidation thereof will have important 
consequences for the development of vaccines and therapeutic agents. 
 
1.3.4 Host binding partners of ESAT-6 
 
ESX-1 mediated secretion occurs early during infection before uptake into phagocytes, therefore 
secreted products can engage host receptors of alveolar macrophages and dendritic cells, as well 
as host components of the phagosome and cytosol. These interactions take place between 
secretory products of M. tuberculosis and the host cells at the primary site of infection; in order 
for infection to be established. In the following sections we discuss findings of ESAT-6 
interactions with host proteins and the role of these interactions in the host-pathogen relationship. 
 
1.3.4.1 Syntenin-1 
 
Syntenin-1 is a host protein which functions in multiple roles related to vesicular trafficking, 
cytoskeletal dynamics, protein turnover, cell adhesion and signaling pathways involved in cell 
differentiation (Bernfield et al., 1999; Lander and Selleck, 2000; Yoneda and Couchman, 2003; 
Sarkar et al., 2004). Syntenin-1 was reported to interact with CD148, a transmembrane protein 
tyrosine phosphatase (Harrod and Justement, 2002). Numerous investigators observed negative 
regulation of T cell activation by CD148, demonstrating that it might play a role in the inhibition 
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of T cell immune responses (de la Fuente-García et al., 1998; Tangye et al., 1998). Syntenin-1 
was identified to also interact with interleukin (IL)-5Rα and SRY-related HMG-box 4 (Sox4). 
The interaction of syntenin-1 with IL-5Rα was required for IL-5 mediated activation of 
transcription factor, Sox4 (Geijsen et al., 2001). This mechanism demonstrates that syntenin-1 
acts as an adaptor molecule. Consequently, authors speculated that the interaction of ESAT-6 
with syntenin-1 might contribute to the ability of M. tuberculosis to induce impairment in T cell 
activation and pro-inflammatory response, to facilitate escape from sterilising immunity 
(Schumann et al., 2006). Further validation studies are required to understand the functional role 
of ESAT-6 and syntenin-1 in the infection process. 
 
1.3.4.2 Toll-like receptor 2 
 
ESAT-6 binds directly to toll-like receptor 2 (TLR2) on the surface macrophages, leading to 
inhibition of nuclear factor (NF)-κβ and interferon regulatory factors (IRF) by inhibiting the 
ligand-mediated recruitment of interleukin-1 receptor-associated kinase 4 (IRAK4) to myeloid 
differentiation primary response gene 88 (MyD88). Pathak and coworkers provided evidence for 
a direct interaction on the extra-cytosolic side of the plasma cell membrane between TLR2 and 
ESAT-6, resulting in suppressed assembly of TLR signaling molecules inside cells required for 
efficient activation of the innate immune responses during tuberculosis infection (Pathak et al., 
2007). 
 
1.3.4.3 Phenylalanine-rich peptides 
 
Kumar and coworkers used a human lung protein library and demonstrated that peptides with a 
high presence of phenylalanine residues displayed preferential binding to ESAT-6 (Kumar et al., 
2009). None of these peptides were classified as host proteins. Further experimental data 
demonstrated that phenylalanine rich peptides (referred to as Hcl1), affected growth and 
pathogenesis of M. tuberculosis. Additionally, microarray data illustrated that these peptides 
altered regulation of mycobacterial genes and influenced growth and survival of mycobacteria 
negatively. These findings present the hypothesis that Hcl1 may function as an antimicrobial 
peptide or that it interacts with other mycobacterial protein(s) leading to the interference of 
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normal cellular processes of M. tuberculosis (Kumar et al., 2009). The binding of ESAT-6 to 
phenylalanine-rich peptides is not essential for M. tuberculosis, but presents rather as a potential 
drug-like target against the pathogen. 
 
1.3.4.4 Laminin 
 
ESAT-6 also interacts with laminin found on the surface of epithelial lungs cells (Kinhikar et al., 
2010). The alveolar epithelial surface is covered by both type 1 and type 2 pneumocytes both of 
which express laminin on their basolateral surface (Dunsmore and Rannels, 1996). In vivo work 
demonstrated an upregulation of ESAT-6 transcripts in pneumocytes, and the binding of ESAT-6 
to laminin, followed by lysis of pneumocyte membranes by either free or bacterium-bound 
ESAT-6. This scenario suggests that M. tuberculosis invades epithelial cells and that the invasive 
phenotype upregulates ESAT-6 expression, increasing the ability of M. tuberculosis to bind to 
cells expressing laminin on their surface, to facilitate dissemination by directly damaging a small 
number of alveolar cells (Kinhikar et al., 2010). 
 
1.4 Mycobacterial virulence strategies inside macrophages 
 
Normally, after uptake of foreign particles, macrophages become activated, resulting in a course 
of action aimed at killing the foreign particles. These include gradual acidification of 
phagosomes, phagosome-lysosome fusion, induction of reactive oxygen intermediates (ROI) and 
reactive nitrogen intermediates (RNI), as well as antigen presentation (Roxas and Li, 2009). 
Together these efforts ensure that the immune system functions properly and is capable of 
handling foreign particles such as parasites, bacteria and viruses. This is not always the case and 
M. tuberculosis has developed the capacity to escape natural sterilising immunity. 
 
1.4.1 Survival during phagosomal acidification 
 
Mycobacterial particles are internalised within the lung macrophage through the process of 
phagocytosis. Viable bacilli can survive and replicate inside this harmful environment, as the 
phagosomes do not completely mature into phagolysosomes (Pieters and Gatfield, 2002). In these 
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non-activated macrophages, M. tuberculosis is capable of preventing the fusion of the phagosome 
with acidic lysosomes, causing the phagosome to remain at a mild pH of ~6.2. The reduced 
acidification (or lack thereof) is due to the exclusion of the vacuolar H
+ 
-ATPase-containing 
vesicles (Stewart et al., 2005; Rohde et al., 2007). Under physiological exposure to interferon 
gamma (IFN-γ) the fusion block is relieved and macrophages fuse with lysosomes, acidifying the 
M. tuberculosis-containing compartment to a pH of ~4.5 (Schaible et al., 1998; Via et al., 1998; 
MacMicking et al., 2003). Mycobacterial survival at a low pH in activated macrophages 
demonstrates the ability of M. tuberculosis to resist acid conditions. 
 
During the early 1900s, Metchnikoff hypothesised that the lipid rich cell wall of M. tuberculosis 
serves as an important barrier against entry of protons (Metchnikoff, 1905). This observation 
(proposed more than 100 years ago) did not receive much interest. More recently, Vandal et al., 
sought to identify essential genes linked to the ability of M. tuberculosis to survive at a low pH 
(Vandal et al., 2008). In this study Vandal and colleagues screened 10 100 M. tuberculosis 
transposon mutants and identified 34 mutants (containing transposons in 21 genes) unable to 
survive at low pH. A total of 15/21 transposons represented genes involved in cell wall functions, 
such as peptidoglycan and lipoarabinomannan biosynthesis. Two acid sensitive transposon 
mutants were isolated, containing insertions in Rv2136c and Rv3671c. These two mutants were 
unable to sustain a neutral intra-bacterial pH during the acid test in vitro, as well as inside IFN-γ 
activated murine macrophages. In the same way, both mutants were severely attenuated for 
growth in mice and the bacterial load was cleared from both lung and spleen of mice during the 
chronic stage of infection (Vandal et al., 2008, 2009b, 2009a). Rv2136c encodes a putative 
bacitracin resistance protein, a homolog of Escherichia coli BacA. BacA is an undecaprenyl 
pyrophosphate phosphatase involved in peptidoglycan biosynthesis (Cole et al., 1998; El et al., 
2004). Rv3671c encodes for a membrane-associated serine protease and may protect M. 
tuberculosis against acid by modifying the bacterial cell envelope by regulating protein or lipid 
control, and/or serving in signaling pathways that may help the bacterium resist extracellular 
stress (Vandal et al., 2009a). 
 
Another cell wall component, OmpA, a pore forming protein or porin, is also important for acid 
resistance and virulence of M. tuberculosis (Raynaud et al., 2002).  A deletion mutant of OmpA 
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showed that M. tuberculosis was strongly affected by its ability to grow at reduced pH, but not 
under normal growth conditions. It was observed that the permeability of this mutant was affected 
at pH 5.5 and that uptake of serine was at a minimum (Molle et al., 2006). The data indicated that 
OmpA might function at two levels: (a) as a pore-forming protein with properties of a porin and 
(b) in enabling M. tuberculosis to respond to reduced environmental pH (Raynaud et al., 2002).  
 
The identification of acid responsive genes, as well as the change in expression profiles of 
mycobacterial transcripts or proteins, indicates that low pH triggers important signals critical for 
adaptation and survival that equips the bacterium to survive within this stress environment 
(Vandal et al., 2009a). 
 
1.4.2 Inhibition of phagosome-lysosome fusion and ―phagosomal maturation‖ 
 
The phenomenon termed phagosomal maturation arrest (PMA) was first described by Armstrong 
and Hart, demonstrating that roughly 70% of M. tuberculosis-containing  phagosomes fail to 
localise with lysosomal trackers (Armstrong and Hart, 1971).  
To accomplish this goal, mycobacteria maintain features of an early endosome. These features are 
characteristic of a neutral pH due to exclusion of the host vacuolar H
+ 
-ATPase pump and 
lysosomal markers such as CD63 and recycling of cell surface molecules (Briken, 2008). The 
phagosome containing M. tuberculosis has small Rab GTPases distinctive of early endosomes 
(Rab4, Rab5 and Rab14) but not in the case of late endosomes and lysosomes (Kyei et al., 2006). 
Additional means by which M. tuberculosis inhibits phagosomal maturation is by the retention of 
host tryptophan aspartate rich coat protein (TACO), also known as coronin-1. The recruitment of 
coronin-1 to the surface of phagosomes prevents delivery to lysosomes. M. tuberculosis infected 
mice deficient in coronin-1 were unable to inhibit phagosome-lysosomal fusion (Ferrari et al., 
1999; Jayachandran et al., 2007). 
 
Host products involved in the formation and maturation of phagosomes are known as 
phosphatidylinositol (PI) 3-kinases (Vieira et al., 2001). The glycosylated M. tuberculosis 
phosphatidylinositol mannose-capped lipoarabinomannan (ManLAM), that closely resembles the 
equivalent of the mammalian lipid form, serves as an inhibitor of PI 3-kinases. This counterpart is 
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responsible for blocking the delivery of lysosomal components from the trans-Golgi network, 
aimed at mycobacterium-containing phagosomes, by preventing the accumulation of 
phosphatidylinositol-3-phosphate (PI(3)P) (Fratti et al., 2003). The inhibitory effect of 
mycobacterial ManLAM increases cytosolic Ca
2+
 and possibly accounts for the known Ca
2+
 
block associated with phagocytosis of M. tuberculosis. Thus, the action of ManLAM prevents the 
binding of PI3 kinase hVPS34 with calmodulin that is required for downstream recruitment of 
early endosome autoantigen 1 (EEA1). EEA1, together with Syntaxin 6, is necessary for the 
delivery of lysosomal compartment from the trans-Golgi network to the phagosome. As a result, 
mycobacterial PMA is accomplished by ManLAM-mediated disruption of Ca
2+
/calmodulin-
dependent regulation of PI(3)P and EEA1 on phagosomes (Vergne et al., 2003). 
 
Numerous other mycobacterial products are involved in the inhibition of phagosomal maturation; 
these include trehalose dimycolate and sulpholipids, 28 kDA acid phosphatase (SapM) and the 
serine/threonine kinase G (PknG) (Rohde et al., 2007). Additionally, a mutant defective in the 
secretion of ESAT-6/CFP-10 during M. marinum infection of murine macrophages demonstrated 
a higher percentage of association with acidified compartments. These results suggested that 
secretion of ESAT-6/CFP-10 contributes to the arrest of phagosome maturation and promotes 
survival of mycobacteria within macrophages (Tan et al., 2006). 
 
1.4.3 Other mechanisms of survival 
 
Apart from the M. tuberculosis subversion strategies discussed above, several other mechanisms 
exist for survival of M. tuberculosis. For example, apoptosis normally leads to the killing of 
pathogens by removing the replication niche and plays a key role in the immune responses 
against M. tuberculosis. However, the bacterium has been found to inhibit cell apoptosis 
(Velmurugan et al., 2007). Induction of apoptosis exerts an anti-microbial effect and prevention 
of macrophage apoptosis appears to be a virulence strategy for M. tuberculosis (Keane et al., 
2000). Other mechanisms involve the inhibition of macrophage response to IFN-γ by 
manipulating signaling events downstream of the receptor through the 19-kDa lipoprotein 
(Pennini et al., 2006).  
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M. tuberculosis can also inhibit the expression of MHC class II on macrophages to prevent 
antigen presentation to CD4+ T cells by blocking transport and presentation of molecules, 
resulting in the inhibition of IFN-γ responses (Noss et al., 2001; Pecora et al., 2006; Gehring et 
al., 2004). Another possible virulence strategy is the exploitation of actin, as actin serves as a 
scaffolding protein of endosomes during interactions with phagosome and has been related to the 
delay of phagosomal maturation (Anes et al., 2003). 
 
1.5 Interaction of Mycobacterium tuberculosis with the macrophage 
 
The interaction of M. tuberculosis with host cells is complex and remains to be completely 
elucidated (Kleinnijenhuis et al., 2011). Various studies suggest that multiple pathways may be 
employed simultaneously during the uptake of M. tuberculosis. Host receptors which are mainly 
involved in the recognition of M. tuberculosis are summarised in Figure 1.7 and will be discussed 
briefly in the following sections.  
 
1.5.1 Complement receptors 
 
Complement receptors (CRs) are expressed on macrophages and facilitate phagocytosis of 
intracellular pathogens (Aderem and Underhill, 1999). Receptors for complement on the surface 
of macrophages include CR1, a monomeric transmembrane protein that binds complement 
components C3b and C4b. CR3 and CR4 (which are heterodimeric proteins) bind C3bi and 
glucan, leading to recognition of complement-opsonised and in some cases unopsonised 
pathogens (Ernst, 1998). M. tuberculosis activates complement via the alternative pathway, 
resulting in C3 deposition on the surface of M. tuberculosis and is initiated by the alternative 
pathway in the presence of high complement proteins. However, when these proteins decrease, 
the classical pathways play a greater role in the deposition of C3 on the surface of the 
mycobacterium via covalent linkages in the forms of C3b and C3bi (Ferguson et al., 2004).  Entry 
of M. tuberculosis via CR3 can be beneficial, resulting in prevention of macrophage activation 
(Caron and Hall, 1998). The interaction of CR3 with its active compound does not prompt a 
respiratory burst, as in the case of Fc receptors; thus leading to a less stressful event for 
successful entry. Several studies have indicated that signaling during CR3 routing suppresses IL-
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12 production by macrophages (Sutterwala et al., 1997; Karp et al., 1996; Marth and Kelsall, 
1997). This cytokine is required for the differentiation of naïve T cells into Th1-type cells, which 
is required for host defenses against invading pathogens like M. tuberculosis. 
 
Furthermore, entry of M. tuberculosis via CR3 is strictly reliant on the presence of membrane 
cholesterol at the host plasma surface (Gatfield and Pieters, 2000; Peyron et al., 2000). The 
presence of cholesterol also prevents fusion of lysosome with mycobacterial phagosome, 
ensuring intracellular survival of M. tuberculosis (Gatfield and Pieters, 2000; Jayachandran et al., 
2007). 
 
In addition, M. tuberculosis may utilise host membrane cholesterol for both carbon and energy 
during chronic stage of infected macrophages (Pandey and Sassetti, 2008). This strongly supports 
the idea that M. tuberculosis engages selective receptors, resulting in an appropriate signaling 
event advantageous to the pathogen by avoiding degradation inside the macrophages. However, 
in vitro and in vivo studies exhibited no substantial difference in the phenotype between CR3 
deficient and wild-type mice with respect to bacterial burden and pathology (Hu et al., 2000). 
Even though the evidence contradicts the role of CR3 on the course of tuberculosis infection, it is 
thought that CR4 may function as an important player in the uptake of M. tuberculosis during the 
early stages of infection. 
 
Human alveolar macrophages are reported to have more CR4 than CR1 or CR3. The effect of 
blocking CR4 with antibodies had a much greater effect on the phagocytosis of M. tuberculosis 
compared to antibodies blocking CR1 and CR3. This may correlate to the observation that CR4 
and mannose receptors are the most highly expressed receptors on the surface of alveolar 
macrophages (Sasindran and Torrelles, 2011) and participate more frequently in the phagocytosis 
of M. tuberculosis. 
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Figure 1.7: Host cell receptors involved in M. tuberculosis infection. TLR, Toll-like receptor; MR, mannose receptor; DC-SIGN, dendritic cell-specific 
intercellular adhesion molecule-3 grabbing non-integrin; CR, complement receptor; SP-A and SP-D, surfactant protein-A and -D; SpR210, 210-kDa receptor; 
MBL, mannose binding lectin; Dectin-1, dendritic cell associated C-type lectin-1; Mincle, macrophage-inducible C-type lectin/FcγR, fragment,crystallizable 
gamma receptor;  NOD-2, nucleotide binding oligomerisation domain-like receptor (Sasindran and Torrelles, 2011). 
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1.5.2 Mannose receptors 
 
The M. tuberculosis cell envelope is particularly rich in a wide variety of unique mannose-
containing biomolecules, including mannose-capped lipoarabinomannan (ManLAM), the related 
lipomannan (LM), higher-order phosphatidyl-myo-inositol mannosides (PIMs), arabinomannnan, 
mannan, and mannosylated glycoproteins (Torrelles and Schlesinger, 2010). These molecules are 
incorporated into the plasma membrane and acts as ligands on the surface of M. tuberculosis. 
Mannose-containing molecules are situated in a perfect structural position, to mediate interactions 
between the macrophage and the pathogen (Torrelles and Schlesinger, 2010). The most abundant 
mannose structure in the cell envelope is ManLAM, which is implicated as a key factor in 
virulence and immunopathogenesis (Brennan and Nikaido, 1995; Nigou et al., 2003). ManLAM 
and higher-order PIMs habour terminal mannosyl elements ideally located in such a way, that 
they interact with mannose receptors on the surface of macrophages and dendritic cells 
(Schlesinger et al., 1994). The mannose receptor has been implicated in homeostatic processes, 
such as clearance of endogenous products and cell adhesion, as well as pathogen recognition and 
antigen presentation (Taylor et al., 2005).  
 
Literature suggest that mannosylation of mycobacterial surfaces contributes to host cell 
recognition and immune responses (Horn et al., 1999). The terminal mannose caps of ManLAM 
bind to the macrophage C-type lectin mannose receptor (MR), and facilitate phagocytosis of 
mycobacteria by human macrophages (Schlesinger, 1993; Schlesinger et al., 1994). The binding 
of cell wall mannose caps induces peroxisome proliferator-activated receptor γ (PPARγ) 
expression through engagement of the mannose receptor. PPARγ is a transcriptional factor that 
regulates inflammation and is expressed in activated alveolar macrophages and macrophage-
derived foam cells. The recognition of M. tuberculosis via MR causes up regulation of PPARγ 
activity, which induces an alternative activation state of alveolar macrophages, to enhance 
intracellular survival (Rajaram et al., 2010). 
 
The recognition of PIMs by the MR has also been demonstrated by a study which showed that M. 
smegmatis strains expressing higher-order PIMs associated more with macrophage MR compared 
to wild type strains (McCarthy et al., 2005). The importance of higher-order PIMs and ManLAM 
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in M. tuberculosis infection have also been illustrated in a comparative study investigating the 
quantities of PIMs associated with virulent M. tuberculosis Erdman, virulent M. tuberculosis 
H37Rv and non-virulent M. smegmatis mc
2
155, and attenuated M. tuberculosis H37Ra (Torrelles 
et al., 2006). The results demonstrated that M. tuberculosis strains had significantly more higher-
order PIMs compared to M. smegmatis. Furthermore, the results showed that virulent M. 
tuberculosis strains had more higher-order PIMs than the attenuated M. tuberculosis H37Ra 
(Torrelles et al., 2006). In addition, virulent M. tuberculosis acquired more cell wall lipoglyco-
conjugates with α (1-2) mannosylated termini. These terminal caps resemble those of mannose N-
linked oligosaccharides of newly produced glycoproteins in eukaryotic cells. It has been shown 
that host molecules released in circulation ‗of such an order‘ are effectively scavenged by 
macrophage MR through pinocytosis to regulate homeostasis.  This may represent a form of 
exploiting structural similarities by increasing α (1-2) mannosylated units on the surface of M. 
tuberculosis to facilitates preferential engagement of the MR for survival in macrophages 
(Martinez-Pomares et al., 2001).  
 
Variation in ManLAMs, as well as PIMs, with respect to length, structure and avidity for the MR 
varies in degree between mycobacterial strains (Valdivia-Arenas et al., 2007). This leads to the 
hypothesis that host-adapted mycobacterial strains may expose heavily mannosylated ManLAM 
and greater amounts of higher-order PIMs in order to bind MR and other C-type lectins. These 
strains are found to be optimised for phagocytosis by engaging both MR and complement 
receptors. Uptake of these strains by the mannose-containing biomolecule/MR pathway provides 
a safe entry for the pathogen with minimal cytokine responses and effective trafficking of the 
bacteria. These strains grow more slowly and are more successful during the infection process, 
contributing likely to latent infection rather than active disease (Torrelles and Schlesinger, 2010). 
 
1.5.3 Surfactant receptors 
 
Airway and pulmonary macrophages are the sites where the initial inoculum of M. tuberculosis 
resides and are the first line of cellular defense. Pulmonary surfactants, which play important 
roles in innate immunity, enhance the binding of M. tuberculosis to epithelial cells or alveolar 
macrophages (Ferguson and Schlesinger, 2000). These surfactants are termed collectins, which 
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include structurally related proteins such as MBL and C1q (Vandivier et al., 2002). These 
proteins have the ability to regulate the initial interaction between M. tuberculosis and the 
macrophage.  
 
Surfactant protein (Sp)–A and –D regulate the early events of mycobacterial infection. Sp-A has 
been shown to increase binding and uptake of M. tuberculosis through direct interaction on the 
surface of macrophages, which upregulates MR activity (Ernst, 1998). Downing and colleagues 
demonstrated that HIV infected individuals had increased amounts of Sp-A in bronchoalveolar 
lavage (BAL) fluid and demonstrated enhanced attachment of M. tuberculosis to murine alveolar 
macrophages (Downing et al., 1995). When BAL fluid was depleted of Sp-A, the attachment was 
lost, and it was again restored with the addition thereof (Downing et al., 1995). Sp-A is known to 
function as an opsonin that allows for opsonisation of M. tuberculosis through recognition via its 
specific receptor, Sp-R210. The recognition of Sp-R210 leads to the secretion of anti-
inflammatory cytokines like interleukin-10 (IL-10) and transforming growth factor (TFG) - β that 
facilitates the suppression of cell-mediated immunity against M. tuberculosis (Samten et al., 
2008). It has been shown that Sp-A also up regulates the expression of macrophage MR and 
contributes to the survival of M. tuberculosis by preventing phagosome maturation. In this 
instance, Sp-A may add to the establishment of successful infection (Sasindran and Torrelles, 
2011).  
 
Sp-D, on the other hand, has been shown to block the uptake of mycobacterial strains into 
macrophages (Ferguson et al., 1999). Recent evidence suggests that Sp-D has high affinity for M. 
tuberculosis ManLAM and PIMs (Ferguson et al., 1999; Carlson et al., 2009). Opsonisation and 
aggregation of M. tuberculosis reduces phagocytosis via the action of Sp-D. Equally, 
opsonisation of M. tuberculosis via Sp-D results in increased phagosome-lysosomal fusion, 
leading to reduced intracellular growth (Ferguson et al., 2006). These observations may therefore 
link various concentrations of surfactant proteins to developmental risk of tuberculosis.  
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1.5.4 Toll-Like receptors 
 
Toll-like receptors (TLRs) are a family of pattern recognition receptors (PRRs), essential for 
immunity against a variation of intracellular pathogens (Akira et al., 2006). TLRs are expressed 
on the surface of macrophages (for example TRL2 and 4) as well as inside cell compartments (for 
example TLR8 and 9), but the most important function is on antigen presenting cells (APC) 
(Kawai and Akira, 2010). The recognition of M. tuberculosis structures by TLRs activates innate 
immunity and enhances adaptive immunity by regulating the secretion of multiple pro-
inflammatory cytokines and anti-bacterial effector molecules (Hou et al., 2008). The interactions 
of TLRs and mycobacterial components are more complex than that of other bacteria in that 
different TLRs interact with different bacterial components.  
 
TLR2 alone or as a heterodimer with either TLR1 or TLR6 have been shown to recognise 
mycobacterial cell wall glycolipids like LAM, LM, 38kDa and 19kDa mycobacterial 
glycoproteins and PIMs as triacylated (TLR2/TRL1) or diacylated (TLR2/TRL6)  lipoprotein 
structures (Thoma-Uszynski et al., 2001; Means et al., 2001; Jones et al., 2001). TLR2 is known 
to be an important regulator of the innate immune response through its mechanisms on tumour 
necrosis factor (TNF)-α production in macrophages (Underhill et al., 1999; Bafica et al., 2005). 
TLR2 is also associated with the release of IL-1β and IL-12 (Pompei et al., 2007; Kleinnijenhuis 
et al., 2009). Deletion mutants of TLR2 in mice have demonstrated defective granuloma 
formation. When challenged with high doses of bacilli, these mutants showed greatly enhanced 
susceptibility to mycobacterial infection compared wild-type mice (Reiling et al., 2002; Drennan 
et al., 2004).  
 
Heat shock proteins secreted by various M. tuberculosis species activate TLR4 (Ohashi et al., 
2000; Bulut et al., 2005). In murine models, macrophages deficient in TLR4 showed less, but not 
completely abolished production of TNFα (Li and Cherayil, 2004). In vivo murine studies have 
demonstrated conflicting results on the function of TLR4 in recognition of M. tuberculosis when 
different mouse strains were used (Reiling et al., 2002). In comparison to TLR2 mutant mice, 
TRL4 mutants showed similar susceptibility profiles when compared to wild-type mice (Reiling 
et al., 2002). In contrast, Abel and colleagues, demonstrated higher mycobacterial growth in the 
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spleen, liver and lungs as well as a low survival rate in the TLR4 mutant compared to the wild-
type mice (Abel et al., 2002).  A body of evidence therefore illustrates conflicting results with 
respect to TLR4 and M. tuberculosis. Recently, simultaneous activation of TLR2 and TLR4 
signaling pathways were shown to induce apoptosis and necrosis of macrophages in response to 
M. tuberculosis via different signaling mechanisms (Sánchez et al., 2010). Further work is 
required to understand the precise processes and to elucidate these conflicting results.  
 
TLR9 recognises unmethylated CpG (cytosine phosphate guanosine) motifs of pathogen-derived 
DNA (Hemmi et al., 2000).  Bafica and colleagues investigated the immunostimulatory effect of 
CpG islands and their recognition by TLR9 and demonstrated that mycobacterial DNA does 
indeed stimulate pro-inflammatory and Th1 responses to live M. tuberculosis in vitro and in vivo 
(Bafica et al., 2005). M. tuberculosis infected TLR9 mutant mice exhibited only minor increases 
in pulmonary bacilli and decreased survival at a low dose challenge, presenting with enhanced 
susceptibility when challenged with a high inoculum, comparable to TLR2 mutant mice (Bafica 
et al., 2005). In contrast to TLR2 mutant mice, those deficient in TLR9 did not illustrate major 
changes in granuloma formation or production of TNFα by antigen presenting cells (APC) 
(Bafica et al., 2005). Even though TLR9 and TLR2 mutant mice revealed similar changes in 
restricting growth at both low and high inoculum challenge, they displayed different immune 
responses to the pathogen in vivo (Bafica et al., 2005).  
 
TLR8 is able to identify circulating single-stranded RNA from pathogens such as RNA viruses 
(Heil et al., 2004). Davila et al., demonstrated significant increases in transcript expression during 
the acute phase of tuberculosis infection, suggesting a possible functional role of TLR8 during M. 
tuberculosis infection (Davila et al., 2008). In vivo studies revealed an increase in protein levels 
of THP-1 cells after infection with M. bovis BCG (Davila et al., 2008). To date, this was the only 
study addressing the possible role of TLR8 during M. tuberculosis infection, with ligands and 
signaling properties remaining unknown.  
 
From several lines of evidence it has become clear that TLRs communicate during the host 
defense against mycobacteria, which supports the notion that complex polygenic events involve 
Stellenbosch University  http://scholar.sun.ac.za
   
30 
 
multiple, rather than single TLR pathways during innate immunity to human infections (Bafica et 
al., 2005). 
 
1.5.5 Nucleotide-binding oligomerisation domain-like receptors 
 
Nucleotide-binding oligomerisation domain-like receptors (NLRs) are cytosolic regulators of the 
pro-inflammatory immune response and have been implicated in M. tuberculosis infection (Shi et 
al., 2003). Structurally, the C-terminal domain consists of a series of leucine repeats that 
recognise pathogen associated molecular pattern (PAMPs) leading to receptor activation of the 
molecule (Proell et al., 2008). The N-terminal region consists of an effector domain of CARD 
(caspase activation and recruitment domain) or BIR (baculovirus inhibitor of apoptosis repeat). 
The CARD regions of NLRs (NOD1 and NOD2) recruit receptor-interacting protein 2 (RIP2) via 
CARD-CARD binding, which activates recruitment of NF-κB (Dufner et al., 2006). NODs sense 
bacteria by recognising peptidoglycans in their cell wall. NOD1 recognises a diaminopimelic acid 
(Chamaillard et al., 2003) and NOD2, a muramyl dipeptide (MDP) (Girardin et al., 2003). In 
most bacteria, MDP is N-acetylated, but in mycobacteria and Actinomycetes MDP is N-
glycolylated (Adam et al., 1969). In animal studies, N-glycolyl MDP was a more potent 
stimulator of the immune response, than N-acetyl MDP (Coulombe et al., 2009).  
 
The stimulation of macrophages with the NOD2 ligand, MDP, followed by M. tuberculosis and 
BCG infection significantly increases the production of both TNF-α and IL-1β. The signaling 
cascades downstream via recognition of MDP with BCG increases the regulation of RIP2 and 
NF-κB, but the latter are decreased with M. tuberculosis, likely as a mechanism to dampen the 
innate immune response (Brooks et al., 2011). The down regulation in RIP2 and NF-κB with M. 
tuberculosis is possibly due to the lack of RD1 in BCG, which is responsible for the secretion of 
ESAT-6 and CFP-10 (Abdallah et al., 2007). These virulence factors have been shown to inhibit 
reactive oxygen species (ROS) NF-κB activation (Ganguly et al., 2008). Furthermore, in vitro 
studies using NOD2 deficient human macrophages demonstrated that NOD2 controlled the 
growth of both M. tuberculosis and BCG, whereas growth of BCG was only controlled in murine 
macrophages (Brooks et al., 2011). 
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1.5.6 Other 
 
Other receptors present on macrophages are the Fcγ receptors, which binds immunoglobulin G 
(IgG) opsonised M. tuberculosis in the presence of a specific humoral response (Maglione et al., 
2008b). Phagocytosis of M. tuberculosis and other particles via the FcγR leads to ROS activation 
and a pro-inflammatory immune response (Maglione et al., 2008a; Haberzettl et al., 2008). 
Previous studies have demonstrated that FcγR-mediated phagocytosis of IgG coated latex beads 
led to rapid phagosomal maturation, followed by acidification of the phagosomal compartment 
within 5 minutes. FcγR-mediated uptake of M. tuberculosis may be one of the pathways that are 
favoured by the host to mount an effective macrophage response before adaptive immunity is 
activated (Ernst, 1998). 
 
In addition to all these, many other proteins and receptors can facilitate the interaction between 
the macrophage and the pathogen. Scavenger receptors bind polyanionic macromolecules and 
particles, including lipopolysaccharides of gram-negative bacteria and lipoteichoic acid of gram-
positive bacteria (Krieger et al., 1993; Dunne et al., 1994). However, the role of scavenger 
receptors in the recognition of M. tuberculosis has not been extensively studied, but a few studies 
have shown involvement (Zimmerli et al., 1996; Neyrolles et al., 2006). Purified class A 
scavenger receptors bind M. tuberculosis and sulfolipids from M. tuberculosis compete with other 
ligands for binding to class A receptors (Ernst, 1998). Recently, class A receptor and macrophage 
receptor with collagenous structure (MACRO) have been involved in the binding of M. 
tuberculosis cord factor (Bowdish et al., 2009). Another receptor that recognises 
lipopolysaccharides of gram-negative and gram-positive bacteria is CD14, a phosphatidylinositol 
glycan-linked membrane protein (Pugin et al., 1994). CD14 can bind LAM of M. tuberculosis 
(Bernardo et al., 1998), while DC-SIGN, mannose binding lectin and possibly dectin-1 bind other 
motifs on mycobacterial surfaces.  
 
1.6 Systematic approach to understanding tuberculosis 
 
The course of M. tuberculosis infection is determined by mycobacterial and human genetic 
factors, the environment and their shared interactions. Given the complexity of M. tuberculosis 
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infection, a systematic approach is necessary to increase our understanding of the interplay of all 
the factors involved in this disease (Figure 1.8). The challenge of understanding M. tuberculosis 
infection at a systems biology level requires multidisciplinary data, which are used to construct 
predictive models. In order to generate such models, a clearer understanding of the biological 
mechanisms operating during host-pathogen interactions is required. In humans, susceptibility to 
tuberculosis is multifactorial, polygenic and displays population heterogeneity (Singh et al., 1983; 
Blackwell et al., 1997; Bellamy et al., 1998; Bellamy et al., 1999, 2000; Hoal-Van Helden et al., 
1999; Greenwood et al., 2000; Roth et al., 2004). Accompanying the human susceptibility profile, 
are strain-specific genetic variation that can cause different pathological signatures of this 
disease. In this section the role of strain variation of M. tuberculosis and human genetic 
susceptibility that contribute to tuberculosis, will briefly be discussed. 
 
 
Figure 1.8: Interplay of factors influencing tuberculosis disease. The host represents all genetic and immunological 
factors; M. tuberculosis represents strain variation, drug resistance and virulence strategies. The environment 
represents all factors associated with co-morbidities, nutrition, urbanisation, globalisation, socio-economics and TB 
control effects. The overlap between these factors is described as ―Systems Epidemiology‖ (Comas and Gagneux, 
2009). 
 
1.6.1 Human genetic variation and host susceptibility 
 
The role of susceptibility and adaptation to the bacterium has been equally observed in 
Qu‘Appelle Indians and illustrates the function of host genetics (Möller et al., 2010). When 
initially exposed to the bacterium, 10% of this population died due to the lack of innate resistance 
as a consequence of no previous historical exposure to the bacilli. Within 40 years more than half 
M. tuberculosis 
Environment Host 
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of the families were eliminated.  The observed reduction in annual death rate (0.2%) is proposed 
to be indicative of a strong selection against TB susceptibility genes within the population 
(Motulsky, 1989). This idea is reasonable, because Europeans also have a greater resistance to 
tuberculosis than individuals from African descent, probably due to the centuries of contact with 
tuberculosis (Dubos, 1986). A study in a nursing home in the United States demonstrated that 
individuals from African descent were twice as likely as individuals from European descent 
within the same environment to be infected with M. tuberculosis (Stead et al., 1990). It therefore 
does appear that genetic factors in certain populations contribute to disease susceptibility.  
  
Host genetic factors explain partly why some individuals within a population display varying 
vulnerability to M. tuberculosis. Among these individuals, only 10% develop clinical 
tuberculosis, while the majority of the population control M. tuberculosis effectively. A tragic 
event in 1926 supports this observation. In Lubeck (Germany), 251 infants within the first 10 
days of life were immunised by mistake with virulent M. tuberculosis (instead of BCG). The 
outcome of this event left some babies remaining unaffected (n = 47) whereas others developed 
severe clinical disease (n = 127) and some died (n = 77) (Dubos, 1986). This demonstrated that a 
wide range of responses to infection with M. tuberculosis exist within a population (Figure 1.9).  
 
 
Figure 1.9: The direction of the arrow illustrates the genetic variation across a population. Some individuals never 
become infected; others are infected and never develop disease, while others are infected and develop active clinical 
disease. 
 
Twin studies support the observed effect of host genetics on disease susceptibility. In these 
studies, disease concordance were found to be higher in monozygotic (essentially identical in 
genetic makeup) than dizygotic twins (Simonds, 1965; Comstock, 1978; Sørensen et al., 1988). 
Since monozygotic twins strongly tend to have a similar environment, it may be indicative that 
genetic factors are playing a major role in the patterns of tuberculosis development. Van der Ejik 
Never infected 
Infected 
No disease 
Infected 
Active disease 
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and colleagues reanalysed the data presented by Simonds, (1963) and Comstock, (1978) to 
reconsider the role of environmental vs. genetic factors in determining the concordance of M. 
tuberculosis infection in twin studies. Environmental factors (i.e. intensity of exposure to the 
tubercle bacilli) outweighed the importance of genetic factors (van der Eijk et al., 2007). Intensity 
of exposure was defined as sputum positivity, physical proximity between twin pairs, 
contagiousness of disease and living together. Giving the findings, the analyses did not include 
the reanalysis of genetic factors and their effect on disease concordance in twins. Furthermore, 
data demonstrates that environmental factors may play a more important role than genetic factors 
in the variability of responses to mycobacterial subunit vaccines, but that genetic factors play a 
central role in the regulation of immune response to M. tuberculosis (Newport et al., 2004). This 
observation, provided by twin studies (Simonds, 1965; Comstock, 1978; Sørensen et al., 1988), 
supports the initial assumption that host genetics contribute to tuberculosis susceptibility. 
 
Additional evidence for the involvement of genetics in host susceptibility was the discovery of 
individuals with the rare human syndrome of Mendelian susceptibility to mycobacterial disease 
(MSMD) (Altare et al., 1998). Individuals with MSMD have impaired cell-mediated immunity 
and show increase susceptibility to poorly pathogenic mycobacteria (non-tuberculous 
mycobacteria (NTM) and BCG), as well as Salmonella (Kumararatne, 2006). Mutation analyses 
reveal that these individuals contain variations in genes related to the IL-12/IL-23/IFN-γ axis 
(Casanova and Abel, 2002; Fieschi et al., 2003; Filipe-Santos et al., 2006). These individuals 
present as ideal cases for whole genome mapping of susceptibility loci in the general population.  
 
The most popular method of studying host susceptibility to tuberculosis is population-based case-
control studies, having a greater power to detect variation in genes with small rather than linkage 
studies, given an adequate sample size (Risch and Merikangas, 1996). A number of genes have 
been investigated for their involvement in TB susceptibility and are illustrated in Figure 1.10. Of 
these, HLA, NRAMP1, IFNγ, NOS2A, SP110, CCL2, MBL, CD209, VDR and TLR have been 
associated with tuberculosis, some repeatedly, whereas others demonstrated no association in 
other populations or not at all (Möller et al., 2010). Even though several genes have been 
implicated in tuberculosis susceptibility, it is necessary to remember that other genes, the 
environment and M. tuberculosis can influence the progression of disease (Möller et al., 2010).  
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Figure 1.10: Genes involved in TB susceptibility. Simplified representation of the different outcomes after M. 
tuberculosis infection and some of the genes that may be involved at the various stages of infection. HLA (human 
leukocyte antigen), NRAMP1 (natural resistance-associated macrophage protein 1), IFNγ (gamma interferon gamma), 
NOS2A (nitric oxide synthase 2), SP110 (nuclear body protein), CCL2 (chemokine (C-C motif) ligand 2), MBL 
(mannose binding lectin), CD209 (gene encoding toll-like receptor DC-SIGN), VDR (vitamin D (1,25- 
dihydroxyvitamin D3) receptor ) and TLR (toll-like receptor ) (Möller et al., 2010). 
 
1.6.2 Strain variation and the influence on host response 
 
Genetic variation in pathogenic species may influence the outcome of disease. For example, 
genes encoding for toxins in staphylococci (Scholl et al., 1989) and streptococci (Mollick et al., 
1993), the distribution of pathogenicity islands in enteric bacterial pathogens (Karaolis et al., 
1998), the naturally occurring lipid A mutants in Neisseria meningitidis that cause low activity of 
lipopolysaccharides (Fransen et al., 2009), capsular variation in Haemophilus influenza 
(Kapogiannis et al., 2005) and Streptococcus pneumonia (Brueggemann et al., 2003). In M. 
tuberculosis, genetic variation primarily evolves by deletion, duplication and insertion events, as 
Stellenbosch University  http://scholar.sun.ac.za
   
36 
 
well as single nucleotide polymorphisms (SNPs) (Nicol and Wilkinson, 2008). This sort of 
genetic variation among the global strains led to the emergence of six phylogenetically distinct 
lineages, with a strong association between lineage and geographical origin of the strain (Figure 
1.11) (Gagneux et al., 2006). 
 
 
Figure 1.11: Global phylogeography of M tuberculosis. The coloured dots indicate the dominant lineage in each 
country (Gagneux et al., 2006). 
 
Several lines of evidence suggest that particular strains of M. tuberculosis demonstrate 
differences in immunogenicity and virulence (Nicol and Wilkinson, 2008; Coscolla and Gagneux, 
2010; Kumar et al., 2010). For example, the difference in virulence of CD1551 and HN878 M. 
tuberculosis strains is linked to specific variation in their lipid cell wall (Gagneux and Small, 
2007). Lipid extracts from strain HN878 and related W/Beijing isolates preferentially induce Th2 
immunity. Whereas CDC1551 induces strong expression of proinflammatory cytokines and other 
molecules associated with macrophage activation and Th1 protective immunity (Manca et al., 
2004).  
 
Moreover, most studies on pathogenesis have focused on laboratory strains H37Rv and Erdman, 
paying little attention to clinical strains segregating more frequently in a population. Recently, 
Portevin and colleagues evaluated macrophage response to 26 M. tuberculosis clinical isolates 
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representative of the global diversity of MTBC and their ability to induce an inflammatory 
response (Figure 1.12) (Portevin et al., 2011). They demonstrated that genetically diverse strains 
of MTBC vary widely in their ability to induce an early inflammatory response during infection 
of human macrophages and that the differences can be linked to the different MTBC lineages. 
The authors found that strains belonging to the more ‗modern‘ lineage produced significantly 
more pro-inflammatory responses compared to ‗ancient‘ lineages. Although the inflammatory 
response differed widely between the various strains, the cytokine profiles demonstrated a trend 
in the conservation of responses between the eight donors (Figure 1.13). 
 
The findings presented by Portevin et al., support the model by which the more ‗modern‘ lineages 
might progress more rapidly to active disease and transmit more easily to new hosts by evading 
early immune recognition. Once this observation is confirmed, it will be consistent with the 
thought that ‗modern‘ lineages adapted under high population densities, which increased 
selection of virulence and transmission factors of M. tuberculosis (Comas and Gagneux, 2011). In 
support of this observation, a study in Gambia showed that patients infected with ‗modern‘ 
strains were more likely to progress to active disease compared to those infected with M. 
africanum, a member of the ancient lineage (de Jong et al., 2008). If this hypothesis holds true, 
the current impact of globalisation, urbanisation and population growth should impact on the 
virulence of MTBC in the future (Comas and Gagneux, 2011). 
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 Figure 1.13: MTBC isolates and their varying ability to 
induce the production of pro-inflammatory cytokines 
(Portevin et al., 2011). 
Figure 1.12: Selection of MTBC isolates representative 
of global genetic diversity (Portevin et al., 2011). 
Stellenbosch University  http://scholar.sun.ac.za
   
39 
 
1.6.3 Tuberculosis and HIV co-infection 
 
Tuberculosis and HIV co-infection is of global concern and should be addressed since the 
dynamics of epidemiology, clinical manifestation and management of both infections are 
different and more complex when present simultaneously. However, our knowledge of the 
interactive mechanism of the two pathogens in the human host has many gaps and need to be 
filled in order to address preventative measures against the two diseases. 
 
The most powerful known risk factor for the predisposition of M. tuberculosis infection and 
progression to active disease is infection with HIV (Sawant et al., 2011). The risk of reactivation 
in latent tuberculosis patients increases with 20-fold (Mofenson and Laughon, 2007). In TB 
patients, tuberculosis is the most common cause of AIDS-related death (Sterling et al., 2010). 
Therefore, tuberculosis/HIV co-infection interacts to accelerate the weakening of host immune 
responses, leading to subsequent death, if left untreated (Pawlowski et al., 2012). 
 
The reduction of CD4+ T cells is the main feature of AIDS and is an important contributor to the 
increase risk of TB reactivation in latently infected individuals and susceptibility to a TB contact 
(Geldmacher et al., 2012). Factors that facilitate the progression of tuberculosis disease in HIV 
infected individuals are the upregulation of entry receptors for M. tuberculosis on macrophages 
(Rosas-Taraco et al., 2006), the manipulation of macrophages bactericidal pathways (Spear et al., 
1990), down regulation of chemotactic receptors (Wahl et al., 1989) and a tipped Th1/Th2 
balance (Havlir and Barnes, 1999). In HIV infection, TNFα-mediated macrophage apoptotic 
response to M. tuberculosis is impaired, which facilitates bactericidal survival (Patel et al., 2007). 
 
In the light of understanding human/M. tuberculosis interactions it is important to note the 
interactions between M. tuberculosis and HIV exist. The mere presence of HIV substantially 
shifts this spectrum in favour of bacillary replication and progression to active disease. This 
highlights the urgent need to understand the interactive role of both diseases. 
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1.6.4 Complexity of interactome analysis 
 
The interaction of M. tuberculosis with the human host is an example of a balanced biological 
system (van Crevel et al., 2002) that allows for communication with various receptors, where the 
bacilli uses host macrophages for replication (Yates et al., 2005) and yet these cell structures 
remain stable in housing this deadly pathogen. Once inhaled, uptake is facilitated by multiple 
receptors (discussed in section 1.5), which are present on the cell surface of host cells. These 
initial interactions determine the subsequent fate of the bacilli (Sasindran and Torrelles, 2011). At 
the interface, cross-talk consists of numerous pathological strategies to successfully invade their 
host, to acquire nutrients, and to evade host immune defenses (Kleinnijenhuis et al., 2011); this 
introduces the existence of high level complexity that translates into dynamic interconnected 
actions. These types of strategies often involve direct protein-protein interactions and the 
formation of protein complexes. Host-pathogen protein-protein interactions (PPIs) play important 
roles in initiating infection (Kumar and Nanduri, 2010). Understanding the complex structure of 
vital PPIs during host-pathogen response can be targeted during drug treatment to relieve PPIs 
important for mycobacterial persistence (Mészáros et al., 2011). The identification of interactions 
between proteins is typically studied using traditional biochemical and genetic experiments, 
focusing only on one protein or pathway. Larger scale experiments, such as yeast-two-hybrid and 
tandem affinity purification, enable more comprehensive detection at the cost of significant false-
negative and false-positive error rates (Hart et al., 2006; Davis et al., 2007).  
 
Much remains to be learned about the vast majority of network interactions between the human 
host and mycobacterial proteins. These are fundamental areas in need of attention and could be 
addressed using approaches described by the field of systems biology, such as system-level 
snapshots of host-pathogen interactions, and have the potential to address numerous questions 
related to mycobacterial entry, escape and persistence. 
 
1.7 The present study 
1.7.1 Problem statement 
 
To date, there is considerable evidence about the mechanisms of M. tuberculosis persistence, but 
little is known about host-pathogen PPIs. M. tuberculosis is an intracellular pathogen that 
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secretes a number of virulence factors that interact with human proteins (i.e. receptors, ligands 
and cytosolic proteins) in a targeted manner to elicit a required response. Substrates of the ESX-1 
system have been shown to contribute to mycobacterial virulence. However, the biological 
function of ESX-1 substrates during host-pathogen interaction remains poorly and incompletely 
understood. 
 
The present study was designed to gain insights into the role of host-pathogen interactions and to 
identify novel proteins that may contribute to the knowledge of how M. tuberculosis secretory 
substrates, ESAT-6 and CFP-10, interact with human host proteins. The knowledge of protein-
protein interaction will prove helpful to understand (a) how M. tuberculosis evades the host 
immune response, and (b) the role of M. tuberculosis secreted virulence factors during the 
infection process. 
 
1.7.2 Hypothesis 
 
M. tuberculosis has developed various mechanisms to persist in the human host and is well 
documented in literature. However, the host-pathogen PPI‘s involved in the initiation and 
establishment of infection are poorly understood. It is therefore hypothesised that secreted 
proteins of M. tuberculosis during infection interact with host proteins in a targeted manner in 
order to elicit a pathogen required response. The focus of this study was to investigate how M. 
tuberculosis secretory substrates, ESAT-6 and CFP-10, interact with human host proteins. 
 
1.7.3 Aim  
 
The aim of the project was to investigate human/M. tuberculosis host-pathogen interactions in 
order to understand how secreted proteins of M. tuberculosis mediate their effects within the 
human host macrophage. 
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1.7.4 Objectives 
 
In this study a high-throughput yeast two-hybrid approach was employed to identify host 
interacting binding partners of secretory antigens, ESAT-6 and CFP-10 and the putative 
interactions were then verified.  
 
The objectives of this study were: 
 
a) To identify host targets of ESAT-6 and CFP-10 using the yeast two-hybrid approach 
b) To verify putative interactions 
 
Throughout the study, a third objective was identified.  
 
c) To perform genetic screens of identified putative candidate genes in a case/control setting 
to identify association with disease. 
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2 Materials and Methods 
 
All protocols were approved by the Health Research Ethics Committee of the Faculty of 
Medicine and Health Sciences, Stellenbosch University (project number 2003/151/N). 
 
2.1 Strains, plasmids and cell lines 
2.1.1 Bacterial strains 
2.1.1.1 M. tuberculosis strain 
 
Genomic DNA from M. tuberculosis H37Rv reference strain, kindly provided by Prof RM 
Warren, University of Stellenbosch, South Africa, was extracted as described previously (Warren 
et al., 2006). The isolated genomic DNA was used to generate PCR inserts of mycobacterial gene 
products (section 2.4.1). 
 
2.1.1.2 Escherichia coli XL-1 blue 
 
E. coli XL-1 blue strains were obtained as a kind gift from Prof NC Gey van Pittius, University of 
Stellenbosch, South Africa. E. coli strain was grown in Luria-Bertani (LB, 1% tryptone, 0.5% 
yeast extract, 1% NaCl, pH 7.0) liquid media or agar plates at 37C. LB was supplemented with 
either 50 g/mL kanamycin or 100 g/mL ampicillin depending on the type of transformed 
plasmid (see Appendix 1A for culturing conditions).  
 
2.1.2 Saccharomyces cerevisiae strains 
 
S. cerevisiae strains Y187 and AH109 were supplied with the MATCHMAKER Two-Hybrid 
System 3 (Clontech Laboratories Inc., Palo Alto, CA). The pGBKT7 bait constructs were 
transformed into Y187 strains, while the cDNA library was transformed into AH109. The yeast 
strains were grown at 30°C in yeast peptone dextrose adenine (YPDA: 2% 1% yeast extract, 
Difco bacto-peptone, 2% dextrose or glucose, 0.003% adenine hemisulfate) or synthetic dropout 
(SD: 2% glucose, 0.007% yeast nitrogen base) liquid media or on agar plates. Selection in yeast 
was performed using amino acid dropout mixtures according to manufacturer‘s recommendation 
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(e.g. LEU
-
 dropout lacks leucine and is encoded by the LEU2 gene of pGADT7) (see Appendix 
1B for culturing conditions). 
 
2.1.3 Plasmids 
 
The plasmids used in this study are summarised in Table 2.1, with a short description, outlining 
the specific use of each vector (see Appendix 2 for vector maps). The experimental procedure 
will be discussed in the sections that follow.  
 
Table 2.1: Plasmids used in this study 
Vector Description Source 
pGemT easy For cloning of PCR products; confers ampicillin resistance. Promega 
pGBKT7 Expresses proteins fused to amino acids 1-147 of the GAL4 DNA binding 
domain (BD); carries kanamycin resistance for selection in E. coli and 
TRP1 nutritional maker for selection in yeast; serves as bait construct in the 
traditional yeast two-hybrid (Y2H) assay. 
Clontech 
pGADT7-Rec Expresses proteins fused to the GAL4 activation domain (AD); carries 
ampicillin resistance for selection in E. coli and LEU2 nutritional marker 
for selection in yeast; engineered for the construction of GAL4/cDNA 
libraries by homologous recombination in yeast; serves as ‗preys‘ in the 
traditional Y2H screen. 
Clontech 
pGADT7-SV40 Expresses the SV40 large-T antigen in yeast; serves as a positive control; 
interacts with murine p53 
Clontech 
pGBKT7-p53 Expresses murine  p53 in yeast; serves as a positive control; interacts with 
SV40  
Clontech 
pGBKT7-Lam Expresses the human laminin C in yeast; serves as a negative control. Clontech 
 
2.1.4 Human cell lines 
 
Immortalised human monocytic leukemia (THP-1) and T lymphocyte (Jurkat) cell lines (kindly 
provided by Dr. Katharina Ronacher-Mansvelt, University of Stellenbosch, South Africa) were 
used to verify the results obtained from the Y2H screening. These verification analyses were 
performed using in vivo co-localisation (section 2.15) and co-immunoprecipitation (section 2.16). 
Cell lines were incubated in a 37°C, 5% CO2 incubator (Farma International, Miami, Florida) in 
Roswell Park Memorial Institute formulation (RPMI) 1640 media (Sigma, St. Louis, MO) 
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supplemented with 10% heat inactivated fetal bovine serum (HI-FBS) (GIBCO Laboratories, 
Grand Island, NY) and 1% penicillin-streptomycin (pen-strep) solution (Sigma, St. Louis, MO) 
(see Appendix 3 for general tissue culture conditions). 
 
2.2 Generation of competent cells 
2.2.1 Electro-competent E. coli XL-1 cells 
 
A glycerol stock culture of E. coli XL-1 was thawed and inoculated into 50 ml LB media 
containing tetracycline (10 µL/mL) and incubated overnight in a 37°C shaking incubator at 3000 
rpm for a starter culture. Following incubation, 250 mL pre-warmed LB media containing 
tetracycline was inoculated with 1/100 of the starter culture. The 250 mL culture was incubated at 
37°C for 3 – 4 hours with shaking until OD600 of 0.7 was reached. Harvesting and washing of 
cells were performed with ice cold 10% glycerol solution. The cell pellet was re-suspended in 2 
mL 10% glycerol. Aliquots (100 µL per tube) were frozen in a liquid nitrogen bath and stored at -
80°C until further use (see Appendix 4A for a detailed protocol). 
 
2.2.2 Chemically competent yeast cells 
 
A small amount of frozen cells (AH109 or Y187) were scraped from the stock cultures and 
inoculated with a sterile loop onto YPDA agar plates. The plates were incubated facing down at 
30°C until colonies appeared (~3 days). A single isolated colony was re-streaked on selection 
media lacking essential amino acids. A stock plate was prepared by re-streaking the isolated 
colony on an YPDA agar plate. The verified stock plate was used to propagate competent yeast 
cells, displaying the expected phenotypes (section 2.13.1). Following verification of yeast 
phenotypes, an isolated colony was inoculated in YPDA media and incubated at 30°C until an 
OD600 of 0.4 – 0.5 was reached. The yeast cells were washed with sterile deionised H2O and re-
suspended in a final solution of 1.1X TE/LiAc (Lithium acetate). The competent cells were used 
directly following preparation (see Appendix 4B for a detailed protocol).  
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2.3 Polymerase Chain Reaction (PCR) 
2.3.1 Primer design 
 
Primers were designed according to the sequences published on Tuberculist for M. tuberculosis 
genes (http://genolist.pasteur.fr/TubercuList/) and NCBI for human genes 
(http://www.ncbi.nlm.nih.gov/). The primer sequences were analysed for self-complementarity, 
primer-primer complimentary and melting temperature compatibility using IDT Oligonucleotide 
Tools online service (http://eu.idtdna.com/analyzer/Applications/OligoAnalyzer/).  The primers 
were synthesised according to the standard protocol by Whitehead Scientific (Pty.) Ltd. 
 
2.3.2 Generation of PCR inserts 
 
PCR amplification of the full-length ESAT-6 and CFP-10 genes from M. tuberculosis H37Rv 
was performed with primer sets listed in Table 2.2. The generated PCR fragments were 
subsequently used for TA cloning into the cloning vector pGemT-easy, followed by sub-cloning 
into the pGBKT7 bait vector (Table 2.1). Enzyme restriction sites are underlined in Table 2.2.  
 
2.4 PCR amplification 
2.4.1 Amplification of insert fragments 
 
All PCR reactions were performed in a total volume of 50 µL containing 1 µL of genomic DNA, 
20 pmol of each primer set (listed in Table 2.2), 2.5 mM of each dATP, dCTP, dTTP and dGTP 
(Promega, Madison WI, USA), 5 µL of 10X PCR buffer, 4 µL of 25 mM MgCl2, 10 µL of 5X Q-
solution and 0.2 µL of HotStar Taq Polymerase (Qiagen, Hilden, Germany) and sterile dH2O to a 
final volume of 50 µL. Parameters for cycling included: initial denaturing 95°C  for 15 min, 35 
cycles of 95°C for 30 sec; Tm according to Table 2.2 for 30 sec; and 72°C for 1 min, a final 
extension step of 72°C  for 10 min were performed using a GeneAmp® PCR System 2720 
thermal cycler (Applied Biosystems, Forster City, CA, USA). The PCR products were stored at -
20°C until further use. 
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Table 2.2: Primers used in this study. Primer pairs for  
NA - T7 and Sp6 were only used for sequencing reaction. 
(1) ESAT-6 and CFP-10 were used to generate PCR fragments for plasmid cloning, (2) FLNA were used to amplify the promoter 
region of FLNA gene (1kb from ATG start site), followed by sequence analysis, (3) pGBKT7, pGADT7, and T9 and Sp6 
(specific for pGemT constructs) were used to verify recombinant vectors using either PCR or sequence analysis to test conformity 
by bidirectional sequencing. Enzyme restriction sites are underlined: GAATTC-EcoRI and CTGCAG-PstI. 
 
2.4.2 Colony PCR 
 
Colony PCR amplification was done to select for recombinant plasmids, which were 
subsequently subjected to restriction enzyme digestion to verify successful cloning. PCR 
reactions for both bacterial and yeast colony PCR was performed as described in section 2.4.1, 
with the genomic DNA being replaced with a toothpick amount of bacterial or yeast cells.  
 
2.4.3 cDNA amplification 
 
Lung messenger RNA (mRNA) (cat# 636105, Clontech Laboratories Inc., Palo Alto, CA) was 
purchased from Clontech Laboratories and was copied into double stranded (ds) cDNA using 
Clontech BD SMART (Switching Mechanism at 5' end of RNA Transcript) technology (Clontech 
Laboratories Inc., Palo Alto, CA). During the first strand synthesis, cDNA was generated by 
converting mRNA into single strand cDNA using an oligo (dT) CDS III Primer (5'-ATT CTA 
GAG GCC GAG GCG GCC GAC ATG-d(T)30VN-3' [N = A, G, C, or T; V = A, G, or C]). As 
amplification reached the 5'-terminus, the enzyme terminal transferase activity added a stretch of 
Gene  Primer Sequence [5’-3’] Tm (°C) Ta (°C) bp Used for 
Sequencing 
ESAT-6  F: GAATTCATGACAGAGCAGCAGTGGAAT 
R: CTGCAGATCCCGTGTTTCGCTATTCT 
45 
47 
 
54 
 
339 
 
No 
CFP-10  F: GAATTCATGGCAGAGATGAAGACCGAT 
R: CTGCAGTGACATTTCCCTGGATTGC 
59 
60 
 
60 
 
414 
 
No 
FLNA F: CTGACAAGTCTTATGGGAACC 
R: CCGAGAGTGGGAGCTACTCAT 
53 
58 
 
55 
 
1181 
 
Yes 
Vector Primer Sequence [5’-3’] Tm (°C) Ta (°C)   
pGBKT7  F: TCATCGGAAGAGAGTAGT 
R: GTCACTTTAAAATTTGTATAC 
49 
42 
 
50 
  
Yes 
pGADT7  F: CTATTCGATGATGAAGATACCCCACCAAACCC 
R: GTGAACTTGCGGGGTTTTTCAGTATCTACGAT 
61 
61 
 
61 
  
Yes 
T7 
Sp6 
F:  TAATACGACTCACTATAGGG 
R:  GATTTAGGTGACACTATAG 
 
NA 
 
NA 
  
Yes 
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deoxycytidine to the 3' end of the cDNA. Thereafter, the SMART III
TM
 Oligonucleotide primer 
was added (5'- AAG CAG TGG TAT CAA CGC AGA GTG GCC ATT ATG GCC GGG -3'), 
which base-paired with the deoxycytidine stretch, creating an extended template. The CDS III 
and SMART III anchors served as priming sites for the universal sense (5'- TTC CAC CCA AGC 
AGT GGT ATC AAC GCA GAG TGG -3') and anti-sense (5'-GTA TCG ATG CCC ACC CTC 
TAG AGG CCG AGG CGG CCG ACA -3') primers during Long Distance PCR (LD-PCR). 
After amplification, the ds cDNA was purified with a BD CHROMS SPIN
TM 
TE-400 column, 
following the manufacturer‘s directions (Clontech Laboratories Inc., Palo Alto, CA) (see 
Appendix 5 for a detailed protocol). 
 
2.5 Agarose gel electrophoresis 
 
All products generated by PCR amplification and restriction enzyme analyses (with EcoRI and 
PstI) were subjected to electrophoresis as follows: 5 µL of product was mixed with 5 µL of 
loading buffer (Fermentas, Burlington, Canada). Each sample was loaded on 1% w/v agarose gel 
containing 250 ng/mL ethidium bromide immersed in 1X TRIS-acetate-EDTA (TAE) buffer and 
electrophoresed at 100 volts for 1 hour (Appendix 6). A 100bp marker (Promega, Madison WI, 
USA) was loaded together with amplified products to determine the relative product sizes. The 
DNA fragments were visualised on a G:BOX Gel Documentation System (Syngene, Cambridge, 
UK). 
 
2.6 Automated DNA sequencing and analysis 
2.6.1 DNA sequencing 
 
Bidirectional automated DNA sequencing of PCR products and cloned inserts were performed at 
the Central Analytical Facility (CAF) of the University of Stellenbosch on the ABI Prism
TM 
3100 
Automated Sequencer (Applied Biosystems, Forester City, CA, USA). The primers used for 
sequencing reactions were identical to the initial PCR primers (i.e. FLNA), while specific primers 
for pGemT-easy (T9 and Sp6), pGBKT7 and pGADT7 were used to test the sequence conformity 
by bidirectional sequencing (Table 2.2).  The concentration of primers in the sequencing reaction 
was 1.1 pmol/µL and the reaction volume was 5 µL. Table 2.3 lists required concentration of 
starting material.  
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Table 2.3: Starting product size and required concentration for sequencing reactions 
Product Concentration required 
< 500 bp 5 ng/µL 
500 – 1000 bp 20 ng/µL 
> 1000 bp 20 ng/µL 
Plasmid DNA 100 ng/µL 
 
2.6.2 Analysis of DNA fragments 
 
Sequence analysis was done using the biological sequence alignment editor (BioEdit) version 
7.0.5.3 (Sanchez-Villeda et al., 2008), to verify whether the sequence integrity of bait constructs, 
as well the interacting prey clone inserts identified during the Y2H screening, were intact and in-
frame. 
 
The nucleotide sequences of mycobacterial bait constructs were compared to the reference 
sequences obtained from Tuberculist (http://genolist.pasteur.fr/TubercuList/). The prey inserts 
were translated in the frame preceding the GAL4 AD reading frame. The identity of individual 
Y2H prey sequences was determined using the BLASTN and BLASTP programs 
(http://www.ncbi.nlm.nih.gov/BLAST/) to screen the GenBank database 
(www.ncbi.nlm.nih.gov/genbank/). 
  
 
2.7 Generation of constructs 
2.7.1 pGemT-easy cloning 
 
PCR products were separated on a 1% TAE agarose gel as discussed in section 2.5. The PCR 
bands of the appropriate size were excised from agarose gel and was purified using the Wizard ® 
SV Gel and PCR clean-Up system (Promega Corp. Madison Wisconsin, USA) (Appendix 7). 
After purification, the concentration of the PCR products was quantified on the Nanodrop ND-
1000 spectrophotometer (Labtech, UK). Ligation reactions were performed using the pGem T-
easy cloning kit from Promega as per manufacturer‘s instructions: 5 µL of the 2X ligation buffer, 
1 µL of pGem T-easy, 1 µL of T4 ligase and 3 µL of purified PCR product. The ligation reactions 
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were carried out overnight at 4°C and transformed into electro-competent XL-1Blue E.coli cells 
as described in section 2.8.1 (see Appendix 8 for a detailed outline of section 2.7, as well as 
additional bait constructs made during this study).   
 
The E.coli transformation mixture was plated on LB plates containing 100 µg/mL ampicillin with 
100 µL of 0.1 M IPTG (Invitrogen, Carlsbad, CA, USA) and 100 µL of 20mg/mL X-gal (Roche, 
Germany) to enable blue/white colony selection. The plates were incubated at 37°C overnight. 
Isolated white colonies were verified by colony PCR (section 2.4.2) and the appropriate glycerol 
stocks cultures were made of all constructed plasmids. Sequence confirmed pGem-ESAT-6 and 
pGem-CFP-10 colonies were inoculated into 10 mL LB/Amp liquid medium and incubated 
overnight in a 37°C shaking incubator. 
 
2.7.2 Restriction digest 
 
Plasmid DNA was isolated from the overnight 10mL cultures of both pGem-ESAT-6 and pGem-
CFP-10 constructs using the Wizard
TM
 SV plus miniprep DNA purification system (section 2.9.1) 
(Promega Corp. Madison Wisconsin, USA) (Appendix 7). The isolated plasmid DNA of pGem-
ESAT-6 and pGem-CFP-10 were digested with EcoRI and PstI, as well as the sub-cloning vector 
pGBKT7. The enzyme restriction reactions were set up as follows: 8 µL of plasmid (i.e. pGem-
ESAT-6, pGem-CFP-10 and pGBKT7) was mixed with 1 µL of EcoRI (5 units/µL) and 
appropriate 1X restriction buffer. The reaction mixtures were incubated for 3 hours at 37°C. After 
digestion, the reaction mixtures were electrophoresed on a 1% w/v agarose gel containing 250 
ng/mL ethidium bromide immersed in 1X TAE buffer. The EcoRI digested pGBKT7 and pGem 
plasmids were excised from the agarose gel and column purified using the Wizard
TM
 SV Gel and 
PCR kit (Promega Corp. Madison Wisconsin, USA) (Appendix 7).  
 
The samples were subsequently eluted in 25 µL dH2O resulting in a residual volume of 15 µL, 
which was mixed with 2 µL PstI and 2 µL appropriate 1X restriction buffer. The reaction 
mixtures were incubated for 3 hours at 37°C. After digestion, the reaction mixtures were 
electrophoresed on a 1% agarose gel, excised from the gel and column purified using the 
Wizard
TM
 SV gel kit (Promega Corp. Madison Wisconsin, USA). To prevent self-ligation, the 
vector was treated with shrimp alkaline phosphatase (SAP) (section 2.7.3).  
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2.7.3 Shrimp alkaline phosphatase treatment 
 
The ends of the linearised construct were treated with SAP to catalyse the dephosphorylation of 
5‘ phosphatase from DNA after the final restriction enzyme digestion step. The reaction was set 
up as follows: 19 µL linearised vector, 1 µL SAP (Roche, Mannheim, Germany), 3 µL of 10X 
buffer and 7 µL dH2O. The reaction mixture was incubated at 37°C for 10 min and inactivated at 
65°C for 15 min, followed by purification using the Wizard
TM
 SV Gel and PCR kit as described 
above (Promega Corp. Madison Wisconsin, USA). 
 
2.7.4 DNA ligation 
 
The DNA ligation reactions were set up in 10 µL reaction volumes as follows: 1 µL T4 DNA 
ligase (Promega Corp. Madison Wisconsin, USA), 1 µL 10X ligase buffer and dH2O to a final 
volume. The amount of double digested vector and insert was determined by the equation below. 
 
         
                 
   kb size of insert   
 
 
                       
 
The reaction was then incubated overnight at 4°C. Following incubation, 2 µL of the ligation mix 
was transformed into electro-competent E. coli XL-1 stains, which was plated onto LB agar 
plates containing the appropriate antibiotics. After incubation, colony PCR (section 2.4.2) was 
performed to verify whether the colony forming units contained the inserts corresponding to both 
ESAT-6 and CFP-10. 
 
2.8 Plasmid transformation 
2.8.1 Bacterial plasmid transformation 
 
Electro-competent XL-1 E. coli cells were thawed on ice and 45 µL of the cells were added to 2 
µL of overnight ligation reaction. The mixture was transferred to a 1mm electroporation cuvette 
(BioRad), taking care to avoid the introduction of air bubbles. Electroporation was performed at 
2.5 kV, 25 µF, 125 µFd and 200 Ω using the MicroPulserTM electroporator (Bio-Rad laboratories, 
Hercules, CA, USA). The electroporated mixture was re-suspended into 1 mL SOC medium (2% 
tryptone, 0.5% yeast extract, 0.05% NaCI, 20% glucose and 0.01% MgCl2) and incubated at 
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37°C with shaking for 1 hour. The E. coli transformation mixture (50 – 100 μL) was plated on 
LB plates with appropriate antibiotics and incubated at 37°C overnight. Isolated colonies were 
verified by colony PCR (section 2.4.2) and glycerol stock cultures were made of all constructed 
plasmids. 
 
2.8.2 Yeast plasmid transformation 
 
Yeast transformation was performed by the standard LiAc method (Gietz and Woods, 2005). 
Briefly, a single colony (<2 mm) was inoculated in 10 mL SD medium lacking tryptophan (Trp
-
) 
and leucine (Leu
-
). The culture was incubated at 30°C overnight with shaking at 250 rpm. The 
following day, the culture was spin down, re-suspended in YPDA rich medium and incubated for 
5 hours at 30°C with shaking. The cells were collected by centrifugation at 3000 rpm for 5 min 
and the appropriate amount of yeast cells (~20-50 µL) were re-suspended in 1 mL sterile dH2O. 
The supernatant was removed and re-suspended in 1 mL 100mM LiAc solution. The cell mixture 
was incubated at 30°C for 5 min with gentle shaking and again centrifuged at 3000 rpm for 5 
minutes. The excess amount of LiAc was removed by pelleting the cells at 10 000 rpm for 20 sec. 
The following layers were added to the yeast pellet in order: 240 µL 50% PEG, 36 µL 1M LiAc, 
25 µL 2mg/mL Herring testes carrier DNA, 10 – 20 µL of purified bait/prey vector (100 ng – 5 
µg) and sterile dH2O up to a volume of 50 µL. The transformation complex was mixed for 1 
minute and incubated in a 42°C water bath for 30 min. The transformed yeast suspension was 
plated on SD plates lacking the appropriate nutritional marker (see Appendix 9 for a detailed 
protocol). 
 
2.9 Plasmid purification methods 
2.9.1 Bacterial plasmid purification 
 
Colonies confirmed by PCR to contain the correct recombinant plasmid were inoculated in 10 
mL LB medium with appropriate antibiotics and incubated overnight at 37°C with shaking. The 
recombinant plasmid was isolated from 10 mL cultures using the Wizard ® SV plus miniprep 
DNA purification system (Promega, Madison WI, USA) (see Appendix 7 for a detailed protocol). 
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2.9.2 Yeast plasmid purification 
 
Yeast cultures (10 mL) were pelleted at 10 000 rpm for 1 min and re-suspended in 200 µL of 
lysis buffer [3ml of 1 M sorbitol, 100 mM NaPO4, 60 mM EDTA and 10 mg lyticase (Sigma, St. 
Louis, MO)] and incubated at 30°C overnight. After the first cell wall digest, the yeast cells were 
pelleted and plasmid isolation was performed using the Wizard ® SV plus miniprep DNA 
purification system (section 2.9.1) (Promega, Madison WI, USA) (see Appendix 7 for a detailed 
protocol). 
 
2.10 Tissue culturing human cell lines 
2.10.1 Culturing from frozen stocks 
 
Frozen cell cultures were kept at -80°C for two days, followed by transfer to liquid nitrogen for 
long term storage. Cell cultures were rapidly defrosted in a water bath at 37°C for 10 min. The 
vial was sterilised with 70% ethanol and the defrosted cells were quickly re-suspended in 10 mL 
RPMI 1640 supplemented with 20% HI-FBS to dilute the DMSO. The cells were pelleted at 1000 
rpm at 21°C for 5 minutes and re-suspended in 10 mL RPMI 1640 supplemented with 20% HI-
FBS and 1% pen-strep. The 25 cm
2
 culture flask containing cells were grown in a 37°C, 5% CO2 
incubator and checked every day. 
 
2.10.2 Splitting the cell culture 
 
Cell cultures were split every 2-4 days when they reached 80% density. The cells were 
transferred to 50 mL falcon tubes (Greiner) and pelleted at 1000 rpm at 21°C for 5 min. The cells 
were then re-suspended in 20 mL RPMI 1640 supplemented with 10% HI-FBS and 1% pen-strep 
solution and transferred to a 75 cm
2
 culture flask. The tissue culture cells were grown in a 37°C, 
5% CO2 incubator and checked every day 
 
2.10.3 Differentiation of THP-1 cells 
 
THP-1 was differentiated using phorbol 12-myristate 13-acetate (PMA) (Sigma, St. Louis, MO) 
at a final concentration of 100 nM for 48 hours. The 100µM PMA stock was prepared by 
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dissolving 1 mg in 16.2 mL of 99.98% ethanol (Sigma, St. Louis, MO). PMA treatment 
stimulates Protein Kinase C which triggers THP-1 cells to differentiate into a macrophage like 
morphology. The cells become adherent, phagocytic and stop dividing. 
 
2.10.4 Generating stock cultures 
 
THP-1 and Jurkat cells were kept in a 37°C, 5% CO2 incubator until the required cell density was 
reached. The flasks were pooled in 50 mL Falcon tubes (Greiner) and pipetted up-and-down to 
detach cells from another. The cells were pelleted at 1000 rpm at 21°C for 5 minutes, followed by 
removal of supernatant. The pellet was re-suspended in 1.5 mL fetal bovine serum and placed at 
4°C for 5 min. Thereafter, RPMI 1640 containing 20% DMSO was added and 1 mL aliquots was 
stored at -80°C in liquid nitrogen for long term storage. 
 
2.11 In vivo treatments 
2.11.1 Etoposide-induced apoptosis  
 
Differentiated THP-1 or Jurkat (1 X 10
6
 cells/mL) cells in RPMI 1640 supplemented with 10% 
HI-FBS were incubated with etoposide (100 µg/mL) (Sigma, St. Louis, MO) for 6 hours at 37°C. 
Induction of apoptosis was established by binding of CaspACE FITC-VAD-fmk (section 2.14.1) 
(Promega Corp. Madison Wisconsin, USA). 
 
2.12 Protein transfection 
 
Human Jurkat cells were cultured in RPMI 1640 (Invitrogen, Carlsbad, CA) supplemented with 
10% fetal bovine serum (Gibco), 1% penicillin-streptomycin solution (Sigma, St. Louis, MO) and 
incubated at 37°C with 5% C02. Pro-Ject protein transfection reagent was purchased from 
Thermo Scientific to effectively deliver recombinant mycobacterial proteins into cultured cells 
(Thermo Fisher Scientific, Rockford, IL). This experimental method was included to overcome 
the limitations of using a mammalian expression vector to express mycobacterial proteins.  
 
Briefly, 5 µg of either recombinant ESAT-6 or CFP-10 was diluted in PBS and was used to re-
hydrate the dried Pro-Ject film. Cells in suspension were counted (5   105 cells/mL), centrifuged 
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at 1200 rpm for 5 minutes and seeded in 900 µL RPMI free medium and 100 µL Pro-Ject 
hydration volumes. The transfection mix together with 5   105 cells/mL were then transferred to 
a 6-well plate and incubated for 4 hours at 37°C with 5% C02. After the incubation step, the 
reaction mixture was supplemented with 1 mL RPMI containing 20% fetal bovine serum. The 
transfection mixture was incubated overnight at 37°C with 5% C02. After protein transfection, 
cell lysates (section 2.16.2) and membrane protein extraction (section 2.16.3) was performed. 
 
2.13 Evaluation of yeast strains and constructs 
2.13.1 Phenotypic assessment of yeast strains 
 
Before AH109 and Y187 were used in the Y2H analysis, the phenotypes were first assessed. 
Both yeast strains have defects in genes vital for the production of adenine, leucine, histidine and 
tryptophan, with neither having a deficiency in uracil production. As a result, these nutritional 
phenotypes were assessable by plating AH109 and Y187 on selection plates based on the 
nutritional requirements shown in the Table 2.4 (see Appendix 4B for a detailed protocol). 
 
  Table 2.4: Nutritional requirements for AH109 and Y187 
Strain SD Ade
- 
SD Trp
-
 SD Leu
-
 SD His
-
 SD Ura
-
 YPDA 
AH109 - + - - + + 
Y187 - - - - + + 
 
A single isolated colony from the verified working stock plate (YPDA) was propagated only if 
AH109 and Y187 displayed expected phenotypes. The verified working stock plates were sealed 
and stored at 4°C, until further use. 
 
2.13.2 Testing the DNA-BD construct for transcriptional activation 
 
Small scale transformation of pGBKT7-ESAT-6 and pGBKT7-CFP-10 were transformed into the 
Y187 yeast strains (section 2.8.2).  The bait constructs were tested for transcriptional activation 
of ADE2 and HIS3 reporter genes by plating the transformed yeast strains on agar plates lacking 
essential amino acids: SD Trp
-
/His
-
 and SD Trp
-
/Ade
-
.  
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2.13.3 Toxicity test of transformed yeast strains 
 
To test whether the DNA-BD constructs had any toxic effect on yeast strains, growth rates in 
liquid culture of yeast strains transformed with the ‗empty‘ DNA-BD vector and those containing 
the bait plasmid were compared. The growth curves were generated by inoculating one colony 
representing the appropriate bait plasmid into 50 mL SD Trp
-
 supplemented with 20 µg/mL 
kanamycin. The culture was incubated at 37°C with shaking (250-270 rpm) and measured every 
2 hours for 8 hours, followed by incubation overnight. The measure OD600 was used to generate a 
linearised graph, comparing the slope of bait plasmids versus ‗empty‘ plasmids. 
  
2.14 Yeast two-hybrid analysis 
2.14.1 Principles of the yeast two-hybrid (Y2H) technique 
 
The yeast two-hybrid assay uses two separate domains, a sequence specific DNA binding domain 
(DNA-BD) and a transcription activation domain (AD). The known insert of interest is fused to 
the DNA-BD, known at the ‗bait‘ and the interacting partner library is expressed as fusions to the 
AD, known as ‗prey‘ peptides. If the prey and bait interact, the DNA-BD and AD are combined, 
activating transcription from the GAL4 responsive promoters. If the bait-prey interactions 
efficiently control transcription of reporter genes, putative binding partners can then be selected 
(Figure 2.1). 
 
 
Figure 2.1: Principle of the yeast two-hybrid assay 
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2.14.2 Library construction 
 
Human lung mRNA (catalog number: 636105, Clontech Laboratories Inc., Palo Alto, CA) was 
used to construct the cDNA library used in this study. The GAL4 activation domain (AD) fusion 
library was produced by co-transforming yeast with SMART generated ds cDNA (section 2.4.3) 
and SmaI-linearised pGADT7-Rec2 vector, as per manufacturer‘s instructions (Clontech 
Laboratories Inc., Palo Alto, CA). This process is outlined in Figure 2.2. One-step in vivo cloning 
using homologous recombination was possible using the BD SMART III and CDS III sequences 
incorporated during RT and LD-PCR. These sites have been engineered into the pGADT7-Rec2 
vector. The transformation protocol as described under section 2.8.2 was used with a slight 
modification for volume adjustment (see Appendix 5 for a detailed protocol). Following 
homologous recombination, the transformants were spread on ~200 SD plates lacking leucine 
(SD-Leu
-
) and incubated at 30C for 5-7 days. Yeast transformants were harvested with 4 mL 
freezing medium (75% YPD and 5% glycerol) per library plate. Library transformants were 
scraped off the plates, pooled and stored as 1 mL aliquots at -80C. 
 
 
Figure 2.2: The construction of lung cDNA library using homologous recombination in yeast 
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The library titer was determined by spreading 100 µL of the following dilutions: 1:100, 1:1000 
and 1:10000 on SD Leu
-
 plates. The plates were incubated at 30°C until colonies developed ~2- 3 
days later. The numbers of colony forming units (cfu) were counted and the numbers of clones in 
the library were determined using the formula below (transformation efficiency*): 
 
                 ⁄  
                  
            (  )           
 
 
                                                                   ⁄  
 
The library titer plates were used to determine whether library construction was successful by 
colony PCR (section 2.4.2). 
 
2.14.3 Establishment of bait culture 
 
A single colony (< 2 mm) was selected on SD Trp
-
 plates containing the transformed ‗bait‘ 
plasmid (section 2.8.2) and inoculated in 50 mL SD Trp
-
 liquid media. The culture was incubated 
overnight at 30°C with shaking. The yeast culture was centrifuged at 2500 rpm for 5 minutes and 
the supernatant was removed. The pellet was re-suspended in 5 mL SD Trp
-
 liquid media and the 
numbers of cells were counted using a hemacytometer (cell density: ≥ 1 X 109 cells/mL).  
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2.14.4 Yeast two-hybrid assay 
 
 
Figure 2.3: Schematic flow diagram of the Y2H analyses and verification studies 
 
The Y2H process is outlined in Figure 2.3 (see Appendix 11 for a detailed protocol). For initial 
screenings, full length ESAT-6 and CFP-10 GAL4BD fusion constructs were used as baits and 
mated overnight with the constructed human lung cDNA library. Briefly, 1 ml of the AH109 
library aliquot was thawed in a room temperature water bath and combined with 5 mL of Y187 
‗bait‘ culture in a sterile 2 L flask, together with 45 mL of 2X YPDA supplemented with 50 
µg/mL kanamycin. The flask was incubated at 30°C for 24 hours in a shaking incubator (< 50 
rpm). After mating, a drop of mating culture was checked under a phase contrast microscope to 
observe the formation of zygotes. The mating mixture was transferred to a sterile 50 mL Falcon 
tube (Greiner) and centrifuged at 2500 rpm for 10 minutes. The mating flask was rinsed with 
0.5X YPDA liquid medium. The rinsed medium was used to re-suspend the mating pellet. Once 
again, the mixture was centrifuged and the pellet was re-suspended in 0.5X YPDA supplemented 
with 50 µg/mL kanamycin. The mating mixture was spread on triple dropout (TDO: lacking Trp, 
Leu and His) agar plates and incubated at 30°C until colonies appeared. The mating efficiency 
was determined by spreading 100 µL of the following dilutions: 1:100, 1:1000 and 1:10000 on 
SD Leu
-
, SD Trp
-
, and SD Leu
-
/Trp
-
 plates. The colonies growing on TDO plates were replica-
plated on quadruple dropout (QDO: lacking Trp, Leu, His and Ade) agar plates and incubated at 
30°C for 2 weeks. Colonies positive for Ade and His were replica-plated on QDO containing X-
α-gal and allowed to grow at 30°C for 4 days. Plates were sealed and stock cultures of diploid 
•Library screen using the constructed cDNA 
lung library against mycobacterial bait vectors 
Y2H analyses 
• Growth on TDO (activation HIS3) 
• Growth on QDO (activation of both HIS3 and 
ADE2) 
Detection of nutritional 
reporter genes 
•X-α-galatosidase acivity indicates MEL1 
activation 
Detection of colourimetric 
reporter genes 
•Heterologous mating → DNA sequencing Interaction specificity test 
•in vivo co-immunoprecipitation 
•in vivo co-localisation 
Verification studies 
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cells were stored at -70°C. The AD library plasmid was isolated and heterologous mating with 
‗bait‘ was performed to confirm the phenotype. The library insert was amplified and the purified 
insert was determined by DNA sequencing (see Appendix 12 for a detailed protocol).   
 
Control experiments were performed in parallel. The positive control was pGADT7-RecT 
(AH109) mated with pGBKT7-53 (Y187) and the negative control was pGADT7-RecT (AH109) 
mated with pGBKT7-Lam (Y187). The control mating efficiency was determined by spreading 
100 µL of the following dilutions: 1:100, 1:1000 and 1:10000 on SD Leu
-
, SD Trp
-
, and SD Leu
-
/Trp
-
 plates.  
 
The Y2H and control dilution plates were used to determine the mating efficiency as follows: 
 
          ( )             ⁄  
    
            (  )            
 
 
     ⁄                                       
     ⁄                                        
     ⁄                                        
 
                  (         )  
      ⁄            
      ⁄                     
          
 
                                                                     ⁄  
 
2.15 In vivo microscopy  
 
 In vivo co-localisation was performed in order to determine whether putative interacting binding 
partners shared the same cellular environment by labeling the proteins of interest with primary 
and secondary fluorescently labeled antibodies. Suspected co-localisation was accessed using 
immunofluorescence (see Appendix 13 for a detailed protocol). 
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2.15.1 Tissue culturing and staining for microscopy 
 
For co-localisation studies, THP-1 cells were cultured in RPMI 1640 supplemented with 10% 
fetal bovine serum, 1% penicillin-streptomycin solution and incubated at 37°C with 5% C02. 
THP-1 cells were allowed to differentiate directly on microscope cover slips in 6-well tissue 
culture plates (CELLSTAR, Greiner Bio-One, LASEC, South Africa). The cover slips were 
transfected with either ESAT-6 or CFP-10 recombinant proteins using Pro-Ject protein 
transfection reagent (Thermo Fisher Scientific, Rockford, IL). 
 
After 24 hours of incubation with recombinant proteins, cover slips were washed with pre-
warmed RPMI 1640 medium, permeabilised by immersing coverslips in 100% methanol at -20°C 
and fixed in a 4% paraformaldehyde solution at room temperature. Various steps of washing with 
1X PBS were performed, followed by incubation in blocking buffer (1% BSA in PBS) at room 
temperature. Primary and secondary antibodies for fluorescence instrumentation are listed in 
Table 2.5. All prepared slides were counterstained with 4',6-diamidino-2-phenylindole, dilactate 
(DAPI) nuclear stain (Invitrogen, Carlsbad, CA). Slides were mounted in Mowiol mounting 
medium with anti-fade (Calbiochem) and stored at 4°C until further use.  
 
Table 2.5: Primary and secondary fluorescence labeled antibodies for use as immunofluorescent microscopy  
Primary antibody 
C1QA Goat polyclonal (1:200) 
FLNA Rabbit monoclonal (1:200) 
ESAT-6 Mouse monoclonal (1:200) 
CFP-10Mouse monoclonal (1:200) 
Secondary antibody 
Goat anti-mouse Alexa 488 (1:500) 
Donkey anti- Rabbit Cy3 (1:500) 
Donkey anti-mouse Cy3 (1:500) 
Donkey anti-goat FITC (1:500) 
 
Similarly, differentiated THP-1 cells were treated with recombinant ESAT-6 and stained with 
FITC-VAD-fmk (according to the manufacturer‘s conditions) in culture to test for activation of 
caspase activity.  
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2.15.2 Fluorescence microscopy and in vivo co-localisation 
 
Fluorescent imaging was performed using the Zeiss Axiovert 200M LSM-510 Meta confocal 
microscope system (Jena, Germany) at the Department of Anatomy, University of Cape Town, 
South Africa.  Fluorescent signals of antibody tags were obtained by excitation using a 488 nm 
line of a multiline argon laser, the DPSS 561-nm laser and the Mai Tai 2-photon deep sea 750nm 
laser with a X63 oil-immersion objective with a numerical aperture of 1.4. The excitation and 
emission wavelengths are listed in Table 2.6. Quantitative co-localisation analyses were 
performed using the Ziess LSM 510 Meta software (Jena, Germany) to measure the co-
localisation coefficient within a defined region of interest (ROI). 
 
Table 2.6: Summary of fluorescent filters  
Excitation Emission Filter set 
488nm 519nm FITC 
494nm 570nm Cy3 
405nm 461nm DAPI 
 
2.16 In vivo co-immunoprecipitation 
2.16.1 Principle 
 
In vivo co-immunoprecipitation, outlined in Figure 2.4, is a method that examines in vivo protein 
complex formation between various proteins. This analysis provides evidence for the coexistence 
of proteins in a complex and further validation is required to prove the interaction in vitro 
experiments (Phizicky and Fields, 1995). The coexistence of protein complexes are important 
structures for many biological processes that give information about the molecular mechanisms 
of these biological processes. 
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Figure 2.4: Principle of in vivo co-immunoprecipitation (Co-IP). In vivo Co-IP determines the dynamic protein 
interaction in living cells. A protein-specific antibody conjugated to protein G beads is used to purify the protein 
interest and its associated complex from cell lysates. The precipitate is eluted from the protein G beads and loaded on 
a sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The resulting SDS-PAGE, with 
separated protein partners, are transferred to a nitrocellulose membrane and Western blot analysis is performed with 
the protein-specific antibody against the interacting protein partner. 
 
2.16.2 Preparation of cell lysates 
 
Twenty four hours after protein transfection, discussed in section 2.12, cells were washed with 
PBS and lysed on ice with Tissue Protein Extraction Reagent (TPER, Thermo Fisher Scientific, 
Rockford, IL) supplemented with protease inhibitors (Calbiochem). The cellular debris was then 
centrifuged at 4°C for 10 min at 10 000 rpm and the total protein concentration of the supernatant 
were estimated using the Bradford Protein assay (Bio-Rad laboratories, Hercules, CA, USA). 
Lysates were stored at -20°C until needed. 
 
2.16.3 Membrane protein extraction 
 
Human Jurkat or THP-1 cells were cultured and transfected as discussed in sections 2.10 and 
2.12. Twenty four hours after protein transfection, the cells were centrifuged and washed with 1X 
PBS. Membrane associated proteins were extracted using the membrane protein extraction kit 
(Mem-PER, Thermo Fisher Scientific, Rockford, IL). Briefly, pelleted cells were lysed using 
Reagent A, followed by re-suspension into one part Reagent B and two parts Reagent C at 4°C 
for 30 minutes. The extraction mix was centrifuged at 10 000 rpm for 3 minute at 4°C and 
transferred to a 1.5 mL centrifugation tube. The supernatant was incubated for 10 minutes in a 
37°C water bath for phase separation of hydrophobic and hydrophilic fractions. The majority of 
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membrane proteins were located in the lower hydrophobic fraction and were stored at -20°C until 
needed. 
 
2.16.4 In vivo semi-endogenous co-immunoprecipitation 
 
Cell lysates and membrane fractions were prepared as described in sections 2.16.2 and 2.16.3. 
The protein fractions were pre-cleared with 20 μL of protein G Dynabeads (Invitrogen, Carlsbad, 
CA) for 1 hour at 4°C. The precipitating antibody (2-5 μg) was allowed to the bind protein G for 
10 minutes at room temperature. Antibodies were cross-linked to Dynabeads using suberic acid 
bis (3-sulfo-N-hydroxysuccinimide ester) sodium salt (BS
3
; Sigma, St. Louis, MO) to prevent co-
elution of antibodies. The cross-linking reaction was stopped by the addition of 12.5 μL 1M Tris-
HCI solution. The bead-antibody complex was washed twice using 1X PBS 0.01% Tween 20. 
The complex was incubated with the prepared lysate fractions for 10 minutes at room 
temperature. After several washing steps with 1X PBS 0.25 mM Lithium chloride (LiCl), the 
complex was suspended in 2X reducing sample buffer and denatured for 5 minutes at 95°C.  
 
The levels of C1qA in both THP-1 and Jurkat cells were extremely low and not sufficient to 
perform precipitation experiments. Therefore, co-immunoprecipitation (Co-IP) experiments were 
performed with human serum and recombinant GST tagged C1QA. Serum was pre-cleared twice 
overnight at 4°C to remove excess amounts of immunoglobulin, followed by 
immunoprecipitation. 
 
2.16.5 Western blot analysis 
 
The denatured protein lysate containing the sample of interest was subjected to electrophoresis on 
6% - 12% polyacrylamide gels. The proteins were separated using a Mini-Protean III System 
(Bio-Rad laboratories, Hercules, CA, USA), then electro-transferred from the gel to 
polyvinylidene difluoride (PVDF) membrane using the iBLOT semi-dry apparatus (Invitrogen, 
Carlsbad, CA). The membrane was blocked overnight with blocking buffer (1X PBS 0.05% 
Tween 20 5% non-fat milk powder). The membrane was incubated with the primary antibody 
overnight at 4°C, after which it was washed 3X for 30 minutes with 1X PBS. The secondary 
HRP-conjugated antibody was added for 1 hour at room temperature, followed by 3 washing 
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steps with 1X PBS for 30 minutes. The concentrations of primary and secondary antibodies 
combinations, diluted in blocking buffer, are listed in Table 2.7. The protein band was visualised 
by developing the membrane in SuperSignal West Pico Chemiluminescent substrate as per 
manufacturer‘s instructions (Thermo Fisher Scientific, Rockford, IL) (see Appendix 14 for a 
detailed protocol). Reciprocal immunoprecipitaion experiments were performed for bait and prey 
combinations. 
 
Table 2.7: Primary and secondary antibody combinations for the detection of proteins using Western blot analysis.  
Protein Identification Primary antibody Secondary antibody 
C1QA Prey* 
# 
Goat polyclonal (1:1000)  Donkey anti-goat IgG HRP (1:1000) 
FLNA Prey* Mouse monoclonal (1:1000) Goat anti-mouse IgG HRP (1:1000) 
ESAT-6 Bait* Mouse monoclonal (1:500) Goat anti-mouse IgG HRP (1:1000) 
CFP-10 Bait
# 
Rabbit polyclonal (1:500) Goat anti-mouse IgG HRP (1:2000) 
β-Tubulin Control Mouse monoclonal (1:500) Goat anti-mouse IgG HRP (1:2000) 
Identifiers*
#
 illustrates binding partners
 
 
2.17 Case-Control study 
2.17.1 Patient and control cohort 
 
A case/control study was performed involving ~500 cases and ~500 controls. All study 
participants were from the South African Coloured (SAC) population. The origins of this mixed 
ancestry population date back numerous generations, with genetic contributions from San, Khoi, 
Malaysian, African black and European lineages (de Wit et al., 2010). This population was 
formed from different populations with different susceptibility features and offers a unique 
opportunity to dissect and identify TB susceptibility alleles, as this population has a high burden 
of tuberculosis (Barreiro et al., 2006). The study cohort in question has been shown to 
demonstrate no difference in substructure between cases and controls (Barreiro et al., 2006) and 
therefore may not influence the observed results. Participants diagnosed with tuberculosis were 
recruited from the Ravensmead-Uitsig an epidemiological field site near Cape Town in the 
Western Cape region of South Africa. Controls were healthy individuals with no history of TB, 
who live in the same catchment area as the patients. Informed consent was obtained from all 
study participants. All protocols were approved by the Health Research Ethics Committee of the 
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Faculty of Medicine and Health Sciences, Stellenbosch University (project number 95/072). All 
participants were HIV negative and all TB cases were bacteriologically confirmed. 
 
2.17.2 Demographics of the study cohort 
 
The mean age of TB cases was 33.7 years (SD 13.8); 52.3% were female and 47.7% were male. 
Patients diagnosed with Tuberculous Meningitis were commonly observed in children (mean age 
7.26 [SD 5.24]); 58.7% were female and 41.3% were male. The mean age of the control group 
was 32.8 years [SD 10.88] with an unequal distribution of gender (females: 76.5% and males: 
23.5%).  Since the difference in age and gender was observed, as seen in Figure 2.5, we corrected 
our statistical analyses to account for these differences. 
 
 
Figure 2.5: Distribution of gender and age of the study cohort  
 
2.17.3 Promoter screening for functional variants 
 
To initially screen for single nucleotide polymorphisms (SNPs), a PCR-based strategy was 
followed by direct sequence analysis. Human genomic DNA was amplified from 10 cases and 10 
controls across the 5‘ flanking region of the human FLNA promoter. Primers were designed 
(section 2.3.1, Table 2.2) according to the FLNA gene sequence published on NCBI 
(http://www.ncbi.nlm.nih.gov/). PCR reactions were performed using sense primer 5‘ CTG ACA 
AGT CTT ATG GGA ACC 3‘ and anti-sense 5‘ CCG AGA GTG GGA GCT ACT CAT 3‘ 
according to the method described in section 2.4.1 (Tm 55°C, Table 2.2). The resulting PCR 
products were purified using the Wizard ® SV Gel and PCR clean-up system (Promega Corp. 
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Madison Wisconsin, USA) and sequenced in both directions using the PCR primers (section 2.6). 
Sequences were aligned and analysed using BioEdit (version 7.0.5.3). 
  
2.17.4 SNP selection 
 
The C1QA gene, identified as a TB susceptibility gene by means of yeast two-hybrid analyses, 
was investigated to test the hypothesis that SNPs within the genomic region spanning the C1q 
molecule may influence susceptibility to mycobacterial disease. Polymorphisms were selected 
from literature based on previous associations or functional effects. The selected SNPs were then 
further explored within the HapMap CEU and YRI population groups to check the frequency 
spectrum of the selected SNPs on the NCBI SNP database (db) 
(http://www.ncbi.nlm.nih.gov/snp). Table 2.6 represents the SNPs selected for this study as well 
as the individual TaqMan assay used to genotype each polymorphism. 
 
Table 2.8: Selected dbSNP used for this study and the TaqMan assay used to type the particular variant. 
C1q region dbSNP bp change ABI TaqMan assay  
5' C1qA rs665691 C → G C_3176793_10 
5' C1qA rs587585 A → G C_3176797_10 
3' C1qA rs12033074 C → G C_31443180_10 
C1qA (exon 3) rs172378 G → A C_3176785_10 
C1qB (intron 2) rs631090 T → C C_992968_10 
 
2.17.5 TaqMan SNP genotyping 
 
TaqMan® SNP genotyping assays consists of a primer set, which amplifies the sequence of 
interest, and two TaqMan probes for allele detection. Each TaqMan probe incorporates a non-
fluorescent quencher attached to a minor groove binder (MGB) at the 3‘ end and a reporter dye 
for each allele at the 5‘ end. Hybridisation of the MGB molecule to the minor groove of the DNA 
helix improves the probe-template complex and increases stability. The final step of detection is 
achieved by 5‘ nuclease chemistry, which cleaves the allele-specific 5‘ dye that generates a 
permanent signal for allele discrimination (Figure 2.8). 
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Figure 2.6: Allelic discrimination, achieved by selective annealing of TaqMan probes 
(http://www.appliedbiosystems.com) 
 
2.17.6 Real Time PCR amplification 
 
Real time PCR amplification for each individual pre-designed SNP assay was performed on a 
384 well plate on an Applied Biosystems Prism 7900HT (Applied Biosystems Inc., Forster City 
CA, USA). The amplification mix was made up as follows: 2.5 µL ABI TaqMan Universal PCR 
master mix, 1.375 µL sterile dH2O and 0.125 µL sequence-specific primers and probe mix. The 
master mix and DNA samples were loaded on a 384 well plate using the EpiMotion pipetting 
robot (Eppendorf, Hamburg, Germany).  Each prepared plate contained 30 non-template controls, 
to test for contamination. PCR conditions were as follows: 50°C for 2 min; 95°C for 10 min, 
followed by 40 cycles of 95° for 15sec and 60°C for 1.5 min. 
 
2.17.7 Allelic discrimination 
 
After PCR amplification, allelic discrimination was performed by an end point plate read using 
the 7900HT Fast Real-Time PCR System (Applied Biosystems). The Sequence Detection 
Systems (SDS) 2.3 software was used to measure the amount of fluorescence during the plate 
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read. The software reads the fluorescence from each sample well and performs automated allelic 
discrimination to generate discrimination plots. 
 
2.18 ELISA assay 
 
Human complement component 1, q subcomponent, A (C1QA) was measured quantitatively 
using an ELISA assay according to a modified method previously described (Beards et al., 1984). 
Briefly, 96-well immunoassay plates (MaxiSorp, Nunc, Wiesban) were coated with 100 µL/well 
rabbit anti-human C1QA monoclonal antibody (0.5 µg/mL; R&D systems, Wiesban, Germany) 
and kept at 4°C overnight. The remaining protein binding sites were blocked at 4°C with 
blocking buffer (100 mM phosphate buffer saline [PBS], 0.05% Tween-20, 5% bovine serum 
albumin [BSA]). Human plasma was diluted 1:500 in blocking buffer and incubated for 90 min at 
37°C in duplicate, together with diluted standards on the same ELISA plate. After sample 
incubation, 100 µL/well detection antibody was added (mouse anti-human C1QA, 200 ng/mL; 
Santa Cruz Biotechnology, Santa Cruz, California, USA), followed by 100 µL/well secondary 
horseradish peroxidase antibody (goat anti-mouse, 100 ng/mL; Santa Cruz Biotechnology, Santa 
Cruz, California, USA). Both of the antibody incubations were performed for 1 hour at room 
temperature. The assay was developed using 3, 3´, 5, 5´ - tetramethyl-benzidine (TMB; Sigma, 
St. Louis, MO) and hydrogen peroxide (H2O2; Sigma, St. Louis, MO) in a total reaction volume 
of 100 µL/well. The reaction was stopped by adding 100 µL of 2M sulphuric acid (H2SO4; 
Sigma, St. Louis, MO) per well. The absorbance was measured at a dual wavelength of 450 nm 
and 650 nm using the iMark microplate reader (Bio-Rad laboratories, Hercules, CA, USA). The 
standard curve was used to determine the mean absorbance of the relative levels of plasma C1QA 
in cases and controls. The data was normalised by subtracting the background absorbance from 
each sample well (see Appendix 15 for detailed protocol). 
 
2.19 Statistical Analysis 
 
Alleles and genotype frequencies for case and control groups were determined by direct counting, 
and frequencies among the groups were tested for conformity to Hardy-Weinberg equilibrium. 
Significant differences between cases and controls for the genotype and haplotype groups were 
tested using a general linear model (glm) – analysis of variance (ANOVA), adjusting for age and 
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gender. In addition, we evaluated whether additive and dominance effects can be assigned to a 
given SNP association. R (freely available from http://www.r-project.org) and the R package, 
genetics (Warnes et al., 2008) was used to test the above assumptions. A result corresponding to 
a p-value below 0.05 was described as statistically significant. 
 
The precision of ELISA measurements was determined by the Shapiro Wilk test. The Levene test 
was used to verify the assumption that the variances are equal or differed across a sample 
population. All ELISA statistics were performed using SPSS software (version 11.5, SPSS, 
Chicago, IL, USA). 
 
 
 
 
  
Stellenbosch University  http://scholar.sun.ac.za
   
72 
 
Chapter 3 
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3 Yeast two-hybrid analysis to identify host binding partners of 
ESAT-6 and CFP-10 
 
3.1 Results 
 
3.1.1 Construction of lung cDNA library 
3.1.1.1 Integrity of lung RNA 
 
The purity and integrity of RNA was evaluated using the Experion RNA StdSens Starter kit (Bio-
Rad laboratories, Hercules, CA, USA), which requires only a small amount of sample material 
(25-500 ng/µL). Figure 3.1 shows two RNA bands corresponding to 18S and 28S ribosomal 
RNA‘s. The bands were clear and the brightness of the 28S band was approximately twice that of 
the 18S band, which demonstrates that the RNA was intact and free of RNA degradation. In 
addition, the RNA loaded onto the chip had no other visible bands, which suggest that the RNA 
sample was free of genomic DNA. The 260/280 ratio of the RNA sample was 1.96. Pure RNA 
has a 260/280 ratio of ~1.9-2.1 and the RNA used in this study thus corresponds to good quality 
RNA (http://www.qiagen.com). The assessment of RNA integrity was a critical first step in 
ensuring that good quality RNA was used for the generation of cDNA for further library 
construction.  
 
Figure 3.1: Assessment of RNA integrity and purity. (A) Virtual gel demonstrating the Experion RNA ladder in 
lane L and the RNA sample in lane 1 showing the 18S and 28S bands. (B) Electropherogram of the 18S and 28S 
peaks obtained using the Experion
TM
 Automated Electrophoresis Station (Bio-Rad laboratories, Hercules, CA, USA). 
28S 
18S 
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3.1.1.2 cDNA amplification  
 
Human lung RNA was reverse transcribed to cDNA using the BD SMART
TM
 cDNA synthesis kit 
(BD Biosciences Pharmingen, San Diego, CA). Amplification was evaluated by loading 7 μL of 
the PCR product, alongside a 100bp DNA ladder (Fermentas, Burlington, Canada), on a 1.2% 
w/v agarose gel containing 250 ng/mL ethidium bromide immersed in 1X TAE buffer was  
(Figure 3.2A, lane 2). After amplification, the ds cDNA was purified using BD CHROMS 
SPIN
TM
TE-400 columns to eliminate excess adaptors and fragments smaller than 400 bp (Figure 
3.2B, lane 3). The purified ds cDNA was used for the construction of the lung cDNA library.  
 
 
Figure 3.2: 1.2% TAE Agarose gel electrophoresis image of size fractionated ds cDNA before and after 
purification (A) Lane 1 contains a 100bp DNA ladder (Fermentas, Burlington, Canada) and lane 2 represents the 
unpurified double stranded (ds) cDNA amplification product. (B) Lane 1 contains a 100bp DNA ladder (Fermentas, 
Burlington, Canada) and lane 2 represents the ds cDNA after purification to exclude fragments smaller than 400 bp. 
Lane 3 represents the smaller fragments not retained by the BD columns. 
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3.1.1.3 Library construction 
 
For library construction, purified ds cDNA and linearised SmaI-pGADT7 vector were co-
transformed into freshly prepared competent AH109 yeast cells. The GAL4 fusion library was 
constructed in a single step reaction using homologous recombination as the cloning method in 
yeast. The transformation reaction was plated on 200 SD Leu
-
 plates and incubated at 30°C until 
colonies developed (~3-6 days) (Figure 3.3A). The library titer was determined by counting the 
number of colonies on the 1:100 SD Leu
-
 dilution plates. The library titer was determined using 
the equation in section 2.13.2 and yielded            cfu/mL. Fourteen colonies were randomly 
selected and amplified by PCR using primers listed in Table 2.2, to identify colonies containing 
cDNA inserts. Colony PCR of the 10 randomly selected colonies contained a PCR insert, which 
indicated that the transformation efficiency was above ~70%. The sizes of the PCR products were 
between 0.5-1kb (Figure 3.3B). 
 
The yeast transformants were scraped from SD Leu
-
 plates using glass balls and 4 mL freezing 
medium per library plate. The transformants from all the 200 library plates were pooled into one 
suspension. The total number of independent clones in the pooled library suspension was 
            clones (equation in section 2.13.2). The constructed library was stored as 1 mL 
aliquots containing           cfu‘s. 
 
 
Figure 3.3: Screening of randomly selected yeast colonies for positive library transformants (A) Colony growth 
of library transformants allowing for restoration of the SmaI-linear vector to circular form, permitting growth on 
selection medium lacking leucine. (B) 1.5% TAE agarose gel of the PCR inserts from 14 randomly selected colonies. 
Lane 1 represents the 100bp DNA ladder (Fermentas, Burlington, Canada). Lanes 2-15 represents the PCR products 
of 14 randomly selected clones, illustrating the diversity in insert length. Lane 16 represents the negative control. 
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3.1.2 Bait construction 
3.1.2.1 Amplification of ESAT-6 and CFP-10 
 
The genes encoding ESAT-6 and CFP-10 were amplified from genomic DNA isolated from the 
laboratory strain, Mycobacterium tuberculosis H37Rv. The PCR products were resolved on a 2% 
agarose TAE/EtBr gel. The amplification of ESAT-6 generated a PCR product of 339 bp and a 
414bp product for CFP-10 (Figure 3.4). Amplification products were purified using the Wizard ® 
SV gel and PCR purification kit (Promega Corp. Madison Wisconsin, USA). 
 
Figure 3.4: 1.5% TAE agarose gel of PCR products of ESAT-6 and CFP-10. Lane 1 contains the 100bp DNA 
ladder (Fermentas, Burlington, Canada). Lanes 2 and 4 contain the amplified PCR product of ESAT-6 (339bp). 
Lanes 3 and 5 contain the amplified PCR fragment of CFP-10 (414bp). Lanes 6&7 contain the negative control of 
each PCR reaction. 
 
3.1.2.2 pGem-T-easy ligation and colony PCR 
 
The purified PCR products were cloned into the pGem-T easy cloning vector (Promega Corp. 
Madison Wisconsin, USA) and transformed into E. coli XL-1 blue strain for blue/white selection 
(Figure 3.5). Bacterial colony PCR was performed in order to select for positive clones 
containing the inserts of interest. Stock cultures were prepared and the constructed plasmid was 
purified from E. coli using the Wizard ® SV plus miniprep DNA purification system (Promega, 
Madison WI, USA). 
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Figure 3.5: Screening of white pGem-T-ESAT-6 and pGem-T-CFP-10 colonies. (A) Recombinants were 
identified by blue/white screening and were confirmed by PCR. White colonies contained the insert of interest 
(indicated with the red arrows), while the blue colonies contained no insert. Blue colonies produce functional β-
galactosidase and cleave the X-gal substrate plated on LB plates, whereas white colonies contain inserts that disrupts 
that functional LacZ gene that produces β-galactosidase. (B) Colony PCR of ESAT-6 (lanes 2-11, 339bp) and (C) 
CFP-10 (lanes 14-23, 414bp) positive clones. Lanes 1 and 13 represents the 100bp DNA ladder (Fermentas, 
Burlington, Canada). Lanes 12 and 24 represents the negative controls for each reaction. 
 
3.1.2.3 Construction of pGBKT7 constructs 
 
The pGem-T-ESAT-6 and pGem-T-CFP-10 were digested with EcoRI and PstI (Figure 3.6A). 
The restricted inserts were excised and gel purified using the Wizard ® SV plus miniprep DNA 
purification system (Promega, Madison WI, USA). The isolated inserts were sub-cloned into 
shrimp alkaline phosphatase (SAP) treated pGBKT7 vector restricted with EcoRI and PstI. The 
ligation reaction for each bait vector was transformed into E. coli cells. The pGBKT7-ESAT-6 
and pGBKT7-CFP-10 were confirmed by colony PCR (Figure 3.6B) and sequenced to verify that 
the inserts were in-frame with the DNA-BD of pGBKT7. These recombinant plasmids were used 
to perform the yeast two-hybrid screens. 
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Figure 3.6: Construction of pGBKT7-ESAT-6 and pGBKT7-CFP-10 constructs. (A) The result of pGem-T-
ESAT-6 and pGem-T-CFP-10 digested with EcoRI and PstI. Lane 1 contains the 100bp DNA ladder (Fermentas, 
Burlington, Canada). Lanes 2 and 5 contain the uncut pGemT vectors. Lanes 3 and 4 contains pGem-T-ESAT-6 after 
the final digest with EcoRI and PstI. Lanes 6 and 7 contains pGem-T-CFP-10 after the final digest with EcoRI and 
PstI. The insert from lanes 4 and 7 were purified using the Wizard ® SV Gel and PCR purification system (Promega 
Corp. Madison Wisconsin, USA). The purified insert of ESAT-6 and CFP-10 were sub-cloned into pGBKT7. (B) 
Bacterial colony PCR of pGBKT7-ESAT-6 (lanes 2 and 3) and pGBKT7-CFP-10 (lanes 5&6). Lane 1 contains the 
100bp ladder (Fermentas, Burlington, Canada). Lanes 4 and 7 are the negative controls for each reaction. 
 
 
3.1.3 Testing of pGBKT7 constructs 
3.1.3.1 Testing pGBKT7 constructs for toxicity 
 
The pGBKT7-ESAT-6 and pGBKT7-CFP-10 constructs were transformed into the Y187 yeast 
strains and the formation of colonies was compared to yeast containing the empty pGBKT7 
vector. The colony morphology was normal in colour and size, when compared to yeast strains 
containing the empty pGBKT7 vector (Figure 3.7). An isolated colony from each plate was 
selected and inoculated into 50 mL SD Trp
- 
liquid medium. The growth rate was recorded to 
assess, whether pGBKT7-ESAT-6 and pGBKT7-CFP-10 constructs were toxic to the Y187 yeast 
strain.   
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Figure 3.7: Recombinant pGBKT7-ESAT-6 and pGBKT7-CFP-10 constructs in Y187 yeast strains. Visual 
inspection of size and colour of yeast colonies containing (A) empty pGBKT7 vector, (B) pGBKT7-ESAT-6 and (C) 
pGBKT7-CFP-10 recombinant vectors. The yeast strains containing ESAT-6 and CFP-10 were normal in size and 
colour. 
 
The log (OD600) of ESAT-6 and CFP-10 were compared to the slope of the empty vector (Figure 
3.8). Normally, if the growth rate of bait protein (i.e. ESAT-6 and CFP-10) is noticeably slower 
than the empty pGBKT7 vector, the fusion proteins would have been considered as toxic to the 
yeast strains. The colony morphology was normal and the transformed strains had compatible 
growth rate in culture, suggesting that the constructs were non-toxic. These strains were thus used 
for further analysis in the Y2H assays. 
 
 
Figure 3.8: Growth rate of pGBKT7-ESAT-6 and pGBKT7-CFP-10. The log(OD600) of the empty pGBKT7, 
pGBKT7-ESAT-6 and pGBKT7-CFP-10 constructs were plotted against time (hours). The observed growth rates 
were non-toxic. 
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3.1.3.2 Testing pGBKT7 constructs for transcriptional activation  
 
In order to test whether pGBKT7-ESAT-6 and pGBKT7-CFP-10 were able to self-activate the 
HIS3 and ADE2 reporter genes, Y187-containing constructs were plated on SD/-Trp/-His and 
SD/-Trp/-Ade selection plates. pGBKT7-ESAT-6 and pGBKT7-CFP-10 demonstrated no growth 
on SD/-Trp/-Ade plates and did not autonomously activate the expression of ADE2 reporter gene. 
However, growth was observed on SD/-Trp/-His for both ESAT-6 and CFP-10. The background 
expression of the HIS3 reporter gene was suppressed by adding 3-aminotrizole (3-AT) to 
selection plates (Table 3.1). Colonies were plated on 10 mM 3-AT SD/-Trp/-His selection plates 
and demonstrated no growth. Therefore, the yeast two-hybrid screens were conducted using 10 
mM 3-AT on TDO plates to select for putative interactions. 
 
Table 3.1: Testing pGBKT7-ESAT-6 and pGBKT7-CFP-10 constructs for transcriptional activation of 
reporter genes. pGBKT7-ESAT-6 and pGBKT7-CFP-10 constructs were plated on SD/-Trp/-His and SD/-Trp/-Ade 
plates to test for transcriptional activation of reporter genes (i.e. –His and –Trp). pGBKT7-ESAT-6 and pGBKT7-
CFP-10 constructs were active on SD/-Trp/-His, indicating the presence of transcriptional activation by ESAT-6 and 
CFP-10 fusion constructs. When these constructs were plated on 10mM 3-AT SD/-Trp/-His plates, no growth was 
observed. 
  
Selection 
 
pGBKT7 Trp/His Trp/Ade 10mM 3-AT Trp/His 
Y187 
ESAT-6 + - - 
CFP-10 + - - 
 
3.1.4 Yeast-two-hybrid screen 
3.1.4.1 ESAT-6 
 
A yeast-two-hybrid screen was performed to identify potential targets that interact with ESAT-6. 
The GAL4AD lung cDNA plasmids in AH109 were mated overnight at 30°C with the GAL4BD 
ESAT-6 bait fusion protein expressed in Y187. The overnight mating culture was plated on 
10mM 3-AT TDO selection plates and SD/Leu
-
, SD/Trp
-
 and SD/Leu
-
/Trp
-
 plates. The number of 
transformants screened was determined by counting the number of viable diploids on the SD/Leu
-
/Trp
- 
plates. In total,          transformants were screened (i.e. number of screened clones = 
cfu/ml of diploids (SD/Leu
-
/Trp
-
) x re-suspension volume (mL)). To identify the positive 
colonies containing an integrated library cDNA insert, a yeast colony PCR was performed by 
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using the primers listed in Table 2.2 (Figure 3.9). The positive bait-prey plasmids were extracted 
from yeast using the method described in section 2.9.2. The isolated plasmids were transformed 
into E. coli and plated on LB/ampicillin and LB/kanamycin, to separate the bait/prey plasmids. 
Each plasmid (i.e. pGADT7 and pGBKT7) was extracted from E. coli and re-transformed into 
yeast. The transformed yeast was used to perform heterologous bait-prey matings to re-test the 
putative phenotype (Figure 3.10). Sequence results of the 79 putative clones containing an 
integrated library cDNA insert were analysed using both BLASTN and BLASTP programs 
(http://www.ncbi.nlm.nih.gov/Entrez). Analyses revealed that only two inserts were in frame 
preceding the DNA-AD of the pGADT7 vector. These inserts matched the C-terminal side of 
filamin A (FLNA, corresponding to repeats 23-24) and the C-terminal side of complement 
component 1, q subcomponent, A chain (C1QA), respectively. 
 
 
 
Figure 3.9: 1.5% TAE agarose gel of PCR products of candidate clones identified during the ESAT-6 screen. 
Yeast colony PCR amplification of candidate clones (lanes 2-37) identified during the ESAT-6 screen. Lane 1 
contains a 100bp DNA ladder (Fermentas, Burlington, Canada) and lane 38 represents the negative control. 
 
Figure 3.10: Heterologous mating to re-test the interaction of ESAT-6 and FLNA and C1QA. Small scale 
mating was performed between pGBKT7-ESAT-6 & C1QA (1A) and pGBKT7-ESAT-6 & FLNA (2A). Both C1QA 
and FLNA were mated with the empty pGBKT7 vector (1B and 2B).  pGBKT7-53 (1C and 2C) and pGBKT7-LAM 
(1D and 2D) were mated with both C1QA and FLNA, separately to test specificity of the identified interactions. The 
negative control (1E) served as a mating between pGADT7-SV40 and pGBKT7-LAM and the positive control (2E) 
served as a mating between pGADT7-SV40 and pGBKT7-53.  
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3.1.4.2 CFP-10 
 
Following large scale preparation of pGBKT7-CFP-10, an additional yeast two-hybrid screen 
was performed with the constructed lung library. Similar to the ESAT-6 screen, the GAL4AD 
lung cDNA plasmids were mated overnight at 30°C with the GAL4BD CFP-10 bait fusion 
protein. The overnight mating mixtures were plated on selection plates and the number of 
transformants was determined by counting the number of viable diploids. In total,            
transformants were screened. To identify the positive colonies, a yeast colony PCR was 
performed using the primers listed in Table 2.2. The amplified insert displayed the same bp size 
repeatedly (Figure 3.11). The yeast colonies containing an integrated library cDNA insert was 
extracted using the yeast plasmid extraction method described in section 2.9.2 and was 
transformed into E. coli with appropriate antibiotics to separate the two interacting plasmids. The 
bait and prey plasmids were re-transformed into the appropriate yeast strains to re-test the 
putative interaction. Additionally, CFP-10 was sub-cloned into a low expression vector (pGBT9) 
and the interactions were re-tested by plating the heterologous small scale matings on 10mM 3-
AT QDO (Figure 3.12) selection plates. The results demonstrated in Figure 3.12 depict the 
identification of a putative interaction, demonstrating minimal growth when C1QA was mated 
with the empty pGBKT7 vector. Sequence results of the 19 putative clones revealed that the 
library clones corresponded to the same insert, matching the C-terminal side of C1qA, also 
identified during the first initial yeast two-hybrid screen with ESAT-6. 
 
 
Figure 3.11: 1.5% TAE agarose gel of PCR products of candidate clones identified during the CFP-10 screen 
Yeast colony PCR of candidate clones (lanes 2-11) identified during the CFP-10 screen. Lane 1 contains a 100bp 
DNA ladder (Fermentas, Burlington, Canada) and lane 12 represents the negative control. 
 
Stellenbosch University  http://scholar.sun.ac.za
   
83 
 
 
Figure 3.12: Heterologous mating to re-test the interaction of CFP-10 and C1QA of six randomly selected 
clones. Small scale mating was performed between pGBT9-CFP-10 & C1QA (1-6B) and pGBKT7-CFP-10 & 
C1QA (1-6D). The empty pGBT9 (1-6A) and pGBKT7 (1-6C) were mated with C1QA to evaluate non-specific 
binding to the bait vector. pGBKT7-53 (1-6E) and pGBKT7-LAM (1-6F) were mated with C1QA to test specificity 
of the identified interactions. The negative control (3G) served as a mating between pGADT7-SV40 and pGBKT7-
LAM and the positive control (4G) served as a mating between pGADT7-SV40 and pGBKT7-53. 
 
The putative interactions of ESAT-6 and CFP-10 were confirmed using heterologous mating and 
were further validated using in vivo techniques (Chapter 4). 
 
3.2 Discussion 
 
Understanding protein complexes in protein-protein interaction (PPI) studies are important 
research topics in cell biology and biochemistry. Protein complexes are composed of many 
subunits which perform the majority of biological processes inside host cells. The identification 
of these complexes is useful in deciphering the molecular mechanisms that translate into many 
cellular functions related to cell structure, signaling and metabolism. These interactions are 
generally recognised as the building blocks of cellular environments or complex cell networks. 
The immune system is also a complex network of cells functioning together to coordinate 
immune regulation. During the course of infection, these networks are interfered with by M. 
tuberculosis to facilitate effective dissemination of the tubercle bacilli.  
 
The ESX-1 secretion system of M. tuberculosis is responsible for the secretion of ESAT-6 and 
CFP-10, and is thought to be involved in membrane lysis of host cells. Secretory proteins of M. 
tuberculosis are likely to play important roles in host-pathogen interactions, by taking advantage 
of its position within the cellular milieu to facilitate interactions with host cells. Despite the vast 
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amount of research performed on these secretory proteins, little is known about the host targets 
that they interact with. Therefore, the current study was designed to gain insights into the host 
targets that interact with ESAT-6 and CFP-10. 
 
The yeast two-hybrid (Y2H) system is a simple, high-throughput and cost-effective approach to 
generate PPI data, making it the most popular screening tool for interactome studies (Vidalain et 
al., 2004). This method can help assign biological functions to proteins, without previous 
knowledge of potential binding partners, and was thus chosen as the preferred technique for the 
current study.  
 
Upon inhalation into the lung, M. tuberculosis comes into contact with airway macrophages and a 
number of other cell types. The establishment of infection therefore depends on the initial 
interactions with host cells. In choosing the right strategy that is representative of the biological 
material of interest, a cDNA yeast two-hybrid library from lung mRNA was constructed to enable 
the identification of PPIs that occur within the lung alveoli.   
 
A key feature of the library construction was the use of BD SMART
TM
 cDNA synthesis, which 
requires only small amounts of mRNA. This method allows for amplification of 5´ ends of genes, 
which tends to be under-represented during conventional cDNA library construction. The 
integration of Long-Distance (LD) PCR greatly improved the reliability of the PCR reaction and 
the length of PCR products (Barnes, 1994). As seen in Figure 3.2, most of the cDNA inserts 
ranged between 0.4 – ~2 kb. The library consisted of over         independent clones, which 
was sufficient to perform a yeast two-hybrid screen. Based on Clareke-Carbon‘s formula, a 
cDNA library should contain at least           independent clones for good coverage 
(Sambrook, 2001). Therefore, the constructed library should represent most transcribed genes, 
assuming that the human genome has about 20 000 to 25 000 protein-coding genes (Pertea and 
Salzberg, 2010). 
 
In judging the quality of a library screen, the number of transformants screened (calculated from 
SD/Leu-/Trp- plates) should exceed number of independent clones within the library. This 
estimate is a measure of the completeness of the library screen (Conn, 2010). 
Approximately,            and             clones were screened for ESAT-6 and CFP-10, 
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respectively. The number of transformants screened was lower than the number of independent 
library clones. Therefore, it may be possible that a number of putative interactions could have 
been missed in both screens with ESAT-6 and CFP-10. The following situations may have 
occurred, resulting in the identification of fewer putative interactions: (1) the hybrid protein may 
not have been stably expressed in the yeast cell, (2) the GAL4 activation and binding domains 
could have blocked the site of interaction, (3) the hybrid proteins may have folded improperly; or 
(4) they did not localise to the yeast nucleus. Although the Y2H system is frequently used as the 
preferred method to identify PPIs, it is not without limitations, which will be discussed later in 
this section. 
 
In this study, ESAT-6 was first used as a bait to screen the constructed lung cDNA library, to 
identify putative host targets of ESAT-6. From the 79 positive colonies, two inserts were 
translated in-frame preceding the GAL4 AD, which were further subjected to in vivo analyses to 
test for biological significance. Although the 77 isolated library clones contained significant 
DNA matches, these inserts did not reveal significant protein matches. When a random fragment 
library is constructed only one-sixth of clones will generate true in-frame fusion constructs with 
the GAL4 AD and most screening libraries provide only one reading frame for the generation of 
fusion constructs. A solution to circumvent this problem could be the new Gateway technology 
(discussed further in the future considerations of this section). The two in-frame inserts were 
identified as filamin A and complement component 1, q subcomponent, A chain (C1QA)  
 
Filamin A was originally identified as a non-muscle actin-binding and polymerising protein 
(Figure 3.13). Three discrete FLNs have been identified in humans, namely, filamin A (FLNA), 
filamin B (FLNB) and filamin C (FLNC). Filamin A is expressed in T cells and has the ability to 
bind actin. The dimerisation domain of filamin A associates with the plasma membrane and 
numerous intracellular signaling intermediates, including enzymes and scaffolding proteins. 
These findings indicate that filamin plays an important role as an adapter molecule that links a 
wide variety of intracellular proteins to the actin cytoskeleton and cell membrane receptors 
(Hayashi and Altman, 2006).  
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Figure 3.13: Representation of FLNA. Schematic representation of filamin A crosslinking actin filaments to the 
cytoplasmic region of host cell membranes (Lin et al., 2001). 
 
The complement system is a central component of the innate immunity and functions to 
recognise foreign particles, to communicate and activate the adaptive immune response and to 
remove cellular debris. The complement system consists of a well-established complex of 
circulating and surface-bound proteins, which serves as substrates, enzymes or modulators of a 
sophisticated series of extracellular proteolytic cascades (Lambris et al., 2008). Complement is 
made up of three pathways: the classical, alternative and the lectin pathway, which involves the 
sequential activation of many proteins involved in the destruction of infecting microorganisms 
(Matsushita and Fujita, 2001). The initial event that triggers these pathways differs considerably 
between the three different systems. The classical pathway is initiated by C1Q recognition of 
antibody-antigen complexes and subsequent activation of the associated serine proteases C1r and 
C1s. The C1Q molecule is made up of three polypeptides chains, including C1QA, C1QB and 
C1QC (Figure 3.14).  
Filamin A 
Dimerisation domain  
Actin binding domain  
Dopamine receptor monomers 
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Figure 3.14: Structure of C1Q. The C1Q molecule is a glycoprotein consisting of 18 polypeptide chains (six C1QA 
chains, six C1QB chains and six C1QC chains). The chains associate as six heterodimers to form the functional C1q 
molecule. The C-terminal domain functions at the globular head and the N-terminal domain contains a collagen-like 
stalk region (Sontheimer et al., 2005). 
 
An additional screen using CFP-10 as bait demonstrated that all 19 isolated clones activated the 
reporter genes and corresponded to the same insert, which was also C1QA, similar to what was 
observed with ESAT-6. In order to evaluate the interaction between CFP-10 and C1QA in yeast, 
3-aminotrizole (3-AT) was added to selection plates, which is a competitive inhibitor of the HIS3 
gene product. The addition of 3-AT inhibits low background expression of HIS3 reporter gene, 
which may lead to spurious results. CFP-10 was expressed in a GAL4 binding domain vectors – 
pGBKT7 (high expression) and pGBT9 (low expression) – to test for the interaction with C1QA 
using heterologous mating. High expression of bait proteins may allow yeast to overcome 
nutritional selection; therefore CFP-10 was evaluated in a low expression vector. The results 
presented in Figure 3.12 demonstrated a putative interaction between CFP-10 and C1QA. 
However, in all methods used to detect PPIs, false positives can occur. Many of these interactions 
are due to proteins having a tendency to generate non-specific binding. In Y2H studies, these are 
termed ―sticky‖ proteins based on their frequent appearance among the isolation of prey proteins 
(Semple et al., 2002). If C1QA was indeed a sticky protein, growth should have been observed 
during the heterologous mating with pGBKT7-53 or pGBKT7-LAM (Figure 3.11). Given the 
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biological evidence that ESAT-6 and CFP-10 interact as a 1:1 heterodimer complex, the 
hypothesis that ESAT-6 and CFP-10 may share similar domains that interact with C1QA could 
not be excluded. Therefore, in vivo validation was performed to verify the putative interactions of 
C1QA with ESAT-6 or CFP-10. These results will be discussed in detail in Chapter 4. 
 
The subcellular localisations of proteins are a crucial part in understanding their biological 
functions. When selecting the most plausible interactions, proteins should localise in compatible 
subcellular environments to support the possibility of direct interactions. Based on experimental 
evidence, ESAT-6 has been shown to be involved in pore formation of host cell membranes 
(Smith et al., 2008). Filamin A stabilises the actin filament network that links actin to the cellular 
membranes (Zhou et al., 2010). Therefore, the likelihood that ESAT-6 and Filamin A share the 
same subcellular location during M. tuberculosis infection could therefore not be excluded. With 
regards to C1QA, M. tuberculosis and M. leprae have been demonstrated to be activators of the 
complement system (Lahiri et al., 2008; Carroll et al., 2009). Evidence suggests that when M. 
tuberculosis is inhaled, the bacterium is opsonised by C3 via the activation of the classical 
pathway within the lung alveolus (Ferguson et al., 2004). For these reasons, a functional 
interaction and subcellular location exist between M. tuberculosis and the complement system, 
which provides evidence for further validation. 
 
The desirable features of the Y2H approach (i.e. simple and cost effective) makes this system an 
excellent choice to identify PPIs; however it is not without limitations and strengths. The 
advantage of the Y2H is that it employs an in vivo method that detects interactions in live yeast 
cells, which has it disadvantages. As a eukaryote, yeast is a suitable host organism for 
investigating interactions of higher eukaryotes compared to most in vitro approaches or methods 
based on bacterial expression (Van Criekinge and Beyaert, 1999). When investigating host-
pathogen interactions in a eukaryotic system, like the Y2H, it is not feasible to model interactions 
between bacterial and mammalian cells (Valdivia, 2004). However, multiple studies have 
demonstrated that it is possible to identify host-pathogen interactions using the Y2H approach 
(MacFarlane and Uhrig, 2008; Zhang et al., 2009; Dyer et al., 2010; de Barsy et al., 2011; Yang 
et al., 2011). Another appealing advantage of the Y2H system is the minimal requirements 
needed to initiate an interaction screen (Van Criekinge and Beyaert, 1999).  
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A limitation of the Y2H system is that the hybrid proteins are expressed artificially and may 
represent a possible risk in identifying false PPIs (Van Criekinge and Beyaert, 1999). Some 
interactions may be dependent on post-transcriptional modifications, which do not occur properly 
or not at all in yeast during artificial expression. These modifications include the formation of 
disulfide bridges, glycosylation and most commonly phosphorylation (Van Criekinge and 
Beyaert, 1999). However, alternative yeast two-hybrid methods co-expressing the modifying 
substrate that is responsible for post-transcriptional modification are available at the discretion of 
the researcher (Brückner et al., 2009). In addition, the incorporation of the GAL4 
activation/binding domains during expression of hybrid proteins in yeast might influence their 
native conformation, possibly altering the activity and binding affinities of the hybrid proteins 
(Van Criekinge and Beyaert, 1999). 
 
Another disadvantage of the Y2H system is the requirement of interacting bait and prey proteins 
to translocate to the nucleus, so that the reporter genes can be activated. The Y2H system requires 
that interactions be targeted to the nucleus and may be a disadvantage for extracellular or 
membrane proteins with a strong target signal to remain in their natural environment (Brückner et 
al., 2009). Therefore, the nucleus may not be the ideal cellular milieu to investigate particular 
proteins interactions. Other classes of proteins that are not suitable for Y2H analyses are 
transcriptional activators, as these proteins may activate the transcription of reporter genes 
without an interacting hybrid protein (Van Criekinge and Beyaert, 1999). In the present study, 
ESAT-6 and CFP-10 activated transcription of only the HIS3 reporter gene, and this was actively 
suppressed by the addition of 3-AT. 
 
In addition, some bait proteins might become toxic upon expression in yeast, resulting in the loss 
of interactions being identified. Such proteins might proteolyse essential yeast proteins that are 
important for the maintenance of the Y2H system (Van Criekinge and Beyaert, 1999).  
 
To address the described  limitations of the present study a number of methods, including 
multiple reporters genes (i.e. ADE2, HIS3 and MEL1), testing toxicity of bait constructs, 
performing heterologous mating, as well as the addition of 3-AT, were applied, to reduce the 
number of non-specific interactions during the Y2H screens. 
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Chapter 4 
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4 Verification studies of ESAT-6 and CFP-10 binding partners  
 
4.1 Results 
 
4.1.1 Recombinant mycobacterial proteins 
 
Purified recombinant mycobacterial ESAT-6 and CFP-10 proteins were obtained from the 
infectious diseases research company BEI Resources (http://www.beiresources.org/) to ensure 
standardisation, repeatability and to minimise the effects of improper folding or formation of 
inactive protein. Recombinant proteins were received purified (done using standard non-
denaturing chromatographic techniques followed by endotoxin removal procedures). Western 
blot analysis with mouse monoclonal antibody (mAb) to ESAT-6 (Santa Cruz Biotechnology, 
Santa Cruz, California, USA) and rabbit mAb to CFP-10 (Abcam, Cambridge, MA, USA) 
detected the protein bands at the expected molecular sizes, and as higher molecular weight bands 
representing dimers and multimers (Figure 4.1). This was expected, and confirms the correct 
structure of the prepared recombinant proteins, as these proteins are known to form aggregates in 
solution and form multimeric proteins (Wang et al., 2009). 
 
 
Figure 4.1: Western blot of ESAT-6 and CFP-10. The purified recombinant ESAT-6 (6 kDa) and CFP-10 (10 
kDa) proteins were analysed by 12.5% SDS-PAGE and visualised through Western blot after electroblotting to a 
nitrocellulose membrane and blotted with ESAT-6 mouse mAb (1:500) and CFP-10 rabbit mAb (1:500). M: 
PageRuler™ Plus Prestained Protein Ladder  (Fermentas, Burlington, Canada). 
 
M   M M            M 
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4.1.2 Transfection of recombinant proteins into cultured cells 
 
To determine the efficiency of the protein delivery system, the cultured Jurkat cells were 
transfected with recombinant ESAT-6 using the Pro-Ject™ delivery system (Thermo Fisher 
Scientific, Rockford, IL), a lipid-based protein delivery system used to deliver recombinant 
proteins into the cytoplasm of cultured cells. After 12-24hrs of transfection, the cultured cells 
were thoroughly washed twice with 1X PBS to remove any undelivered recombinant proteins, 
and the cells were subsequently lysed using Tissue Protein Extraction Reagent (TPER, Thermo 
Fisher Scientific, Rockford, IL). Recombinant ESAT-6 was detected in the cell extracts of the 
Jurkat cells by Western blot (Figure 4.2), indicating that the recombinant proteins were 
successfully delivered into the cytoplasm of the cultured cells. 
  
 
Figure 4.2: Western blot of Jurkat lysates transfected with recombinant ESAT-6. The efficiency of protein 
delivery using the Pro-Ject transfection reagent was analysed by 12.5% SDS-PAGE and visualised by Western blot 
after electroblotting to a nitrocellulose membrane and blotted with ESAT-6 mouse mAb (1:500). Lane 1 represent 
100ng ESAT-6 (positive control for detection). Lanes 2-6 represents delivery of ESAT-6 into Jurkat cells. Lanes 7 
and 8 represents un-transfected Jurkat cells (negative control), demonstrating no non-specific binding of ESAT-6 
mAb to endogenous proteins. 
 
The cultured THP-1 cells were differentiated into macrophage-like cells by stimulation with 
100nM phorbol myristate acetate (PMA). For the delivery of recombinant proteins into cultured 
differentiated THP-1 cells, recombinant proteins was added exogenously and delivered into THP-
1 cells taking advantage of the macrophage-like phenotype of engulfing exogenous components 
via phagocytosis. In addition, recombinant proteins were also transfected into THP-1 cells using 
the Pro-Ject transfecting reagent, to ensure that recombinant proteins are freely accesible in the 
cytosol to interact with host proteins for co-immunoprecipitation experiments. Cells were 
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subsequently lysed with Tissue Protein Extraction Reagent (TPER, Thermo Fisher Scientific, 
Rockford, IL) and membrane protein extraction kit (Mem-PER, Thermo Fisher Scientific, 
Rockford, IL). The extracted proteins were subjected to Western blot analysis, to evaluate the 
relative proportion of recombinant ESAT-6 and CFP-10 in tissue cell and membrane fractions. 
Figure 4.3A and B illustrates the detection of ESAT-6 and CFP-10 in whole cell extracts, 
demonstrating delivery of recombinants proteins into THP-1 cells. ESAT-6, but not CFP-10, was 
also detected in the membrane fractions of THP-1 cells, which was significant as it has been 
reported that purified ESAT-6 (but not CFP-10) associates with and disrupts membranes (Hsu et 
al., 2003; de Jonge et al., 2007; Derrick and Morris, 2007). 
 
 
Figure 4.3: Western blot of differentiated THP-1 lysates treated with recombinant ESAT-6 and CFP-10. THP-
1 cells at 1×10
6
 cells/mL were differentiated with 100 nM PMA for 48 hours at 37°C, 5% CO2. The uptake of 
recombinant proteins by PMA-differentiated THP-1 cells were analysed by 12.5% SDS-PAGE and visualised by 
Western blot after electroblotting to a nitrocellulose membrane and blotted with ESAT-6 mouse mAb (1:500) and 
CFP-10 rabbit mAb (1:500). ESAT-6 was detected in the total cell lysates and membrane extracts of the THP-1 cells, 
while CFP-10 was only detected in the cell lysates. 
 
Further experiments showed that ESAT-6 exhibited a lytic phenotype (lysing both THP-1 and 
Jurkat cells); while the inverse was true for CFP-10, which demontrated no cytotoxic effect. 
Using fluorescence microscopy and a fluorescently labelled antibody specific for ESAT-6, it was 
shown that the lysed THP-1 cells associated with ESAT-6 (Figure 4.4). This lytic feature was 
further investigated and the results are described in Section 4.1.9. For subsequent co-
A
                                       
B                                      
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immunoprecipitation experiments, THP-1 and Jurkat cells were treated or transfected with 2.5 μg 
of ESAT-6 and incubated between 10-12 hrs, in order to minimise the cytolytic effects of ESAT-
6. 
 
 
Figure 4.4: Cytolysis of differentiated THP-1 by recombinant ESAT-6. THP-1 cells at 1×10
6
 cells/mL were 
differentiated with 100 nM PMA for 48 hours at 37°C, 5% CO2. The PMA-differentiated THP-1 cells were left 
untreated or treated with 5 μg of ESAT-6. The culture cells were washed with 1X PBS, fixed and permeabilised. The 
fixed cells were stained with DyLight 350 to fluorescently labelled  monoclonal antibody against ESAT-6 (mouse). 
(A) Differential interference contrast (DIC) image of un-treated and (B) treated THP-1 cells with 5 μg of ESAT-6, 
(C) fluorescent detection of ESAT-6 (labelled with Dylight 350 NHS Ester) and (D) overlay of DIC and fluorescent 
images, demonstrating a high fluorescent signal of ESAT-6 associated with lysed cells. The images were acquired at 
20 µm. 
 
4.1.3 Detection of endogenous proteins 
 
For the detection of bait-prey interactions, cell lysates demonstrating the highest expression of 
endogenous prey proteins (i.e C1QA and filamin A) were used for subsequent co-localisation and 
co-immunoprecipitation experiments (see Section 4.1.4 and 4.1.5). THP-1 cells differentiated 
with PMA has been shown to have reduced production of C1Q (Walker, 1998). Therefore, the 
cells were stimulated with interferon-γ to induce production of C1Q in the THP-1 cells (Figure 
4.5A). C1Q was detected in THP-1 lysates as complexes comprising the A-B and C-C dimers 
(Tenner and Volkin, 1986).  Antibodies against C1QA (recognising the C-terminal side and the 
internal portion of the protein, respectively) were shown to be able to precipitate the protein form 
of C1QA using recombinant C1QA-GST tagged protein (Abcam, Cambridge, MA, USA)(Figure 
4.5B). However, C1QA was not detected in Jurkat lysates (Figure 4.5B). Recombinant C1QA-
GST tagged protein (Abcam, Cambridge, MA, USA) and serum associated C1QA were thus used 
to verify the interactions with ESAT-6 and CFP-10. 
 
A B  C D 
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Endogenous filamin A was detected in Jurkat cell lysates using Western blot analysis (Figure 
4.5C). In some experiments, filamin A was detected as a doublet (280 and 250 kDa) (data not 
shown). This is not uncommon, as the 250 kDa band has been identified previously as the 
proteolysed form of filamin A (Jiménez-Baranda et al., 2007). 
 
 
Figure 4.5: Western blot detection of prey proteins. (A) THP-1 cells at 1×10
6
 cells/mL were differentiated with 
100 nM PMA for 48 hours at 37°C, 5% CO2. Following differentiation, THP-1 cells were stimulated with 25μg/mL 
interferon-γ for 12 hours to induce expression of C1QA. THP-1 lysates (lanes 1-3, 50 ng per well) were resolved on 
a 12.5% SDS-PAGE and visualised by Western blot with C1QA polyclonal goat antibody. (1:500). C1Q in THP-1 
lysates were detected as A-B (55 kDa) and C-C (43 kDA) dimers. (B) Additional source of C1QA (12.5% SDS-
PAGE): lane 1 represents human serum (1:2000 dilition in PBS) demonstrating the detection of C1QA at 23 kDa, 
lane 2 represents Jurkat lysates demonstrating no detection of C1QA, lane 3 represents recombinant C1QA-GST 
tagged protein, lane 4 represents immunoprecipitation of C1QA-GST using a C1QA polyclonal antibody recognising 
the C-terminal side and lane 5 represents  immunoprecipitation of C1QA-GST using a C1QA polyclonal antibody 
recognising the internal portion.  Lanes 4 and 5 demonstrate that antibodies against C1QA are able to precipitate the 
protein form of C1QA.  Lanes 6-7 represent immunoprecipitation of Jurkat lysates using the two C1QA polyclonal 
antibodies (recognising the C-terminal side and the internal portion of C1QA, respectively). (C) Lane 1 represents 
the PageRuler™ Plus Prestained Protein Ladder (Fermentas, Burlington, Canada). Lane 2 represents Jurkat lysates 
resolved on a 6% SDS-PAGE and visualised by Western blot with filamin A mouse mAb (1:1000), demonstrating 
high levels of filamin A expression.  
 
4.1.4 In vivo co-localisation of C1QA with ESAT-6 and CFP-10 
 
In order to confirm the yeast two-hybrid results, it was necessary that the interactions between 
C1QA/ESAT-6 and C1QA/CFP-10 could be co-localised to the same sub-cellular environment. 
Since PMA reduced the expression of C1QA, interferon-γ treated THP-1 cells were used to test 
co-localisation of the putative bait and prey interactions. In vivo immunofluorescence was used to 
test this, however, sub-cellular localisation of C1QA in the THP-1 cells could not be detected 
1   2    3    4   5   6   7  1          2          3       
5 
 1                   2                 
5 
Stellenbosch University  http://scholar.sun.ac.za
   
96 
 
(Figure 4.6). Therefore, co-localisation of ESAT-6 and CFP-10 with endogenous C1QA could 
not be investigated. In the light of these findings, immunoprecipitation experiments were 
performed to verify whether the interaction could be physically demonstrated in THP-1 lysates 
(Section 4.1.5). 
 
 
Figure 4.6: In vivo localisation of endogenous C1QA. THP-1 cells were grown in RPMI 1640 medium 
supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin. THP-1 cells were differentiated for 48 
hrs with 100nM PMA. The differentiated THP-1 cells were washed and treated overnight with interferon-γ. Non-
specific background of slides were first analysed by acquiring fluorescent signals of prepared slides that received 
only donkey anti-goat FITC antibodies. A1 represents the non-specific background fluorescence and A2 the DIC 
image of A1. Once the baseline settings were determined, all images were aquired using these settings. 
Immunofluorescence staining, using a goat polyclonal antibody specific for endogenous C1QA, followed by staining 
with  secondary donkey anti-goat labelled with FITC, demonstrated no detection of C1QA in THP-1 cells (B1 and 
B2). The scale bar represents 20 µm. 
 
4.1.5 Co-immunoprecipitation of C1QA with ESAT-6 and CFP-10 
 
Differentiated THP-1 cells were transfected with ESAT-6 and CFP-10, respectively. Co-
immunoprecipitaion (Co-IP) experiments were performed using tissue cell lysate and membrane 
fractions, since literature suggest that a membrane form of C1Q exist (Martin et al., 1987). In 
order to determine whether the interactions could be demonstrated, immunoprecipitation with 
polyclonal C1QA antibodies were performed, followed by Western blotting with monoclonal 
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antibodies against CFP-10 (Figure 4.7A) and ESAT-6 (Figure 4.7B), respectively. Similar 
experiments were performed using reciprocal conditions, i.e. immunoprecipitation with CFP-10 
(Figure 4.7C) and ESAT-6 (Figure 4.7D), respectively, followed by Western blotting with 
polyclonal C1QA antibodies. The interactions between C1QA and ESAT-6/CFP-10 could not be 
demonstrated in vivo with endogenous C1QA.  
 
 
Figure 4.7: In vivo co-immunoprecipitation of C1QA with CFP-10 and ESAT-6. THP-1 cells were transfected 
with ESAT-6 and CFP-10, separately. Membrane and tissue cell lysate were prepared using the Membrane Protein 
Extraction kit (Thermo Fisher Scientific, Rockford, IL) and Tissue Protein Extraction Reagent (Thermo Fisher 
Scientific, Rockford, IL). The presence of ESAT-6, CFP-10 and C1QA were detected by Western blot with anti-
ESAT-6 (lane B1), anti-CFP-10 (lane A1) and anti-C1QA (lanes C1 and D1), respectively. The membrane and tissue 
cell lysates were immunoprecipitated with anti-C1QA (lanes A3, A5, B3 and B5) conjugated to protein G and 
analysed for precipitation by Western blot using anti-CFP-10 (Image A) and anti-ESAT-6 (Image B). Similarly, the 
membrane and tissue cell lysates were immunoprecipitated with CFP-10 (lanes C3 and C5) and anti-ESAT-6 (lanes 
D3 and D5) conjugated to protein G and analysed for precipitation by Western blot using anti-C1QA (Images C and 
D). Unconjugated protein G and anti-prosaposin conjugated to protein G served as negative controls (lanes A7, A8, 
B7, B8, C7, C8, D7 and D8). Lanes A2, B2, C2 and D2 served as controls to test the crosslinking reaction that 
prevented co-elution of antibodies with precipitated proteins. 
 
Using other approaches, several attempts were made using human serum and recombiant C1QA-
GST tagged protein to precipitate the putative interations (each immunoprecipitaiton experiment 
with either total cell lysate, serum or GST-tagged C1QA protein were performed in triplicate). 
The human serum was pre-cleared twice overnight at 4°C with Dynabeads protein G to remove 
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excessive immunglobulins causing non-specific binding. The Western blot with human serum 
demonstrated no precipitated interaction using the different antibodies raised against the internal 
and C-terminal region of C1QA. Also, no band was detected when Co-IP experiments were 
performed with C1QA-GST tagged protein. Despite several attempts, the interactions identified 
with C1QA and ESAT-6/CFP-10 could not be confirmed in the subsequent Co-IP assays.  These 
yeast two-hybrid defined interactions may thus be an example of a false positive result. 
 
4.1.6 In vivo co-localisation of filamin A and ESAT-6  
 
Filamin A crosslinks actin and stabilises the plasma membrane and the cell cortex. As previously 
demonstrated, ESAT-6 associated with the membrane fractions (Figure 4.3A), supporting the 
possibility that ESAT-6 and filamin A co-localise in the same cellular environment. Prior to 
determining co-localisation between ESAT-6 and filamin A, baseline fluorescent settings were 
first determined (Figure 4.8). These settings were used to acquire all images to avoid obtaining 
false-positive results.  
 
 
Figure 4.8: Non-specific background correction for ESAT-6 and filamin A co-localisation. Non-specific 
background of slides were first analysed by acquiring fluorescent signals of prepared slides that received only 
secondary antibodies (i.e. goat anti-mouse Alexa 488 and donkey anti-rabbit Cy3). A represents non-specific 
background fluorescence of goat anti-mouse Alexa 488, B represents the DIC image, C represents non-specific 
background fluorescence of donkey anti-rabbit Cy3, D represents DAPI staining for the cell nuclei and F represents 
the overlay of images A – D. The scale bar represents 20 µm. 
C 
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Co-localisation images were recorded using a Zeiss LSM510-Meta laser scanning confocal 
microscope. The immunofluorescent staining for filamin A and ESAT-6 in THP-1 cells were 
granular and cytoplasmic (Figure 4.9). 
 
 
Figure 4.9: In vivo co-localisation of ESAT-6 and filamin A. THP-1 cells were grown in RPMI medium 
supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin and differentiated for 48 hrs with 100nM 
PMA. The cells were teated with 2.5 µg/ml of ESAT-6 for 12hrs. The culture cells were washed with 1X PBS, fixed 
and permeabilised. The fixed cells were double stained with monoclonal antibodies against ESAT-6 (mouse) and 
filamin A (rabbit) and were detected with secondary fluorescent antibodies (i.e. goat anti-mouse Alexa 488 and 
donkey anti-rabbit Cy3). The prepared slides were counter stained with DAPI for cell nuclei and visualised using a 
Zeiss LSM 510 laser scanning confocal microscope. (A) represents the fluorescent signal for ESAT-6, (B) represents 
the DIC image, (C) represents the fluorescent signal for filamin A, (D) represents DAPI staining for the cell nuclei 
and (E) represents the overlay of images A – D. The scale bar represents 20 µm. The information in image D (red 
arrow) will be discussed in section 4.1.9). 
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Figure 4.10: Example of co-localising pixels.  The distribution of ESAT-6 (green) and filamin A (red) can be 
separate or close together, overlapping partially and overlapping completely (yellow) within the focal plane of the 
acquired image. The value of the co-localisation coefficient  ranged between 0 - 1, where 0 represents no co-
localisation and 1 represents pixels that co-localise. The co-localisation coefficient was analysed using acquired 
image of Figure 4.9E. The results is demonstrated in Figure 4.11. 
 
Co-localisation analyses were performed using the Zeiss LSM 510 Meta software. The value of 
the co-localisation coefficient  ranged between 0 - 1, where 0 represents no co-localisation and 1 
represents pixels that co-localise (Figure 4.10). The number of co-localising pixels observed in 
channel 1 or 2, respectively, were compared to the total number of pixels above threshold and 
pixels with zero intensity were considered as background. In this experiment, the intensity of the 
threshold was set at a 100 and are indicated with the red arrows in Figure 4.11A. The pixels that 
co-localised are demonstrated in Figure 4.11B. The co-localisation coefficients for the green and 
red channels were 0.674 and 0.472, respectively, indicating that 67.4% of ESAT-6 co-localises 
with filamin A, whereas 47.2% of filamin A co-localised with ESAT-6 (Figure 4.11C). In other 
words, more than two-thirds of the total amount of ESAT-6 were specifically localised with 
filamin A. The staining of ESAT-6 and filamin A was specific and did not cross react or did not 
produce a signal bleed-through rendering separation of the fluorescent probes (Figure 4.12). 
 
 
 
0 
1 
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Figure 4.11:  Measurement of co-localisation coefficient of ESAT-6 and filamin A. Ziess LSM 510 meta software was used to measure the co-localisation 
coefficients. Scatter region 1 represents the pixels for ESAT-6, scatter region 2 represents the pixels for filamin A and scatter region 3 represents the relative number of 
co-localising pixels containing a signal for both ESAT-6 and filamin A. The co-localisation coefficient range is  0 – 1, where 0 represents no co-localisation and 1 
represents co-localisation. These results are based of Figure 4.9. Ch2 – channel for ESAT-6, Ch3 – channel for filamin A, T1 – scatter region for ESAT-6 pixels, T2 – 
scatter region for filamin A pixels and T3 – scatter region for co-localising pixels for ESAT-6 and filamin A.   
A B 
C 
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Figure 4.12: Spectral profile of ESAT-6, filamin A and the cell nuclei. (A) The cross section indicated with the 
white arrow indicates the (B) fluorescent spectral profile of ESAT-6, filamin A and the cell nuclei. The red blocks 
indicate where the fluorescent signal between ESAT-6 and filamin A co-localises. Note that the signal is different, 
excluding the possibility of cross reaction between antibodies or bleed through of the fluorescent probes. 
 
Furthermore, during acquisition of images, strong signals for ESAT-6 were also observed in 
vacuolar inclusions, that seems to be at the membrane of THP-1 cells (Figure 4.13A). This was 
seen when recombinant ESAT-6 was added exogenously. To exclude the possiblity that these 
were not clumps on the outside of cells, an XYZ section throught the cell was analysed. From this 
analysis, the signal was observed in close proximity to the nucleus and was surrounded by the red 
signal, corresponding to filamin A (Figure 4.14). If this observation is true, ESAT-6 had to 
exhibit membrane lysing activity to be detected throughout the cytosol of THP-1 cells.  
 
A 
B 
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Figure 4.13 Inclusion bodies with ESAT-6. THP-1 cells were grown in RPMI medium supplemented with 10% 
fetal bovine serum and 1% penicillin/streptomycin and differentiated for 48 hrs with 100nM PMA. The cells were 
treated with 2.5 µg/ml of ESAT-6 for 6 hrs. The culture cells were washed with 1X PBS, fixed and permeabilised. 
The fixed cells were double stained with monoclonal antibodies against ESAT-6 (mouse) and filamin A (rabbit) and 
were detected with secondary fluorescent antibodies (i.e. goat anti-mouse Alexa 488 and donkey anti-rabbit Cy3). 
The prepared slides were stained with DAPI to visualise the cell nuclei. A Zeiss LSM 510 laser scanning confocal 
microscope was used to acquire images. (A) represents the fluorescent signal for ESAT-6 using the 100X objective 
lens, (B) represents the DIC image, (C) represents the fluorescent signal for filamin A, (D) represents DAPI staining 
for the cell nuclei, (E) represents the overlay of images A – D and (F) represents the staining for ESAT-6 of the same 
area using the lower magnification 63X objective lens. The scale bar of images A – E is 10 µm and F is 20 µm. 
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Figure 4.14: XYZ section through THP-1 cells containing ESAT-6 inclusion bodies.  Figure represents data 
information from Figure 4.13E. The scale bar of the images is 20 µm. Images were enlarged using Zeiss LSM 510 
Meta software. 
 
4.1.7 In vivo co-immunoprecipitation of filamin A and ESAT-6 
 
The interaction between ESAT-6 and filamin A was investigated in Jurkat cells, since these cells 
demonstrate effective expression of filamin A. Cells with a high expression of protein of interest 
are normally preferred when analysing interactions of endogenous proteins. Semi-endogenous in 
vivo Co-IP was performed by transfecting recombinant ESAT-6 into the cytosol of Jurkat cells 
using the Pro-Ject transfecting reagent (Thermo Fisher Scientific, Rockford, IL). Cell lysates 
were prepared using Tissue Protein Extraction Reagent (TPER, Thermo Fisher Scientific, 
Rockford, IL) and Membrane Protein Extraction Kit (Mem-PER, Thermo Fisher Scientific, 
Rockford, IL). Cell lysates were precipitated with monoclonal antibodies against filamin A and 
were then analysed by Western blot using anti-ESAT-6 antibodies. The results demonstrated that 
ESAT-6 and filamin A co-precipitate together (Figure 4.15A), confirming the interaction shown 
by the yeast-2-hybrid and in vivo co-localisation studies detailed above. The interaction between 
ESAT-6 and filamin A was also demonstrated in reciprocal experiments, where 
immunoprecipitation of ESAT-6 resulted in co-precipitation of filamin A (Figure 4.15B). A 
stronger interaction between ESAT-6 and filamin A was observed in the membrane fractions 
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compared to the tissue cell lysates. This result is supported by literature, demonstrating that 
filamin A is partially inserted into the hydrophobic domain of liposomes (Tempel et al., 1994). It 
has also been shown that ESAT-6 destabilises and lyses liposomes (de Jonge et al., 2007). 
Together, the results from the yeast-2-hybrid, in vivo co-localisation and co-immunoprecipitation 
studies, confirmed the biological interaction between mycobacterial ESAT-6 and host filamin A.  
 
 
Figure 4.15: In vivo co-immunoprecipitation filamin A and ESAT-6. Jurkat cells were transfected with ESAT-6. 
Membrane and tissue cell lysates were prepared using the Membrane Protein Extraction kit (Thermo Fisher 
Scientific, Rockford, IL) and Tissue Protein Extraction Reagent (Thermo Fisher Scientific, Rockford, IL). The 
presence of ESAT-6 and filamin A was detected by Western blot with anti-ESAT-6 (lane A1) and anti-filamin A 
(lane B1), respectively.The membrane and tissue cell lysates were immunoprecipitated with anti-filamin A (lanes A3 
and A5) and anti-ESAT-6 (lanes B3 and B5) conjugated to protein G and analysed for precipitation by Western blot 
using anti-ESAT-6 and anti-filamin A, respectively. Unconjugated protein G and anti-prosaposin conjugated to 
protein G served as negative controls (lanes A7, A8, B7 & B8). Lanes A2 and B2 served as a control to test the 
crosslinking reaction by preventing the co-elution of antibodies with precipitated proteins. 
 
4.1.8 Effect of ESAT-6 on Jurkat cells and endogenous filamin A 
 
A number of intracellular pathogens including Salmonella, Yersinia, Shigella and Eschericia coli 
are dependent on the manipulation of cytoskeletal dynamics for intracellular survival (Hestvik et 
al., 2005). Filamin A mediates interactions between cytoskeletal proteins and in a manner 
controls cytoskeletal dynamics of host cells. In this section, the next question was whether the 
protein levels of filamin A were affected by the presence of ESAT-6 in Jurkat cells.  
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Western blot was used to examine the endogenous level of filamin A in Jurkat cells treated with 
1, 2.5 and 5 μg/mL of ESAT-6 and CFP-10. In each well,          cells were seeded. In order to 
verify whether any observed effect was dependent and specific to ESAT-6, treatment was 
performed with CFP-10 in a separate experiment to act as a control. Cells were lysed after 24 hrs 
of treatment with ESAT-6 and CFP-10, respectively. The same amounts of cell lysates were then 
analysed by Western blot with anti-filamin A antibodies. Anti-β-tubulin was used to equilibrate 
the loading amounts of cell lysates (Figure 4.16). When Jurkat cells were treated with higher 
concentrations of ESAT-6 (higher than 2.5 μg/mL), both filamin A and β-tubulin proteins 
disappeared and could not be detected by Western blotting anymore (lanes 4 and 5 in Figure 
4.16A and B). However, the abundance of filamin A and β-tubulin remained unchanged in the 
presence of the same high concentrations of CFP-10, suggesting that the effect demonstrated is 
specific to ESAT-6. A possible reason for the fact that no observable protein bands were present 
at higher concentrations of ESAT-6, may be related to the cytolytic properties and induction of 
cell death by ESAT-6, which lead to the destruction of these cells and the concurrent loss of 
protein content.  
 
 
Figure 4.16: Expression levels of filamin A in the presence of ESAT-6 and CFP-10. Jurkat cells were seeded at a 
cell density of        and treated with 1 μg/mL (lanes 2 and 5), 2.5 μg/mL (lanes 3 and 6) and 5 μg/mL (lanes 4 
and 7) ESAT-6 or CFP-10, respectivly. Lane 1 is the untreatd control. Tissue cell lysates were prepared using the 
Tissue Protein Extraction Reagent (Thermo Fisher Scientific, Rockford, IL). The presence of Filamin A and β-
tubulin were detected by Western blot with anti-filamin A and β-tubulin antibodies.  Anti-β-tubulin was used to 
equilibrate the loading amounts of cell lysates. The abundance of filamin A and β-tubulin remained unchanged in the 
presence of varying levels of CFP-10, while the filamin A and β-tubulin were undetected at a higher concentrations 
of ESAT-6. This result is likely due to the cytolytic properties of ESAT-6.  
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In order to examine the events that occur at a higher concentration of ESAT-6, cells were treated 
with 2 μg/mL of ESAT-6 (and CFP-10 as a negative control) and lysates were prepared at various 
time points. ESAT-6 has been shown to induce expression of caspase genes in a dose-dependent 
manner, and filamin A, in turn, has been shown to be a substrate for cleavage by activated 
caspases (Browne et al., 2000; Umeda et al., 2001). Therefore, if ESAT-6 is involved in 
prompting a death signal that leads to the activation of proteases, cleavage of filamin A should be 
observed. Jurkat cells were also treated separately and in parallel with etoposide. Etoposide 
activates the apoptosis cascade by inducing the expression of caspase-related genes (de Bruin et 
al., 2003), and were thus used as a positive control for caspase activation and caspase-associated 
filamin A degradation. Cells were lysed at pre-determined time points (0, 1, 2, 4, 6, 12 and 24 
hrs) after treatment with 2 μg/mL of ESAT-6. As shown in Figure 4.17, the levels of filamin A 
remained unchanged in the presence of CFP-10. However, in cells treated with ESAT-6, 
endogenous filamin A demonstrated significant breakdown (Figure 4.18B) compared CFP-10 
treated Jurkat at 12 hrs (Figure 4.17). After 24 hrs, the protein content for both endogenous 
filamin A and  β-tubulin could only be faintly detected, similar to the results observed in lanes 4 
and 5 of Figure 4.16. This correlated well with the morphological changes seen in the case of 
etoposide-induced apoptosis used as a positive control (Figure 4.18A). The results demonstrate 
that treatment of Jurkat cells with ESAT-6 induces cleavage of filamin A.   
 
 
Figure 4.17 Expression level of filamin A and β-tubulin in the presence of CFP-10. Jurkat cells were seeded and 
treated with 2 μg/mL CFP-10. Tissue cell lysates were prepared using the Tissue Protein Extraction Reagent 
(Thermo Fisher Scientific, Rockford, IL). The presence of filamin A (Image A) and β-tubulin (Image B) was 
detected by Western blot with anti-filamin A and β-tubulin antibodies.  Anti-β-tubulin was used to equilibrate the 
loading amounts of cell lysates. The abundance of filamin A remained unchanged in the presence of CFP-10. 
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Figure 4.18 Expression level of filamin A and β-tubulin in the presence of  ESAT-6 and etoposide. Jurkat cells 
were seeded and treated with 2 μg/mL ESAT-6 (A) or etoposide (B). Tissue cell lysates were prepared using the 
Tissue Protein Extraction Reagent (Thermo Fisher Scientific, Rockford, IL). The presence of filamin A (Images A1 
and B1) and β-tubulin (Images A2 and B2) was detected by Western blot with anti-filamin A and β-tubulin 
antibodies.  Anti-β-tubulin was used to equilibrate the loading amounts of cell lysates. At 12 hrs after treatment with 
ESAT-6 and etoposide, significant cleavage products of filamin A was observed (lanes 12 in images A1 and B1) and 
a 24 hrs after treatment the proteins were only barely detectable. 
 
4.1.9 Cytotoxicity and cell death mediated by ESAT-6 
 
An unusual morphological structure was observed for the cell nuclei of THP-1 cells treated with 
ESAT-6 during the co-localisation experiments. The nuclei demonstrated dot-like structures that 
are suggestive of DNA fragmentation (see Figure 4.9D). This feature is reminiscent of 
programmed cell death and also occurs during certain periods of necrosis (Gold et al., 1993). This 
observation is clearly portrayed in Figure 4.19, comparing nuclear morphology in cells treated 
and untreated with recombinant ESAT-6. The result demonstrates that access of ESAT-6 to the 
cytosol of THP-1 cells is associated with cell death (i.e. DNA fragmentation of the cell nuclei). 
This observation supports the hypothesis that ESAT-6 escapes inclusion bodies i.e. phagosomes 
and gain entry to the cytosol, leading to the induction of cell death (Simeone et al., 2012).  
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Figure 4.19: Comparison of THP-1 nuclear morphology in (A) treated and (B) untreated with recombinant 
ESAT-6. THP-1 cells treated with ESAT-6 demonstrated dot-like structures due to DNA fragmentation of the 
nucleas. Cell nuclei were stained with DAPI. The scale bar represents 20 µm. 
 
4.2 Discussion  
 
In order to identify host targets of the mycobacterial proteins ESAT-6 and CFP-10, a yeast two-
hybrid system was used to screen the constructed human lung cDNA library. Both C1QA and 
filamin A were identified as ESAT-6 interacting proteins. In an additional screen, C1QA was also 
identified as a binding partner for CFP-10. However, the interactions of C1QA with ESAT-6 and 
CFP-10 could not be confirmed, despite numerous attempts. Unfortunately, even though C1QA 
was shown to interact with both ESAT-6 and CFP-10 in the yeast nucleus, this interaction could 
not be demonstrated by subsequent in vitro and in vivo experiments. The yeast two-hybrid system 
is known for producing high numbers of false positive results, which may result from improper 
folding during the expression of bait and prey fusion proteins. This may result in improper 
folding presenting as unnatural structures, causing non-specific binding. It is thus possible that 
the interaction with C1QA could be one of these false positives. On the other hand, it is also 
possible that there could be other factors involved in the confirmatory experiments, such as 
buffering conditions of lysis buffers, which are not suitable to identify the interaction, so that the 
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interaction of C1QA with ESAT-6 and CFP-10 might still be true interactions. The yeast two-
hybrid systems detect interaction between bait and prey proteins expressed in yeast and present 
with the advantage that reporter genes may be activated by weak or transient interactions which 
are not detatable using in vivo detection methods. Alternative approaches to address the 
verification of weak or transient interactions are crosslinking- or label transfer-protein interaction 
analyses. 
 
Nonetheless, the interaction between filamin A and ESAT-6 was confirmed by both in vivo co-
localisation and co-immunoprecipitation, indicating that this was a true interaction between the 
mycobacterial and host proteins. 
 
The findings from this section of the work conclusively confirmed the interaction between 
filamin A and ESAT-6 and showed that ESAT-6 co-localised and co-immunoprecipitated with 
filamin A in host Jurkat and THP-1 cells. The co-immunoprecipitation results indicated that the 
majority of ESAT-6 interacting with filamin A was associated with the membrane fraction of 
Jurkat cells, rather than the tissue cell lysate. This observation is strengthened with the result 
presented in Figure 4.3A, demonstrating that ESAT-6 associated with the membrane fraction of 
THP-1 lysates, and that filamin A is a membrane-associated cytoskeletal protein. As the co-
immunoprecipitation result was not suitable to confirm a direct protein-protein interaction (as the 
precipitate may have consisted of a subset of proteins belonging to a larger protein complex), 
future studies using in vitro methods would be required to investigate whether there is in fact a 
direct interaction between ESAT-6 and filamin A.  
 
It has previously been shown that filamin A binds F-actin and associates with the plasma 
membrane and with numerous other intracellular signaling intermediates, including enzymes and 
scaffolding proteins (Hayashi and Altman, 2006). These findings indicate that filamin A plays an 
important role as an adapter molecule that links a wide variety of intracellular proteins to the 
actin cytoskeleton and cell membrane receptors (Hayashi and Altman, 2006). Pathogenic species 
of mycobacteria have been found to interfere with the host cell‘s actin filament network, 
influencing cellular processes ranging from migration, phagocytosis, motility and cellular 
adherence (Hestvik et al., 2005). Phagosomes containing pathogenic M. avium coincide with the 
disorganisation of the F-actin distribution in macrophages compared to uninfected cells (Guérin 
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and de Chastellier, 2000). We have shown that the abundance and/or molecular composition of 
filamin A in Jurkat cells were altered in the presence of ESAT-6. This alteration caused by 
ESAT-6 on Jurkat cells was similar to etoposide-induced cell death. Exposure of cells to 
etoposide induces endonucleolytic cleavage of DNA during the early stages of cell death, which 
is followed by cytoskeleton degradation (Kaufmann, 1989). Therefore, the evidence suggests that 
disorganisation and induction of cell death via the action of ESAT-6 are events that are not 
mutually exclusive. 
 
The ESX-1 system is required for secretion of effector proteins, including CFP-10 and ESAT-6, 
and is important for virulence of pathogenic mycobacterial species (McLaughlin et al., 2007). 
Mutants of M. bovis, M. marinum and M. tuberculosis lacking an intact ESX-1 secretion system 
or substrates necessary for secretion, have been shown to be attenuated in cultured macrophages 
and animal models of infection, demonstrating defects in cell-to-cell spread, altered cytokine 
profile or phagosomal maturation arrest (Gao et al., 2004; Smith et al., 2008; Kinhikar et al 2010; 
Welin et al., 2011). Moreover, it has been demonstrated that secretion of ESAT-6 by M. marinum 
causes the induction of membrane pores in bone marrow derived macrophages (Smith et al., 
2008). Therefore, it is suggested that ESAT-6 secretion by the ESX-1 system of M. marinum 
could play a direct role in producing pores in membranes of cells that contain mycobacteria, 
facilitating the escape from the vacuole into the cytosol, and enabling cell-to-cell spread (Smith et 
al., 2008). In this study, recombinant ESAT-6 exhibited membrane lysing activity on both THP-1 
(Figure 4.4) and Jurkat cells (data not shown, observed by visual inspection using light 
microscope), demonstrating the lytic phenotype of ESAT-6. Therefore, it suggests that ESAT-6 
had to lyse vacuolar membranes in order to be detected throughout the cytosol of THP-1 cells 
(Figure 4.16F). This hypothesis is consistent with the potential role of ESAT-6 in the disruption 
of phagosomal membranes, to release bacterial content into cytosol of infected cells to facilitate 
spread (Derrick and Morris, 2007). The findings are also in agreement with literature 
demonstrating that purified ESAT-6 from M. tuberculosis results in disruption and lysis of 
artificial lipid bilayers and liposomes (Hsu et al., 2003; de Jonge et al., 2007). As seen in Figure 
4.4, lysis of THP-1 cells correlated to a strong fluorescent signal of ESAT-6. Furthermore, the 
open reading frame for ESAT-6 from M. tuberculosis encodes a 95 amino-acid (aa) protein with 
90.5% similarity to its M. marinum homologue (Gao et al., 2004). Therefore, ESAT-6 secreted by 
M. tuberculosis may potentially share the same function with M. marinum, resulting in the 
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translocation of M. tuberculosis from the phagosomal compartments to the cytosol of infected 
cells.  
 
Recently, Simeone and coworkers (2012) have demonstrated that both M. marinum and M. 
tuberculosis gain access to the cytosol of infected macrophages, by taking advantage of a newly 
developed tool that allows for quantitative analysis of vacuolar rupture and cytosolic entry of 
bacteria. The authors revealed that phagosomal rupture was facilitated by ESAT-6 (Simeone et 
al., 2012). In addition, they demonstrated that phagosomal rupture precedes host cell death, which 
is in agreement with the work presented in this study (see Figures 4.23 and 4.25). Others have 
also demonstrated that ESAT-6 in its purified form induces cell death in macrophages (Derrick 
and Morris, 2007).  
 
Given that cell death in the form of apoptosis is a mechanism that the human host employ to 
remove infected cells, while reducing cell death and tissue destruction in nearby uninfected cells 
has importance in the control of M. tuberculosis infection (Abebe et al., 2011). In addition, M. 
tuberculosis can directly interfere with the induction of apoptosis of cells in vitro and it appears to 
be related to virulence in vivo (Keane et al., 1997, 2000; Rojas et al., 1997; Santucci et al., 2000). 
Furthermore, M. tuberculosis is able to promote necrotic death in infected human macrophages 
(Wong and Jacobs, 2011). A suitable explanation is that necrosis is important for dissemination 
within the host and cell-to-cell spread, but also blocking it to allow the pathogen to persist in the 
human host. In both aspects, M. tuberculosis may manipulate responses to favour of apoptosis 
(reducing inflammation, allowing for persistent infection) or necrosis (promoting tissue 
destruction, dissemination and spread to uninfected cells) (Abebe et al., 2011). In the light of 
these findings and documented reports in literature, we suggest expanding the knowledge of how 
M. tuberculosis actively control pathways related to cell death and could potentially identify 
mycobacterial or host features that can be targeted for vaccine development 
 
In conclusion, the results presented in this section show that ESAT-6 interacts with filamin A and 
precipitated a process which results in cell death. We suggest the following hypothesis for the 
progression of this process. ESAT-6 is an early-secreted antigen and is thus expressed and 
secreted from early after uptake of the bacterium by host cells, reaching a critical concentration 
required for vacuolar membrane destruction. It has been shown that secreted ESAT-6 has the 
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ability to facilitate phagosomal rupture, releasing the mycobacterium into the cytosol of infected 
cells (Simeone et al., 2012). As the process of phagosomal rupture is initiated, we speculate that 
small amounts of ESAT-6 leak into the cytosol via pore formation, preparing the cytosolic 
environment for mycobacterial entry. During this time, ESAT-6 interacts with filamin A and 
destabilises the actin cytoskeleton structure by inducing structural degradation of filamin A and 
inducing programmed cell death of the infected cells. As the mycobacterium enters the cytosol, 
the infected cells are unable to effectively recognise the pathogenic bacteria as a result of the 
initiation of cell death, leading to a deficiency in the acquired immune response. As M. 
tuberculosis exits the infected cell after cell death, it is taken up by newly arriving uninfected 
macrophages, resulting in disease progression. The results of the work presented here open the 
way to new exciting future studies to explore this and other hypotheses. This study highlights the 
importance of understanding the molecular events whereby M. tuberculosis manipulate and 
control cell death pathways, which can be exploited to gain insight into new approaches to 
control tuberculosis infection. 
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Chapter 5 
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5 Association studies of the C1Q gene cluster 
 
5.1 Results 
 
Filamin A and complement component 1q A (C1QA), identified during the yeast two-hybrid 
screens, were further investigated as genetic candidates for susceptibility to tuberculosis. The 
genetic analyses in this part of the study were completed before the outcome of the in vivo 
verification of the putative interactions was completed. A case-control study involving 604 cases, 
of which 109 were Tuberculous Meningitis (TBM) and 486 controls from the South African 
Coloured (SAC) population were selected from the Ravensmead-Uitsig sample cohort according 
to the description in section 2.17.1 (Chapter 2). The criteria for the selection of SNPs are 
discussed in sections 5.1.1 and 5.1.2. 
 
5.1.1 FLNA gene 
 
The filamin A (FLNA) gene is highly conserved and genetic evidence suggests that filamins are 
vital for human development. Filamin A is widely expressed in multiple organ types and controls 
actin cytoskeleton organisation by connecting integrins, transmembrane receptors and second 
messengers to the plasma membrane of host cells. Mutations found in the FLNA gene have been 
associated with human genetic developmental disease of the brain, bone, cardiovascular system, 
and many other organs in the human body (Feng and Walsh, 2004). Therefore, due to strong 
mutational influence resulting developmental disorders, only the promoter region of the FLNA 
(1kb upstream of ATG start site) was screened for SNPs that may possibly interfere with 
transcriptional binding sites or expression levels of filamin A that may contribute to tuberculosis 
susceptibility. 
 
5.1.1.1 PCR amplification of the promoter of FLNA  
 
DNA samples from 10 TB cases and 10 healthy individuals were amplified and sequenced using 
primers listed in Table 2.2 (Chapter 2). Due to the strong conservation of filamin A gene, only 20 
samples were screened to identify polymorphic sites in the promoter region. The amplified 
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products were resolved on a 1% TAE agarose gel and yielded a product size of 1181 bp (Figure 
5.1). The PCR products were purified and sequenced to screen for potential promoter variants. 
 
  
Figure 5.1: 1% TAE Agarose gel electrophoresis image of the PCR products of the FLNA promoter. (A) Lanes 
1 and 13 contain the 100bp ladder (Fermentas, Burlington, Canada). Lanes 2-11 represent the PCR products of TB 
patients and (B) lanes 14-23 represent the PCR products of healthy individuals. Lanes 12 and 24 represent the 
negative control of each PCR reaction. 
 
5.1.1.2 Sequence analysis 
  
The sequence information obtained by bidirectional sequencing using primers listed in Table 2.2 
(Chapter 2) was analysed using the BioEdit program to detect SNPs in the promoter region of the 
FLNA gene. Sequence analysis revealed a low-frequency SNP (G>C, 20%) indicated with arrow 
in Figure 5.2). Furthermore, sequence alignment demonstrated complete homology with the 
reference sequence of the FLNA gene (NCBI RefSeqGene NG_011506.1) (Figure 5.2). Due to 
the low frequency of variation across the promoter region of the FLNA gene; the investigation 
into the role of FLNA in tuberculosis susceptibility was discontinued. 
 
 
Figure 5.2: Sequence alignment of TB cases to the reference sequence of FLNA. Sequence alignment of the 10 
TB patients to reference sequence of FLNA (NCBI RefSeqGene NG_011506.1) revealed a low frequency SNP 
(indicated with arrow). The full length alignment demonstrated low rates of variation. 
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5.1.2 C1QA gene 
 
The most important molecular complexes affecting susceptibility to infectious disease are those 
related to immune defenses. Therefore, it was appropriate to investigate immune complexes that 
function during M. tuberculosis infection. It is well known that M. tuberculosis is phagocytosed 
via complement receptors expressed on human alveolar macrophages and that the classical 
pathway is more functional in the lungs than the alternative pathway (Ferguson et al., 2004). The 
C1Q molecule is the first component of the classical pathway that leads to activation of 
complement. 
 
The coding region for C1Q has been mapped to chromosomal position 1p34-36 and is composed 
of three genes, C1QA, C1QB and C1QC. The protein product of each of the three genes 
associates as six heterotrimers in a ‗bouquet-like‘ structure, forming the mature molecule (Figure 
3.14, Chapter 3). This molecule participates in the clearance of immune complexes and apoptotic 
cells. Structurally, C1Q is related to the family of collectins that play key roles in the innate 
immune response and defense against invading pathogens. Therefore, we hypothesised that C1Q 
related polymorphisms may influence the biological function of the C1q protein and thus may 
confer genetic susceptibility to Tuberculosis. 
 
For SNP selection, a literature search was done regarding associations between C1Q gene 
variants and various diseases in case control studies. The five selected SNPs were inspected for 
heterogeneity and minor allele frequencies (MAF) using the HapMap population groups 
(http://www.ncbi.nlm.nih.gov/snp). Table 5.1 lists the MAF of the five selected SNPs within the 
C1Q gene cluster. The power as a percentage of chance to detect risk associated effects is 
dependent on the MAF ≥ 0.05, which in this study was 90%. All selected SNPs complied with the 
requirements (see Table 5.1). Given the evidence in literature, the level of heterogeneity and the 
MAF ≥ 0.05, a case control study was designed to investigate the role of C1Q as a candidate for 
tuberculosis susceptibility in the South African Coloured Population. 
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Table 5.1: HapMap MAF of the five selected SNPs. The MAF of African, European and Asian populations of 
rs587585, rs665691, rs172378, rs12033074 and rs631090. 
  MAF: NCBI 
Marker Minor allele CEU YRI HCB JPT 
rs587585 G 0.128 0.429 0.151 0.128 
rs665691 C 0.438 0.841 0.64 0.669 
rs172378* A 0.583 0.169 - 0.367 
rs12033074 G 0.350 0.425 0.467 0.511 
rs631090 C 0.051 0.617 0.278 0.256 
CEU – Utah residents with ancestry from northern and western Europe 
YRI – Yoruba in Ibadan 
HCB – Han Chinese in Beijing 
JPT – Japanese in Tokyo 
*low coverage population panel (CHB and JPT combined) 
 
5.1.2.1 TaqMan allelic discrimination results 
 
The selected variants spanning the C1Q gene complex were genotyped by PCR using pre-
developed TaqMan SNP genotyping assays. After amplification, allelic discrimination was 
performed by end point plate reading using the ABI Real-time PCR system 
(http://www.appliedbiosystems.com/). The plate readings were analysed using the SDS 2.3 
software to measure the amount of fluorescence and to convert the fluorescent signal into allelic 
discrimination plots. An example of the end point results of rs631090 is shown in Figure 5.3, 
representing the allelic discrimination plots obtained using the SDS software 
(http://www.appliedbiosystems.com). The plate readings of the end point analyses were exported 
and the sample IDs were assigned to each reading. 
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Figure 5.3: Representative result for a TaqMan allelic discrimination plot. Genotyping results for rs631090 
representing the allelic discrimination plot generated using SDS software (Allele Y → T and Allele Y → C). 
 
5.1.2.2 Genotype and allele frequencies 
 
The success rate of genotyping (the percentage of samples that could be analysed) was >95% for 
all genetic variants in both cases and controls. The genotype and allele frequencies of the five 
SNPs in the controls, pulmonary tuberculosis (TB) and Tuberculous Meningitis (TBM) are 
shown in Table 5.2. The distributions of genotype and allele frequencies of the C1Q gene 
variants, in both case and control groups, were in Hardy-Weinberg Equilibrium (P > 0.05) and 
were subjected to further analysis. 
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Table 5.2: Genotype and allele frequencies of the C1Q gene variants in the control, tuberculosis and 
Tuberculous Meningitis group. Hardy Weinberg Equilibrium was determined for each individual SNP and the 
corresponding HWE P values are show at the bottom of each SNP section. All genetic variants segregated according 
to the assumption of Hardy Weinberg (P > 0.05) and were subjected to further analyses. 
 
Control TB TBM 
rs587585 
AA 277 (0.58) 237 (0.49) 50 (0.46) 
AG 179 (0.37) 205 (042) 48 (0.44) 
GG 24 (0.05) 44 (0.09) 11 (0.10) 
A 0.764 0.699 0.679 
G  0.236 0.301 0.321 
    
HWE P – VALUE 0.473 0.972 0.917 
rs665691 
CC 59 (0.12) 49 (0.10) 9 (0.08) 
CG 211 (0.44) 205 (0.42) 50 (0.46) 
GG 213 (0.44) 235 (0.48) 49 (0.45) 
C 0.341 0.310 0.315 
G 0.659 0.690 0.685 
    
HWE P – VALUE 0.547 0.663 0.447 
rs172378 
AA 65 (0.14) 57 (0.12) 15 (0.14) 
AG 221 (0.46) 224 (0.46) 44 (0.42) 
GG 195 (0.41) 205 (0.42) 47 (0.44) 
A 0.365 0.348 0.349 
G  0.635 0.652 0.651 
    
HWE P – VALUE 0.849 0.724 0.373 
rs12033074 
CC 143 (0.30) 173 (0.36) 40 (0.37) 
CG 241 (0.51) 221 (0.46) 54 (0.50) 
GG 90 (0.19) 85 (0.18) 15 (0.14) 
C 0.556 0.592 0.615 
G 0.444 0.408 0.385 
    
HWE P - VALUE 0.517 0.325 0.632 
rs631090 
CC 50 (0.10) 69 (0.14) 20 (0.18) 
TC 218 (0.45) 225 (0.46) 49 (0.45) 
TT 213 (0.44) 191 (0.40) 40 (0.37) 
C  0.331 0.374 0.331 
T 0.669 0.626 0.669 
    
HWE P – VALUE 0.598 0.834 0.598 
 
Single SNP association tests were performed using allele, genotype, and dominant models. All 
analyses were adjusted to account for sampling differences in age and gender. The genotype and 
allelic frequencies of rs665691, rs172378 and rs631090 were similar in cases and controls and 
showed no significant association with TB or TBM cases (Table 5.3A). However, rs631090 
demonstrated an association at allele level with TB, whereas rs587585 demonstrated an 
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association at both allele and genotype level with TB (genotype: P = 0.001 and allele P = 0.000). 
No significant associations were seen in the TBM cases with rs631090 and rs587585.  
 
Although the G-allele frequencies for rs587585 were comparable between TB and TBM (0.301 
and 0.321 vs. controls 0.236), rs587585 was associated with TB but not TBM, possibly due to the 
small sample number of TBM cases (n = 109). Furthermore, rs12033074 demonstrated a weak 
association in the TBM group, but as a result of the small sample size of the TBM group, no 
concrete conclusion could be made. No significant associations were observed with the dominant 
model demonstrating that the observed associations are likely additive. A summary of the 
significant additive effects of the associated allele are shown in Table 5.3B.  
 
Table 5.3: Results from association analyses of rs587585, rs665691, rs172378, rs12033074 and rs631090. (A) 
Significant association at genotype, dominant and allelic level. (B) Additive effects of allelic associations (markers in 
table A are colour coded to markers in table B). 
A  Marker Genotype Dominant Allelic 
 TB TBM TB TBM TB TBM 
rs587585 0.001** 0.158 0.703 0.058 0.000** 0.745 
rs665691 0.186 0.424 0.558 0.822 0.082 0.197 
rs172378 0.559 0.300 0.437 0.662 0.454 0.137 
rs12033074 0.122 0.045* 0.469 0.423 0.055 0.018* 
rs631090 0.050 0.881 0.590 0.946 0.017* 0.618 
P value less than 0.05* and 0.001** 
TB – Tuberculosis 
TBM – Tuberculous Meningitis 
B   Marker Diagnosis Allele OR 95% CI 
rs587585 TB G 1.48 1.21 1.82 
rs12033074 TBM G 4.98 1.30 24.31 
rs631090 TB C 1.25 1.04 1.51 
 
Among the identified SNPs, the G allele of rs587585 was significantly associated with TB in the 
additive model (P = 0.002, OR: 1.48 95% CI 1.21 – 1.82). Similarly, the C allele of rs631090 was 
associated with TB (P = 0.018, OR 1.25 95% CI 1.04 – 1.51) using the same model. Given these 
results, it seems likely that rs587585 contributes more to tuberculosis susceptibility than 
rs631090. 
 
In the current analysis we did not use Bonferroni correct for multiple testing, which refers to a 
situation that involves the simultaneous testing of more than one association within the same 
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sample population (Nyholt, 2004), with risk of eliminating important findings. The 
inappropriateness of Bonferroni, in this instance, is the unlikelihood that all genes important for 
susceptibility can be found a priori with tuberculosis (Perneger, 1998), whereas Bayesian 
methods for correction relies on prior knowledge of involvement, which is currently unknown for 
most genetic variants (Campbell and Rudan, 2002). 
 
5.1.3 Linkage disequilibrium and haplotype analysis 
 
To delineate the haplotype architecture of the C1Q gene complex, linkage disequilibrium and 
haplotype analyses were performed. The linkage disequilibrium, measured by D', suggested that 
rs587585 and rs665691 were in moderate disequilibrium across a genetic region of 2 kb (D' = 
0.99, r
2
 = 0.18, Figure 5.4). The haplotype frequencies within block 1 are shown in Table 5.4. 
 
 
Figure 5.4: LD structure for rs587585, rs665691, rs172378, rs12033074 and rs631090. Linkage block (2kb) 
between marker rs587585-rs665691 was in moderate disequilibrium (D‘ = 0.99, r2 = 0.18). 
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Table 5.4: Haplotype pairs of rs587585 and rs665691. Haplotype frequency of rs587585-rs665691 in case and 
controls. The odds ratio corresponding to the reference haplotype is 1.  Note that if the odds ratio is significant, the 
95% confidence intervals do not span 1. The data is interpreted as follows: G-G haplotype compared to the A-G 
haplotype increases the odds of TB with 45% (between 15 and 82%, with 95% confidence). 
 
 
 
 
 
Haplotype analysis was performed to determine if certain haplotype pairs were transmitted 
together more frequently. Statistically significant haplotype pairs for all loci are listed in Table 
5.5. Haplotype analysis revealed that the association from block 1 to block 5 decayed. This 
observation led to the conclusion that rs587585 contributed significantly to the association 
observed with haplotype rs587585-rs665691. To see whether rs587585 had any functional 
consequences, the serum levels of C1QA were assessed in 18 cases and 18 controls using an 
ELISA assay. 
 
Table 5.5: Results of haplotype associations. Haplotype frequencies were determined in R-project using a GLM-
ANOVA model; all analyses were adjusted for age and gender. The association from block 1-5 highlighted in orange 
demonstrates a decaying trend in association. 
TB Number in haplotype 
Starting SNP 2 3 4 All 
rs587585 0.0015 0.0140 0.0205 0.0830 
rs665691 0.2509 0.0436 0.0736  
rs172378  0.0347 0.0695   
rs12033074 0.0233    
rs631090     
Starting SNP 2 3 4 All 
rs587585 0.3925 0.7953 0.5469 0.9326 
rs665691 0.5632 0.3642 0.7344  
rs172378 0.1449 0.5343   
rs12033074 0.0056    
rs631090     
 
 
 
 
TB Frequency OR of TB, adjusted for 
age and gender 
Haplotype: Control Case OR 95% CI 
A-C 0.34 0.31 0.97 0.79 1.19 
G-G 0.24 0.30 1.45 1.15 1.82 
A-G 0.42 0.38 1   
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5.1.4 C1QA ELISA  
 
5.1.4.1 Analysis of normality  
 
In order to avoid inaccurate interpretation of the ELISA data, the normality was checked using 
the null hypothesis of the Shapiro-Wilk test that explores the distribution of samples and tests 
whether the data is distributed normally. In the analyses, a P-value of greater than 0.05 was 
considered as statistically significant. If the P-value was less than 0.05, then the null hypothesis 
that the data was distributed normally would be rejected, leading to inaccurate interpretation. 
 
The ELISA data fitted the linear distribution and the null hypothesis was therefore not rejected 
(P-value of 0.101). The ELISA measurements were distributed normally and further subgroup 
analyses were performed as follows: (1) TB vs. controls and (2) subgroups of the different 
genotypes in relation to TB and controls (Figure 5.5). 
 
 
Figure 5.5: Representation of the ELISA data distribution. The ELISA data of the total group fitted the linear 
distribution. The null hypothesis that the data was not distributed normally was rejected (P-value of 0.101). 
 
5.1.4.2 Group and subgroup analyses 
 
The results from the ELISA analyses revealed that the serum levels of C1QA were higher in TB 
subjects compared to control individuals (P = 0.037, Figure 5.6A). A significant difference was 
observed in the distribution of serum C1QA across the three genotypes of rs587585 (P = 0.0409, 
Figure 5.6B). Adding a G allele of rs587585 was associated with an increased level of circulating 
C1QA in the total sample group. 
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Figure 5.6: Levels of C1QA distribution between groups and subgroups. (A) Demonstrates an elevation in the 
serum levels in TB vs. controls. (B) Difference in serum levels of the three genotype of rs587585 in the total sample 
group. The GG genotype is associated with the highest C1QA levels.  
 
We stratified the groups according to controls and TB patients, and observed a dosage effect of 
the G allele. The observation was not significant, but demonstrated a trend (P = 0.098). The 
serum levels of C1QA remained constant in the controls, while increasing in TB patients (Figure 
5.7). This result demonstrated a functional trend associated with the GG genotype of rs587585. 
The apparent association of this SNP could also be due to linkage disequilibrium with the true 
functional variant or other genetic factors that could explain the elevation seen in GG individuals. 
 
 
Figure 5.7: Levels of C1QA distribution stratified according to subgroups and rs587585 genotypes. Levels of 
C1QA stratified according to the rs5857585 genotype in the TB and control group, demonstrated an increase in 
serum C1QA in the TB group vs. controls. The observation was not significant, but demonstrates a trend (P = 0.098). 
The elevation of serum C1QA in individuals with the GG genotype in the TB group could be a result of linkage with 
a true functional SNP or other genetic factors (a vs. b: no significant difference, but demonstrates a trend). 
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5.2 Discussion 
 
This study reports an association analysis of five polymorphisms of the C1Q gene cluster (i.e. 
C1QA, C1QB and C1QC) in ~500 cases and ~500 controls from the South African Coloured 
(SAC) population. The results showed a novel association of a regulatory variant located 
upstream of the C1QA gene and determined that C1QA serum levels showed a trend towards 
increased values in patients with the associated genotype. 
 
In our association study we screened 486 cases and 480 controls and demonstrated an association 
at both genotype and allele level with rs587585 (genotype: P = 0.001 and allele: P = 0.000; OR = 
1.48; 95% CI 1.21 – 1.82). We did not identify additional associations with C1Q and 
tuberculosis. One possible explanation is the incomplete polymorphism coverage of the C1Q 
gene cluster. The associations demonstrated were additive and together with other risk alleles 
may provide a synergistic interaction between multiple risk alleles.  
 
The G-allele of rs587585, located upstream of C1QA, demonstrated a trend towards increased 
serum levels, but this difference was not statistically significant (P = 0.0977). In the control 
individuals carrying the G-allele of rs587585, no significant elevation in serum levels was 
observed. Thus, other genetic factors may contribute to the increase observed in GG individuals 
infected with tuberculosis. A potential explanation for this observation could be linked to the 
measure of linkage disequilibrium between rs587585 and rs665691 located in the promoter 
region of C1QA (D‘ = 0.99, r2 = 0.18, Figure 5.5) that may possibly hold the true functional 
variant causing the increase in serum levels. Regulatory variants that are located hundreds of kb 
upstream can influence the control of gene expression (Forton et al., 2007; Stranger et al., 2007). 
Therefore it should be considered that other unidentified promoter variants could contribute to the 
observed phenotype, as well as other variants affecting the production of C1QA and ultimately 
the functional protein. In future studies the sample size of the ELISA cohort should be increased 
to verify the findings using freshly prepared serum from genotyped cases and controls. Currently, 
published methods for determining the levels of C1Q vary greatly in their application, results, and 
reproducibility. For further analysis, a protocol such as that described by Dillon et al., should be 
considered for the quantification of serum C1Q levels, as this method is an improvement in scale, 
theory, precision, reproducibility, cost efficiency and ease (Dillon et al., 2009). 
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The role of complement is very complex and serves the host by providing protection. It has been 
reported that C1Q binds both IgM and MBL, which co-operate to promote phagocytosis of 
apoptotic or necrotic cells (Xu et al., 2008). Therefore, one possible explanation for our finding is 
that the G allele of rs587585, is in linkage with the true functional variant and that higher levels 
of complement may facilitate opsonisation of dead or dying cells. The rapid clearance could 
possibly facilitate entry of M. tuberculosis into host cells via phagocytosis, and in so doing evade 
destruction by the host immune response. Another possible explanation has been recently 
described by Carroll and colleagues (2009). In this study, they demonstrated that M. bovis BCG is 
able to directly bind to C1Q, MBL and L-ficolin in both an antibody-dependent and independent 
manner (Carrol et al., 2009). It is thought that the activation of complement could be one of the 
mechanisms employed by macrophage-ingested mycobacteria to escape the immune system i.e. 
by remaining intracellular in the phagosome. Previous studies have shown that M. tuberculosis 
can activate complement and gain entry via macrophage complement receptors (Ramanathan et 
al., 1980; Schlesinger et al., 1990; Schlesinger, 1993; Ferguson et al., 2004). The involvement of 
the classical pathway has been demonstrated by the depletion of C1Q from serum, which 
significantly reduced the binding of C3 to M. tuberculosis in vitro. It has been shown that entry of 
M. tuberculosis is dependent on C3 opsonisation and that it is initiated by the classical pathway 
within the human alveolus (Ferguson et al., 2004).  
 
The genetic variants reported on in this study, have not previously been investigated in 
tuberculosis susceptibility and represent an intriguing area for future research. Variants within the 
C1Q gene cluster are typically associated with systemic lupus erythematous (SLE). In this study, 
rs587585 G allele demonstrated a trend of increased serum C1QA levels. However, Martens and 
co-workers demonstrated that the G-allele of rs587585 is associated with low serum C1Q levels 
and total hemolytic complement activity (CH50) in SLE Caucasian patients (Martens et al., 
2009). Similarly, in animal studies, a polymorphism in this regulatory region was also found to be 
associated with low C1Q levels in a murine model of New Zealand Black (NZB) mice; therefore 
the authors suggest that the region upstream of the C1Q gene cluster may possibly be important 
(Miura-Shimura et al., 2002), keeping in mind that functional variants may act differently within 
ethnically diverse populations. This difference in reported serum levels can be explained by the 
fact that our cohort is infected with tuberculosis compared to SLE patients and the sample cohort 
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are SAC compared to Caucasians or NZB mice. In addition, low C1Q and CH50 levels may also 
be a reflection of complement consumption by the disease activity of lupus (Martens et al., 2009).  
 
The etiology of lupus remains unknown and is characterised by autoantibodies against self-
antigens, leading to inflammation-mediated multi-organ failure. The majority of deaths in SLE 
patients are caused by infection, renal failure and cardiovascular diseases. In most cases, 
infections are caused by gram-positive or gram-negative bacteria, with an increased prevalence of 
M. tuberculosis infection. These opportunistic infections explain the increase of mortality 
observed in lupus patients (Agrawal and Prabu, 2010). 
  
The surge of M. tuberculosis infection in SLE is caused by a defective immune system and the 
treatment of immunosuppressive therapy, including high doses of corticosteroids. Normally the 
response to infection involves cellular immunity and in lupus patients this system is deficient, 
which is due to the features of the disease and the effects of immunosuppression (Agrawal and 
Prabu, 2010). The clinical presentation of tuberculosis and lupus may present with similar 
phenotypes and at times, mimic each other. The probability of lupus patients developing 
tuberculosis depends on the population prevalence and incidence of tuberculosis within a 
geographical area (Agrawal and Prabu, 2010). In some instances tuberculosis may precipitate 
lupus, especially in a genetically predisposed individual living in endemic areas (Ghosh et al., 
2009). 
 
Wadee and colleagues reported that in South African hospitals, death in lupus patients is mainly 
associated with infections and documented that three of the 18 infection-related deaths were due 
to tuberculosis (Wadee et al., 2007). A similar observation was demonstrated in lupus patients 
hospitalised in KwaZulu-Natal (Mody et al., 1994). In a retrospective review of tuberculosis in 
SLE patients from South Africa, they reported that 13.6% of all lupus and lupus-like patients 
contracted tuberculosis during the course of follow up, of which 26.4% had extra-pulmonary 
disease (Wadee et al., 2007). 
  
It is interesting to speculate that there exists interplay on a biological level where the one disease 
precipitates the other and vice versa, and this may possibly lead to the identification of genes and 
pathways involved in both diseases. 
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Lastly, the work presented in this section of the work demonstrates a novel association with the 
regulatory variant, rs587585, located upstream of the C1QA gene. The associated genotype 
demonstrates an increased trend with elevated levels of C1qA in patients infected with M. 
tuberculosis.  In any situation, there may be additional complement related genes and an 
undefined cluster of genes in close vicinity to the C1Q gene complex that may be involved in 
tuberculosis susceptibility and warrants further investigation. 
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Chapter 6 
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6 Conclusion 
 
Tuberculosis (TB) is one of the most ancient diseases known to mankind and has re-emerged in 
recent years as one of the leading causes of death worldwide. Mycobacterial pathogenesis is 
characterised by a high rate of infectivity and long periods of persistence without disease. The co-
habitation of the mycobacterial and host immune cells, results in the regulation of sophisticated 
mechanisms that are advantageous to either the host or microbe. Defining these relationships 
offers rich opportunities to reveal relevant human-mycobacterial interactions. The elucidation of 
these mechanisms is critical in understanding how disease phenotypes manifest during infection. 
As such interactions can either facilitate or neutralise intracellular growth of the mycobacterium, 
the characterisation thereof provides new ventures for therapeutic strategies through the 
understanding of mycobacterial physiology and biological interactions that can be manipulated to 
control tuberculosis infection. 
 
In this study, a systematic high-throughput technique called the yeast two-hybrid system was 
employed to identify host interacting binding partners of secretory antigens, ESAT-6 and CFP-
10. Although our data demonstrated a high level of false positive hits, this study did identify at 
least two possible host interacting proteins of ESAT-6 and CFP-10, of which one was 
subsequently confirmed through in vivo and in vitro methods. This raised new questions and 
demonstrates the usefulness of the yeast two-hybrid assays, to capture potential protein-protein 
interactions. The opening hypothesis of this study was to gain insight into the functions of ESAT-
6 and CFP-10, and their role in host-pathogen interactions. More specifically, we aimed to obtain 
some level of understanding on how M. tuberculosis evades immune responses and how secreted 
substrates regulate the host infection.  
 
The results from this study illustrated the plausible interaction between ESAT-6 and the host 
protein, filamin A. This finding was confirmed using co-localisation and co-immunoprecipitation. 
The co-immunoprecipitation results showed that the majority of ESAT-6 interacting with filamin 
A associated with the membrane fraction, rather than the cell lysate. This observation is in 
agreement with literature validating the role of purified ESAT-6 from M. tuberculosis causing 
disruption and lysis of artificial lipid bilayers and liposomes by the interaction of ESAT-6 with 
host membranes (Hsu et al., 2003; de Jonge et al., 2007). Furthermore, ESAT-6 induced cleavage 
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of filamin A and we therefore suggest that ESAT-6 influences the dynamics of cytoskeletal 
proteins for intracellular survival, as was previously observed in Salmonella, Yersinia, Shigella 
and Eschericia coli (Hestvik et al., 2005). In addition, we emphasise the role of ESAT-6 in 
influencing cell death pathways in order to replicate and spread. From these results, we conclude 
that the release of ESAT-6 into the cytosol of infected cells and induction of cell death are events 
which are not mutually exclusive and are prerequisites for cell-to-cell spread. Furthermore, we 
hypothesise that during the release the interaction between ESAT-6 and filamin A weakens the 
cytoskeletal structure by inducing structural degradation of filamin A. This study, together with 
others (Lee et al., 2011; Simeone et al., 2012), highlights the importance of understanding the 
molecular events whereby M. tuberculosis manipulate and control cell death pathways, which can 
be exploited to gain insight into new approaches to control tuberculosis infection. 
 
In addition to the research question to identify host targets that interact with secretory substrates 
of M. tuberculosis, we designed an additional study to investigate the identified binding partners 
(filamin A and C1QA) as possible genetic markers for susceptibility studies to tuberculosis. A 
case-control study involving 486 cases and 480 controls from the South African Coloured 
population within the Ravensmead-Uitsig area (an epidemiological field site near Cape Town) 
were selected to investigate the role of selected gene variants and tuberculosis susceptibility. In 
our analysis, we demonstrated a novel association of a regulatory variant located upstream of the 
C1QA gene. Furthermore, we stratified the control and tuberculosis patients according to the 
rs587585 genotype and demonstrated that the associated genotype displayed an increasing trend 
towards increased levels of C1q in tuberculosis patients. The complement system functions by 
providing the host with initial protection by promoting phagocytosis of apoptotic or necrotic 
cells. Consequently, the elevated levels of C1q as a result of the associated genotype may 
facilitate opsonisation of dead or dying cells, facilitating rapid uptake of M. tuberculosis into host 
cells via phagocytosis, and thereby escaping host immune responses. This is the first study to 
initiate the investigation of C1Q gene polymorphisms in tuberculosis susceptibility and presents 
as an interesting area for further research. 
 
In an effort to better understand the results presented in this dissertation, the following future 
research should be considered. 
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To address and expand our knowledge of host-pathogen interactions, appropriate tools should be 
in place to strengthen the throughput of identifying PPIs. A weakness of the present study was the 
problem of out-of-frame constructs. Future studies should consider the use of Gateway vectors to 
address this problem. This technology, which was not available at the time when our study was 
initiated, uses site-specific recombination functions of phage λ. The bait insert or cDNA material 
is cloned into the donor (pDONR) vector. Using site-specific LR reactions, the sequences are 
shuttled into Gateway modified pGBKT7 or pGADT7 vectors (Figure 6.1 A & B). The 
recombination reactions are highly efficient, quick and simple. The addition of one and two 
nucleotides (Figure 6.1 C & D) enables correct expression of the bait and prey vectors in all three 
reading frames (Maier et al., 2008). 
 
 
 
Figure 6.1: Illustration and description of the set of six Gateway-compatible yeast two-hybrid (Y2H) pGBKT7 bait 
vector (A) and pGADT7 prey vector (B). Each vector was constructed using blunt-end cloning using the three 
Gateway cassettes in forward (C) and reverse (D) direction into the original SmaI restriction site. The first part of the 
SmaI site is underlined and the bases inserted to shift the reading frame are highlighted in gray (Maier et al., 2008). 
 
The modified Gateway Y2H vectors are fully functional and do not influence the selection system 
in yeast or activate transcription of reporter genes (Maier et al., 2008). The total number of 
positive transformants will be divided across three pGADT7 vectors via Gateway 1, 2 and 3 
making this approach more laborious. However, this technique may increase the number of 
correct fusion proteins and therefore ultimately the number of in-frame interactions. As 
mentioned before, this technique was only published in 2008 and was not available when the 
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study commenced. It could therefore not be applied to the present study, since the experimental 
work was already well in progress when it became available. 
 
The combination of Gateway vectors and appropriate mRNA for the construction of a screening 
library, in future, may increase the specificity and coverage of a cDNA library screen. The 
libraries prepared should be representative of the biological content of interest, as in the case of 
this study, using lung mRNA to construct a cDNA library. Future studies may also focus on 
mRNA extracted from M. tuberculosis infected macrophages or T-cells, to enrich the expression 
of mRNA transcripts specific to M. tuberculosis infection. The construction of such a library will 
be uniquely descriptive of the gene expression pattern that defines the response to M. tuberculosis 
infection. 
 
The classical Y2H is created to reconstruct a transcription factor and is not suitable for proteins 
that can activate transcription. The use of such baits would trigger transcription and would not be 
ideal for screening purposes. In future, if bait vectors enable self-activation of selection genes 
(i.e. HIS3, ADE2 and MEL1); then alternative yeast two-hybrid methods should be considered.  
 
Alternative systems to analyse proteins like these can be based on methods suppressing 
transcription, using an alternative polymerase III transcription pathway or the split-ubiquitin type-
systems. However, all of the above systems require that interaction takes place in the nucleus, 
which is not suitable for membrane associated, integral membrane and soluble cytosolic proteins. 
Table 6.1 provides a brief description of the current available Y2H techniques to aid in choosing 
the right strategy and condition to increase the sensitivity of the Y2H screen for future studies 
(Brückner et al., 2009). 
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Table 6.1: Variations of Y2H systems and their specificities (Brückner et al., 2009). 
Year Y2H method Possible baits Response Location
  
1989 Classical Y2H Non-transactivating proteins 
capable of entering nucleus 
Transcriptional activation Nucleus 
1994 SOS recruitment Transactivating, cytosolic 
proteins 
Ras signaling Membrane 
periphery 
1994 Split-ubiquitin Nuclear, membrane and 
cytosolic proteins 
Uracil auxotrophy and 5-FoA 
resistance 
Cytosol 
1998 Membrane split-
ubiquitin 
Membrane proteins Transcriptional activation Membrane 
periphery 
1998 Ras recruitment Transactivating, cytosolic  Ras signaling Membrane  
1999 Dual bait Two non-transactivating proteins 
capable of entering nucleus 
Transcriptional activation Nucleus 
2000 G-protein fusion Membrane proteins Inhibition of proteinG 
signaling 
Membrane 
periphery 
2001 RNA polymerase 
III based 
Transactivating proteins (in the 
RNA pol II pathway) 
Transcriptional activation Nucleus 
2001 Repressed 
transactivator 
Transactivating proteins capable 
of entering nucleus 
Inhibition of transcriptional 
activation 
Nucleus 
2001 Reverse Ras 
recruitment 
Membrane proteins Ras signaling Membrane 
periphery 
2003 SCINEX-P Extracellular and transmembrane 
proteins 
Downstream signaling and 
transcriptional activation 
Endoplasmic 
reticulum (ER) 
2004 Split-Trp Cytosolic, membrane proteins Trp1p activity Cytosol 
2007 Cytosolic split-
ubiquitin 
Transactivating, cytosolic 
proteins 
Transcriptional activation ER membrane 
periphery 
 
Further work could also be done with regard to the further elucidation of the filamin A-ESAT-6 
interactions. Since the results of the co-immunoprecipitation may consist of a subset of proteins 
belonging to a larger protein complex, future studies should aim to validate the direct protein-
protein interaction between ESAT-6 and filamin A.  
 
Experimentally, the precipitated protein complex could possibly be analysed by combining Blue 
Native (BN)-PAGE retardation assay and mass spectrometry analyses to identify interactions of 
biomolecules within a protein complex. Following the results of mass spectrometry, each 
identified target should be validated by in vitro methods to identify the true binding partner. This 
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approach would me more favourable since physiological host-pathogen interactions are more 
likely to occur in complexes and therefore the importance should not be disregarded.  
 
Given that we observed DNA fragmentation of nuclei in cells treated with ESAT-6 and the 
evidence that ESAT-6 is involved in the induction of cell death pathways, future studies may 
focus on isolating nuclear RNA from tissue culture cells treated with ESAT-6 in a time course 
manner. The up and down regulated genes may then be extracted from the dataset to identify the 
biological pathways involved in the induction of cell death pathways, specific to mycobacterial 
infection. The information taken from this study may further promote our understanding of how 
M. tuberculosis manipulates host mechanisms in favour of itself. 
 
Future studies should also be conducted to confirm the association between rs587585 and 
tuberculosis, by exploring the associations in other populations (i.e. Caucasians and Black 
individuals) before firm conclusions can be drawn on the true genetic association.  Furthermore, 
additional C1Q polymorphisms should be genotyped in a larger sample cohort to increase 
coverage of the C1Q gene complex and to improve statistical power. In this study, rs587585 was 
associated with C1QA serum levels and since the function of this variant was not identified in 
this study, future studies should focus on confirming the levels of C1QA in a larger cohort of 
genotyped cases and controls to identify the true function of this variant. In addition, reporter 
gene assays should be considered to evaluate the promoter activity of rs587585 and the effect of 
gene expression of C1QA. 
 
Given the evidence that lupus and tuberculosis may at times mimic each other (Agrawal and 
Prabu, 2010), it is interesting to speculate that genes and molecular pathways may exist that could 
explain the similarities between tuberculosis and lupus. Therefore, follow up studies should focus 
on investigating genes involved in the classical complement pathway (for example C1Q, C3 and 
C4) in TB, since numerous studies have focused on investigating the role of complement in SLE 
patients (Miura-Shimura et al., 2002; Martens et al., 2009; Namjou et al., 2009; Mok et al., 2010; 
Rafiq et al., 2010; Said et al., 2010; Hayakawa et al., 2011; Katsumata et al., 2011) and together 
with the existing body of evidence that document an increase in tuberculosis susceptibility among 
SLE patients, could therefore be a worthwhile research direction. This study should be designed 
to include significant SNP coverage of genes, a larger study cohort and the measurement of 
Stellenbosch University  http://scholar.sun.ac.za
   
137 
 
serum complement levels of genes under investigation. Given the design of the study, it provides 
the possibility of investigating gene-gene interactions within the classical pathway. 
 
In conclusion, the present study represents a noteworthy contribution to the field of host-pathogen 
interaction research. It identified at least one confirmed interaction of a mycobacterial virulence-
associated protein with a host protein and paved the way to further investigate the physiological 
role of the interaction between ESAT-6 and filamin A. In addition, this study has initiated and 
demonstrated the novel role of complement related genes in tuberculosis susceptibility, which has 
unlocked exciting areas for additional research. 
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Appendix 1 
 
Preparing buffers and media for E. coli cultures 
 
Reagents and materials 
 
IPTG stock solution (0.1M) 
 Dissolve 1.2 g of IPTG into 50 mL of dH2O.  
 Filter-sterilise, aliquot and store at 4°C. 
 
X-Gal (20 mg/mL)  
 Dissolve 40 mg of 5-bromo-4chloro-3-indolyl-β-D-galactoside into 2 mL N, N‘-dimethyl-
formamide.  
 Cover with aluminium foil and store at 4°C. 
 
Ampicillin (100 mg/mL) 
 Dissolve 1 g of ampicillin into 10 mL of dH2O.  
 Filter-sterilise and store at -20°C 
 
Kanamycin (50 mg/mL) 
 Dissolve 0.5 g of kanamycin into 10 mL of dH2O.  
 Filter-sterilise and store at -20°C  
 
LB medium (per liter) 
 10 g Bacto® -tryptone 
 5 g Bacto® -yeast extract 
 5 g NaCl 
 Adjust pH to 7.0 with NaOH 
 
LB plates with ampicillin 
 Add 12 g agar to 1L of LB medium, autoclave.  
 Allow the medium to cool to 50°C before adding ampicillin to a final concentration of 
100 μg/mL.  
 Pour 30-35 mL of medium into 85mm petri dishes.  
 Let agar harden.  
 Store at 4°C (1 month) or at room temperature (1 week) 
 
LB plates with ampicillin/IPTG/X-Gal 
 Add 100 μL of 0.1M of IPTG and 100 μL of 20mg/mL X-Gal, spread over the surface of 
LB-ampicillin plate.  
 Allow to absorb for 30 minutes prior to use. 
 
SOB medium 
 20 g Bacto-Tryptone 
 5 g   Bacto-Yeast extract 
 0.5 g NaCl 
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 2.5 mL 1M KCl 
 
 Dissolve into 800 mL dH2O. 
 Adjust pH to 7.0 with 10M NaOH. 
 Adjust volume to 990 mL with dH2O.  
 Sterilise by autoclaving and store at room temperature.  
 Before use, add 10 mL sterile 1M MgCl2. 
 
SOC medium 
 Identical to SOB media, except that it contains 20 mL sterile 1M glucose 
 
1M MgCl2 (1 L) 
 Dissolve 203.31 g of magnesium chloride-6H2O into 800 mL dH2O.  
 Adjust volume to 1 L with dH2O.  
 Divide in aliquots of 100 mL and sterilise by autoclaving.  
 Store at room temperature. 
 
1M KCl (1 L) 
 Dissolve 74.56 g of potassium chloride into 800 mL dH2O.  
 Adjust volume to 1 L with dH2O.  
 Sterilise by autoclaving.  
 Store at room temperature. 
 
Preparing buffers and media yeast culturing 
 
YPDA Liquid (1 L) 
 50 g YPD  
 15 ml of 0.2% stock solution  L-adenine hemisulphate   
 Dissolve into 900 mL dH2O. 
 Adjust pH to 6.5 if necessary. 
 Adjust volume to 1 L with dH2O.  
 Sterilise by autoclaving.  
 
YPDA Agar (1 L) 
 50 g YPD  
 20 g Bacto Agar 
 15 ml of 0.2% stock solution  L-adenine hemisulphate   
 Dissolve into 900 mL dH2O. 
 Adjust pH to 6.5 if necessary. 
 Adjust volume to 1 L with dH2O.  
 Sterilise by autoclaving.  
 
2X YPDA Liquid (1 L) 
 100 g YPD  
 15 ml of 0.2% stock solution  L-adenine hemisulphate   
 Dissolve into 900 mL dH2O. 
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 Adjust pH to 6.5 if necessary. 
 Adjust volume to 1 L with dH2O.  
 Sterilise by autoclaving.  
 
 
0.5 X YPDA Liquid (1 L) 
 25 g YPD  
 15 ml of 0.2% stock solution  L-adenine hemisulphate  
 Dissolve into 900 mL dH2O. 
 Adjust pH to 6.5 if necessary. 
 Adjust volume to 1 L with dH2O.  
 Sterilise by autoclaving.  
 
0.2% L-Adenine Hemisulphate stock 
 Dissolve 0.2 g of L-adenine hemisulphate into 100 mL of dH2O.  
 Filter-sterilise and store at room temperature 
 
Synthetic Defined (SD) Dropout (DO) Liquid (1L) 
 26.7 g of minimal SD base. 
 Add the amount supplement required (see list below*) 
 Dissolve into 900 mL dH2O. 
 Adjust pH to 5.8. 
 Adjust volume to 1 L with dH2O.  
 Sterilise by autoclaving.  
 Store plates at 4°C 
 
SD/-DO Agar (1L) 
 46.7 g of minimal SD base supplemented with agar. 
 Add the amount supplement required (see list below*) 
 Dissolve into 900 mL dH2O. 
 Adjust pH to 5.8. 
 Adjust volume to 1 L with dH2O.  
 Sterilise by autoclaving.  
 Store plates at 4°C 
 
Supplement* 
 -Leu DO suppl   0.69 g 
 -Trp DO suppl    0.74 g 
 -Leu/-Trp DO suppl   0.64 g 
 -His/-Leu/-Trp TDO suppl  0.62 g 
 -Ade/-His/-Leu/-Trp QDO suppl 0.60 g 
 -His/-Trp 
 Use media prepared with 0.62 g of -His/-Leu/-Trp DO suppl   
 Dissolve 6.55 g of L-Leucine into 500 ml dH2O. 
 Sterilise by autoclaving (use at 16.7 mL LEU stock per 1 L of SD-His/-Leu/-Trp 
media ) 
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 -Ade/-Trp 
 Use media prepared with 0.6 g of -Ade/-His/-Leu/-Trp DO suppl 
 Dissolve 200 mg L-Histidine HCl monohydrate and 1000 mg L-Leucine into 1 L of 
dH2O. 
 Sterilise by autoclaving  
 Store at 4°C up to 1 year 
 Add 100 mL of 10X His/Leu to 900 mL autoclaved media 
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Appendix 2 
 
Maps of vectors used in this study 
 
Reagents and materials 
pGem T-easy 
 
pGBKT7 (bait vector) 
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pGADT7-Rec (Library (prey) vector) 
 
 
pGADT7-SV40 (control activation domain (AD) vector) 
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pGBKT7-p53 (control binding domain (BD) vector) 
 
 
pGBKT7-LAM (control BD vector) 
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Appendix 3 
Tissue culturing  
 
Reagent and Material 
 
RPMI 10% heat inactivated fetal bovine serum (HI-FBS) 1% penicillin/streptomycin  
 500 mL of RPMI-1640 
 50 mL of HI-FBS 
 5 mL of pen/strep 
 
100μM  Phorbol 12-myristate 13-acetate (PMA) 
 Dissolve 1 mg of PMA into 16.3 mL 100% ethanol. 
 Cover with aluminium foil and store at 4°C. 
 Use at a final concentration of 1:100 (100nM) 
 
PMA treatment stimulates Protein kinase C which triggers the THP-1 cells to differentiate into a 
macrophage like morphology, the cells become adherent and phagocytic and stops diving.  
 
Protocol 
 
Defrosting cells (THP-1 cells are kept in liquid nitrogen for long term storage) 
 
1. Hold tube in water bath (or warm hands), taking care not to overheat 
 
2. Cells should be defrosted but not warm 
 
3. Dilute DMSO in stock culture ASAP 
 
4. Place cells in 50mL tube with 9mL media 
 
5. Pellet cells at 1000 rpm at 21°C for 5 min 
 
6. Remove supernatant 
 
7. Add 10 mL media and pipet in to a tissue culture flask 
 
8. Incubate in a 37°C, 5% CO2 incubator 
 
9. Check cells every day and add fresh media when cells are too many 
 
Differentiation of THP-1 cells with PMA 
 
1. Harvest cells and re-suspend in 10mL RPMI lacking antibiotics and count using a 
haemocytometer  
 
2. Adjust the concentration of cells to 1 X 106 cells per mL 
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3. Add PMA to final concentration of 100nM 
 
4. Vortex 3X for 10sec 
 
5. Add 1 mL of cells to each 24 well plate 
 
6. Incubate for 2 days and remove non-adherent cells by washing with 2X RPMI/FBS media 
 
7. Add fresh medium incubate for 4 hrs or overnight 
 
Preparation of THP-1 and Jurkat stock cultures 
 
1. Pool flask in 50 mL tube 
 
2. Centrifuge at room temperature at 1000-1500 rpm for 5min  
 
3. Remove and discard the supernatant 
 
4. Re-suspend pellet in 100% FBS (1.5 mL per 50 mL flask) and cool on ice for 5 min 
 
5. Prepare 20% DMSO/RPMI and add to FBS cell mixture 
 
6. Aliquot 1 mL into cryovials 
 
7. Freeze at -80°C and transfer to liquid nitrogen for long term storage 
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Appendix 4 
Electro-competent E. coli 
 
Reagents and materials 
 
XL1-Blue genotype 
 recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F´ proAB lacIqZΔM15 Tn10 (Tetr)] 
 
Tetracycline 5 mg/mL 
 Dissolve 5 mg of tetracycline into 1 mL 100% ethanol 
 Store at -20°C, protected from light 
 
10% Glycerol  
 Take 1 volume of molecular-biology-grade glycerol in 9 volumes of sterile dH2O. 
 Sterilise by passing it through a 0.22μm filter. 
 Store at 4°C 
 
Protocol 
 
1. Spread competent cells onto a LB plate containing tetracycline (10 μL/mL of a 5 mg/mL 
stock in methanol). Incubate overnight at 37°C. 
 
2. Inoculate into 50 mL LB containing tetracycline for a starter culture. Incubate overnight at 
37°C with shaking. Also prepare 4X 250 mL flasks containing LB with tetracycline and 
pre-warm overnight at 37°C with shaking. 
 
3. Inoculate the above pre-warmed (37°C) in 4X 250 mL flasks containing LB with 
tetracycline, with 1/100 of starter culture. Incubate 3-4 hrs at 37°C with shaking. 
 
4. Grow until OD600 reaches 0.7 (not higher than 0.8). Put on ice. All steps from this point 
forward must be performed under icy-cold conditions. 
 
5. Harvest cells by spinning in GSA rotor for 10 minutes at 5000 rpm at 4°C. 
 
6. Re-suspend pellet very carefully (cells are extremely fragile) in a volume of ice-cold 10% 
glycerol equal to the original culture volume. 
 
7. Spin at 5000 rpm for 10 minutes at 4°C. 
 
8. Carefully pour off the supernatant (pellet will be quite loose), re-suspend cells again in 
10% glycerol equal to the original culture volume. 
 
9. Spin at 5000 rpm for 10 minutes at 4°C. 
 
10. Carefully pour off the supernatant, re-suspend cells in the volume if glycerol remaining in 
the centrifuge bottle. Pool the cells in one small centrifuge tube (SS34). 
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11. Spin for 10 minutes at 7000 rpm in SS34 rotor at 4°C. 
 
12. Carefully pour off supernatant and re-suspend cells in 10% glycerol using a volume of 
2mL per liter of initial culture. 
 
13. Aliquot to micro-centrifuge tubes (100 μL per tube) and freeze quickly in a liquid 
nitrogen bath. 
 
14. Store cells at -80°C. 
 
Preparation of Competent Yeast Cells (LiAc Method) 
 
Yeast strain genotypes 
 AH109: MATa trp1-901 leu2–3,112 ura3-52 his3-200 gal4Δgal80Δ LYS2::GAL1UAS-
GAL1TATA-HIS3 MEL1 GAL2UAS-GAL2TATA-ADE2, URA3::MEL1UAS-MEL1TATA-lacZ 
 
 Y187: MATα, ura3-52, his3-200, ade2-101, trp1-901, leu2-3, 112, gal4Δ, met-, gal80Δ, 
URA3::GAL1UAS-GAL1TATA-lacz 
 
1M LiAc (10X) 
 Dissolve 5.1 g of LiAc into 50 mL dH2O 
 Filter-sterilise. 
 Store at room temperature 
 
 
10X TE buffer (1 L) 
 Prepare from 1 M stock of Tris-HCl (pH 7.5) and 500 mM stock of EDTA (pH 8.0). 
 To make 1 liter 10X TE (Tris-EDTA) Buffer, mix following: 
 100 mL 1M Tris-HCl (pH7.5) 
 20 mL 500mM EDTA (pH8) 
 Add 880 mL with sterile dH2O 
 Store at room temperature 
 
1.1X TE/LiAc solution 
 Mix the following: 1.1 mL of  10X TE with 1.1 mL of 1M LiAc 
 Bring the total volume to 10 mL using sterile, dH2O. 
 
50% PEG 
 Dissolve 25g of polyethyleneglycol 4000 into 50 mL dH2O by stirring 
 Sterilise by autoclaving 
 Store at 4°C 
 
Protocol 
1. Prepare YPDA agar plates  
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2. To recover strains from frozen stock, scrape a small amount of cells from the surface with 
a sterile loop or wooden stick and streak them onto YPDA plates. 
 
3. Incubate plates at 30°C for 3 - 5 days until colonies appear. Propagate additional cultures 
only from isolated colonies on this working stock plate. 
 
4. Using a sterile loop or toothpick, streak 3–4 colonies from the working stock onto 
separate appropriate SD selection plates as indicated in the table. 
 
 
Strain SD/–Ade SD/–Met SD/–Trp SD/–Leu SD/–His SD/–Ura YPDA 
AH109 – + – – – + + 
Y187 – – – – – + + 
 
 
5. Incubate plates at 30°C for 4 - 6 days. Yeast grows slower on SD selection medium than 
on YPDA. 
 
6. Compare the results with those shown in the Table. Proceed only if AH109 and Y187 
have the expected phenotypes. 
 
7. Use well-isolated colonies from the verified working stock plate to inoculate liquid 
cultures for mating or for preparing competent cells. Seal the verified working stock plate 
with Parafilm and store at 4°C. 
 
8. Streak a well-isolated colony (AH109 or Y187) from the verified working stock plate on 
YPDA agar plate  
 
9. Incubate the plate upside down at 30°C until colonies appear (~3 days). (Note: yeast 
strains can be stored for up to 1 month at 4°C on YPDA culture plates sealed with 
parafilm) 
 
10. Prepare 1.1X TE/LiAc Solution. 
 
11. Inoculate one colony (< 4 weeks old, 2–3 mm in diameter) into 3 mL of YPDA medium 
in a sterile, 15 mL centrifuge tube. Incubate at 30°C with shaking for 8 hrs. 
 
12. Transfer 5 μL of the culture to a 250 mL flask containing 50 mL of YPDA medium.  
Incubate at 30°C with shaking at 230–250 rpm for 16–20 hrs. The OD600 should reach 
0.15–0.3. 
 
13. Centrifuge the cells at 700 x g for 5 min at room temperature.  Discard the supernatant 
and re-suspend the cell pellet in 100 mL of YPDA medium. 
 
14. Incubate at 30°C for 3 - 5 hrs (OD600 = 0.4 - 0.5). 
 
15. Centrifuge the cells at 700 x g for 5 min at room temperature. Discard the supernatant and 
re-suspend the cell pellet in 60 mL of sterile, dH2O. 
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16. Centrifuge the cells at 700 x g for 5 min at room temperature. Discard the supernatant and 
re-suspend the cells in 3 mL of 1.1X TE/LiAc Solution. 
 
17. Split the re-suspension between two 1.5 mL micro-centrifuge tubes (1.5 mL per tube). 
Centrifuge each tube at high speed for 15 sec. 
 
18. Discard the supernatant and re-suspend each pellet in 600 μl of 1.1X TE/LiAc Solution. 
 
19. Competent cells should be used for transformation immediately following preparation; 
however, if necessary, they can be stored at room temperature for a few hours without 
significantly affecting the competency. 
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Appendix 5 
 
cDNA Generation 
 
Reagents and Materials 
 
BD Matchmaker™ Library Construction & Screening Kit 
 
95% ethanol (-20°C) 
 
Bromophenol blue loading dye 
 Bromophenol blue  0.2% (w/V) 
 Glycerol   50% 
 Tris (pH8)   10mM 
 Dissolve bromophenol blue, and Tris in 49 mL of dH2O. 
 Stir in 50 mL of glycerol to make 100 mL total solution. 
 
Protocol 
 
Synthesise First-Strand cDNA using an Oligo (dT) Primer 
 
1. Combine the following reagents in a sterile 0.25ml microcentrifuge tube: 
1-2 µL RNA sample (0.025–1.0 µg poly A+ or 0.10–2.0 µg total RNA) 
1.0 µL CDS III Primer 
1-2 µL H2O to bring volume up to 4.0 µL. 
4.0 µL Total volume 
 
2. Mix contents and spin briefly. Incubate at 72°C for 2 min.  Cool on ice for 2 min. Spin 
briefly 
 
3. Add the following to the reaction tube: 
2.0 μL 5x First-Strand Buffer 
1.0 μL DTT (20 mM) 
1.0 μL dNTP Mix (10 mM ) 
1.0 μL MMLV Reverse Transcriptase 
9.0 μL Total volume 
 
4. Mix gently by tapping. Spin briefly and incubate at 42°C for 10 min. 
 
5. Add 1.0 μL BD SMART III Oligonucleotide. 
 
6. Incubate at 42°C for 1 hr in an hot-lid thermal cycler. 
 
7. Place the tube at 75°C for 10 min to terminate first-strand synthesis. 
 
8. Cool the tube to room temperature, then add 1.0 μL (2 units) RNase H. Incubate at 37°C 
for 20 min. 
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9. 2 μL of first-strand cDNA is necessary to generate enough ds cDNA.  Take a 2μL aliquot 
from the Oligo (dT) first-strand synthesis and place it in a clean, pre-chilled, 0.5 mL tube. 
Place the tube on ice until the second first-strand generating reaction (using the random 
primer) is finished.   
 
10. Store the rest of the first-strand reaction mixture at -20°C for up to three months. 
 
Synthesise First-Strand cDNA using a Random Primer 
 
1. Combine the following reagents in a sterile 0.5 mL microcentrifuge tube: 
1-2 μL RNA sample (0.025–1.0 μg poly A+ or 0.10–2.0 μg total RNA) 
1.0 μL CDS III/6 Primer 
1-2 μL Deionised H2O to bring volume up to 4.0 μL. 
4.0 μL Total volume 
 
2. Mix contents and spin briefly. Incubate at 72°C for 2 min. Cool on ice for 2 min. Spin 
briefly. 
 
3. Keep the tube at room temperature and add the following: 
2.0 μL 5X First-Strand Buffer 
1.0 μL DTT (20 mM) 
1.0 μL dNTP Mix (10 mM) 
1.0 μL MMLV Reverse Transcriptase 
9.0 μL Total volume 
 
4. Mix gently by tapping. Spin briefly. 
 
5. Incubate at 25–30°C for 10 min at room temperature, and thereafter at 42°C for 10 min. 
 
6. Add 1.0 μL BD SMART III Oligonucleotide, and Incubate at 42°C for 1 hr in a hot-lid 
thermal cycler. 
 
7. Place the tube at 75°C for 10 min to terminate first-strand synthesis. 
 
8. Cool the tube to room temperature, then add 1.0 μL (2 units) RNase H and incubate at 
37°C for 20 min 
 
9. Take a 2 μL aliquot from the Random Primed first-strand synthesis and place it in a clean, 
pre-chilled, 0.5 mL tube.  
 
10. Store the rest of the first-strand reaction mixture at -20°C for up to three months. 
 
Amplify ds cDNA by Long Distance PCR (LD-PCR) 
 
1. The next table shows the optimal number of thermal cycles to use based on the amount of 
RNA used in the first-strand synthesis. Fewer cycles generally mean fewer nonspecific 
PCR products. 
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2. Preheat the PCR thermal cycler to 95°C. 
 
3. To prepare sufficient ds cDNA for transformation, two 100 μL PCR reactions are usually 
set up for each experimental sample. As we are generating ds cDNA from both the Oligo 
(dT) and Random primers (i.e. two reactions), this will act as two reactions and after the 
ds cDNA is pooled should be sufficient for transformation.  Set up one reaction for the 
Control sample. In each reaction tube, combine the following components: 
    2 μL  First-Strand cDNA 
  70 μL  Deionised H2O 
  10 μL  10X BD Advantage 2 PCR Buffer 
    2 μL  50X dNTP Mix 
    2 μL  5' PCR Primer 
    2 μL  3' PCR Primer 
  10 μL  10X GC-Melt Solution 
    2 μL  50X BD Advantage 2 Polymerase Mix 
100 μL  Total volume 
 
4. Mix gently by flicking the tube. Centrifuge briefly, place in a preheated (95°C) thermal 
cycler and cycle as follows: 
95°C for 30 sec 
 
X cycles 
95°C for 10 sec 
68°C for 6 min 
68°C for 5 min 
 
  where x is the amount of cycles from the table above 
 
Program the cycler to increase the extension time by 5 sec with each successive cycle. For 
example, in the second cycle, the extension should last 6 min and 5 sec; in the third, 6 min and 10 
sec.  
 
5. When the cycling is complete, analyze a 7 μL aliquot of the PCR product from each 
sample alongside 0.25 μg of a 1 kb DNA size marker on a 1.2% agarose/EtBr gel.  This 
should appear as a moderately strong smear from  ≥ 0.1 kb to 4 kb (or more).   
 
6. ds cDNA can be stored at -20°C until use. 
 
Total RNA (μg) Poly A+ RNA (μg) Number of Cycles 
1.0–2.0 0.5–1.0 15–20 
0.5–1.0 0.25–0.5 20–22 
0.25–0.5 0.125–0.25 22–24 
0.05–0.25 0.025–0.125 24–26 
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Purify ds cDNA with a BD CHROMA SPIN™ TE-400 Column 
 
1. Remove the BD CHROMA SPIN Column from the protective plastic bag and invert it 
several times to re-suspend the gel matrix completely. Use one column for each ~95 μL 
cDNA sample. 
 
2. Holding the BD CHROMA SPIN Column upright, grasp the break-away end between 
your thumb and index finger and snap off.  Place the end of the spin column into one of 
the 2 mL micro-centrifuge tubes, and lift off the top cap. Save the top cap and the white-
end cap. 
 
3. Centrifuge at 700 x g for 5 min in a swinging bucket or horizontal rotor.  
 
4. After centrifugation, the column matrix will appear semi-dry. This step purges the 
equilibration buffer from the column and re-establishes the matrix bed.   
 
5. Remove the spin column and collection tube from the centrifuge rotor, and discard the 
collection tube and column equilibration buffer. 
 
6. Place the spin column into a 1.5 mL micro-centrifuge tube. Carefully and slowly apply 
your cDNA sample (~95μL) to the center of the gel bed‘s flat surface. Do not allow any 
sample to flow along the inner wall of the column. 
 
7. Centrifuge at 700 x g for 5 min in a swinging bucket or horizontal rotor. 
 
8. Remove the spin column and collection tube from the rotor and detach them from each 
other. The purified sample is at the bottom of the collection tube. 
 
9. Combine the two samples (one from the Oligo (dT) priming and the other from the 
Random priming) in a single tube. 
 
10. Add the following reagents: 
1/10 vol. Sodium Acetate (3 M; pH 4.8) 
2.5 vol. 95% ethanol (-20°C) 
 
11. Mix gently by rocking the tube back and forth. 
 
12. Place the tube in a -20°C freezer or a dry-ice/ethanol bath for 1 hr. Better recoveries are 
obtained at -20°C overnight.   
 
13. Centrifuge the tube at 14,000 rpm for 20 min at room temperature. 
 
14. Carefully remove the supernatant with a pipette. Do not disturb the pellet. Briefly 
centrifuge the tube to bring all remaining liquid to the bottom. 
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15. Carefully remove all liquid and allow the pellet to air dry for ~10 min. Re-suspend the 
pellet in 20 μL of dH2O and mix gently. The cDNA is now ready for in vivo 
recombination (library construction) with pGADT7-Rec or pGADT7-Rec2. 
 
16. cDNA can be stored at -20°C.   
 
Library Construction 
 
Reagents and Materials 
 
100% Glycerol 
 
Freezing Medium: YPD medium with 25% (v/v) glycerol 
 Combine 25 mL 100% glycerol with 75 mL of prepared YPD media 
 
Sterile glass beads 
 
SD/–Leu ~200 150-mm plates 
 
SD/–Leu ~5–10 100-mm plates 
 
PEG/LiAc Solution 
 Combine the following 
 8 mL 50% PEG 
 1 mL 10x TE buffer  
 1 mL 10x LiAc 
Protocol: 
 
Transform yeast strain AH109 with ds cDNA and pGADT7-Rec 
 
1. NB! Prepare competent AH109 yeast cells before starting library construction (see 
Section 8) 
 
2. Transfer ~50 μL of Herring DNA to a micro-centrifuge tube and heat at 100°C for 5 min. 
Then, immediately chill the DNA by placing the tube in an ice bath. Repeat once more 
before using the DNA in the next reaction. 
 
3. In a sterile, pre-chilled, 15 mL tube combine the following: 
20 μL ds cDNA 
6 μL pGADT7-Rec (0.5 μg/μL) 
20 μL Herring Testes Carrier DNA, denatured 
 
4. Add 600 μL of competent AH109 cells to the DNA and gently mix by vortexing 
 
5. Add 2.5 mL PEG/LiAc Solution and gently mix by vortexing. 
 
6. Incubate at 30°C for 45 min. Mix cells every 15 min. Add 160 μL DMSO, mix, and then 
place the tube in a 42°C water bath for 20 min. Mix cells every 10 min. 
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7. Centrifuge at 700 x g for 5min, discard the supernatant and re-suspend in 3 mL of YPD 
Plus Liquid Medium. 
 
8. Incubate at 30°C with shaking for 90 min. 
 
9. Centrifuge at 700 x g for 5 min, discard the supernatant and re-suspend in 30 mL of NaCl 
Solution (0.9%). 
 
Select transformants on SD/–Leu plates. 
 
1. Spread 150 μL on each 150mm plate (~200 plates total).  To check the transformation 
efficiency, spread 100μl of a 1:10, 1:100, 1:1 000, and 1:10 000 dilution on 100mm SD/–
Leu plates. 
 
2. Incubate plates upside down at 30°C until colonies appear (~3–6 days). 
 
3. Calculate the transformation efficiency - expected results: ≥1 x 106 transformants / 3 μg 
pGADT7-Rec 
 
Harvest (pool) transformants. 
 
1. Chill plates at 4°C for 3–4 hrs, and then add 5 mL Freezing Medium to each plate.  
 
2. Use sterile glass beads and gentle swirling to dislodge the cells into the liquid, and 
combine all liquids in a sterile flask. Mix well. 
 
3. Check the cell density using a hemacytometer. If the cell density ≤ 2 x 107 cells/mL, 
reduce the volume of the suspension by centrifuging. 
 
4. Aliquot (1 mL) and store at –80°C (not longer than 1 year).  To determine the library titer, 
spread 100 μL of a 1:100, 1:1 000, and 1:10 000 dilution on 100mm SD/–Leu plates. 
Incubate at 30°C until colonies appear (~2–3 days). Count the colonies (cfu) and calculate 
the number of clones in your library. 
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Appendix 6 
 
Electrophoresis solutions, loading dyes and agarose gels 
 
Reagents and materials 
 
50X TAE (500 mL) 
 Dissolve 121 g of Tris base into 250 mL dH2O, stir to dissolve 
 Add 28.6 mL acetic acid 
 Add 50 mL 0.5M EDTA (pH 8) 
 Make up to 500mL 
 
Bromophenol blue loading dye 
 Bromophenol blue  0.2% (w/V) 
 Glycerol   50% 
 Tris (pH8)   10mM 
 Dissolve bromophenol blue, and Tris in 49 mL of dH2O. 
 Stir in 50 mL of glycerol to make 100 mL total solution. 
 
Ethidium bromide solution (5 mg/mL) 
 Dissolve 5 mg of ethidium bromide into 1 mL dH2O  
 Cover with aluminium foil and store at room temperature 
 Add 5 μL to final volume of 100 mL agarose gel solution (see list below for %  agarose 
gels): 
 Agarose concentration 
 1% = 1g + 100mL 1X TAE buffer 
 1.5% = 1.5g + 100mL 1X TAE buffer 
 2% = 2g + 100mL 1X TAE buffer 
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Appendix 7 
Promega Wizard® SV PCR, Gel and Plasmid Clean-up  
 
Reagents and materials 
 
Wizard® SV Gel and PCR Clean-Up System (kit) 
 
Wizard® Plus SV Minipreps DNA Purification System (kit) 
 
Protocol 
  
Wizard® SV PCR Clean-Up 
1. Add an equal volume of Membrane Binding Solution to the PCR reaction 
 
2. Incubate at room temperature for 1 min 
 
Wizard® SV Gel Clean-Up 
1. Excise DNA band from gel and place gel slice in a 1.5 mL tube 
 
2. Add 10 µL Membrane Binding Solution per 10 mg gel slice. Vortex and incubate at 50-
65°C 
 
Wizard® Plus SV Minipreps 
1. Harvest 1–5 mL (high-copy-number plasmid) or 10 mL (low-copy-number plasmid) of 
bacterial culture by centrifugation for 5 minutes at 10,000 x g. Pour off the supernatant. 
 
2. Add 250 μL of Cell Re-suspension Solution and completely re-suspend the cell pellet by 
vortexing or pipetting. 
 
3. Add 250 μL of Cell Lysis Solution and mix by inverting the tube 4 times. Incubate until 
the cell suspension clears (approximately 1–5 min). 
 
4. Add 10 μL of Alkaline Protease Solution and mix by inverting the tube 4 times. Incubate 
for 5 minutes at room temperature. 
 
5. Add 350 μL of Neutralisation Solution and immediately mix by inverting the tube 4 times. 
 
Follow the next instructions for each above 
 
1. Insert SV mini-column into Collection tube. 
 
2. Transfer prepared PCR/gel/bacterial solution to the Mini-column. Incubate at room 
temperature for 1 min. 
 
 
Stellenbosch University  http://scholar.sun.ac.za
   
180 
 
3. Centrifuge at 10 000 x g for 1 min. Discard flow through and re-insert Mini-column into 
Collection Tube. 
 
4. Add 700 μL Membrane Wash Solution (ethanol added). Centrifuge at 10 000 x g for 1 
minute. Discard flow through and re-insert Mini-column into Collection Tube. 
 
5. Repeat with 500 μL Membrane Wash Solution. Centrifuge at 10 000 x g for 5 min. 
 
6. Carefully transfer Mini-column to a clean 1.5 mL micro-centrifuge tube. 
 
7. Add 25 μL of Nuclease-Free Water (Promega Corp. Madison Wisconsin, USA) to the 
Mini-column. Incubate at room temperature for 1 min. Centrifuge at 10 000 x g for 1 min. 
 
8. Discard Mini-column and store DNA at 4°C or -20°C. 
 
High yield DNA extraction from larger volumes of bacterial culture 
Reagents and materials 
NucleoBond® PC 100 Midi High Yield Plasmid DNA purification (MACHEREY-NAGEL 
GmbH & Co. KG) from E.coli 50mL culture 
1. Cultivate and harvest bacterial cells 
 Centrifuge LB culture at 3000 X g for 15 min at 4°C 
 
2. Cell lysis 
 Re-suspend the pellet of bacterial cells in 4 mL S1 buffer + RNase A 
 Mix using pipette 
 Add 4 mL S2 buffer, invert 6-8 times. Incubate at RT (20-25°C) for 2-3 min (max 
5min). [Do not vortex] 
 Add 4 mL pre-cooled S3 Buffer (4°C), invert 6-8 times until the homogenous 
suspension containing an off-white flocculate is formed. Incubate on ice for 5min. 
 
3. Equilibration of the column 
 Equilibrate the AX 100 (Midi) column with 2.5 mL N2 buffer. Allow column to 
empty by gravity flow and discard the flow-through. 
 
4. Clarification of the lysate 
 Filter the suspension (25min) 
 Place a NucleoBond® folded filter in a funnel and pre-wet the filter with a 
few drops of sterile dH2O. Load the bacterial lysate onto the wet filter and 
collect the flow-through.  
 
5. Binding 
 Load the cleared lysate from step 4 onto the NucleoBond® column. Allow the 
column to empty by gravidity flow. 
 
6. Washing 
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 Wash the column with 10 mL N3 buffer. Discard the flow-through. 
 
7. Elution 
 Elute the plasmid DNA using 5 mL N5 buffer into a new tube 
 
8. Precipitation 
 Prepared 6X 1.5 mL eppendorf tubes with 680μL room temperature iso-propanol. 
Add 840 μL of the eluted plasmid. Mix and centrifuge at top speed for 30min at 
4°C. 
 
9. Wash and dry DNA pellet 
 Once centrifuged, remove pellets from iso-propanol with tip and place in new 
eppendorf with 500 μL 70% ethanol. Mix briefly and centrifuge at top speed for 
10min at room temperature (20-25°C). 
 Remove ethanol and allow pellet to air dry at RT 
 
10. Reconstitute DNA 
 Re-dissolve the DNA pellet in 50 μL sterile dH2O 
 
Yeast plasmid extraction 
Reagents and materials 
1M NaPO4 [pH 7] 
 Dissolve 138 g NaH2PO4 into 1 L of dH2O 
 Dissolve 142 g Na2HPO4 into 1 L of dH2O 
 Autoclave to sterilise each solution, store at room temperature 
 Combine 423 mL of 1M NaH2PO4 and 577 mL 1M Na2HPO4. Store at room temperature. 
 
2M sorbitol 
 Dissolve 36.4 g of Sorbitol into 100mL dH2O to a final volume of 100mL  
 Autoclave to sterilise, store at room temperature 
 
250 mM EDTA 
 Dissolve 93.06 g of EDTA into 800 mL dH2O 
 Bring to pH 8 with 4M NaOH 
 Adjust volume to 1 L 
 Autoclave to sterilise, store at room temperature 
 
Lysis buffer (100mM NaPO4 [pH 7], 1M sorbitol, 60mM EDTA) 
 Combine the following: 
 50 mL of 2M Sorbitol 
 10 mL of 1M NaPO4 
 24 mL of 250mM EDTA 
 
Wizard® Plus SV Minipreps DNA Purification System (kit) 
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Protocol 
1. Collect yeast from a liquid culture (10ml) and re-suspend in 200µL of lysis buffer 
(100mM NaPO4 [pH 7], 1M sorbitol, 60mM EDTA). Mix vigorously by vortexing. 
 
2. Digest the cell wall by adding lyticase (0.33 mg/mL, Sigma, St. Louis, MO Cat.# L2524) 
to each tube. Incubate at 37°C overnight without shaking. 
 
3. Collect yeast by centrifugation for 5 min at 4000 rpm. Remove and discard the 
supernatant. 
 
4. Perform plasmid DNA isolation on the yeast pellet with the Wizard® Plus SV Minipreps 
DNA Purification System as described.  
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Appendix 8 
 
Bait Construction 
 
Reagents and Materials 
 
pGBKT7 
Electro-competent E. coli cells.  
T4 DNA ligase and 10X T4 ligation buffer  
LB/amp plates 
Restriction enzymes: EcoRI and PstI 
Wizard SV Promega Plasmid isolation kit  
 
Protocol 
 
1. Design primers for in-frame cloning of both ESAT-6 (esxA), CFP-10 (esxB) in pGBKT7. 
 
2. Primers look like follows: 
 
 
ESXA f              5'  G|AA TTC ATG ACA GAG CAG CAG TGG AAT  3' (27 bases) 
ESXA r              5'  CTG CA|G ATC CCG TGT TTC GCT ATT CT  3' (26 bases) 
 
 
 
ESXB f              5'  G|AA TTC ATG GCA GAG ATG AAG ACC GAT  3' (27 bases) 
ESXB r              5'  CTG CA|G TGA CAT TTC CCT GGA TTG C  3' (25 bases) 
 
 
3. The amplified PCR fragments of ESXA = 339bp, ESXB = 414bp was purified and cloned 
into pGem-T Easy vector for propagation and sequence confirmation. 
 
4. Recombinant pGem-ESAT6 and pGem-CFP-10 were digested with with appropriate 
enzymes and purify. 
 
5. The DNA-BD vector, pGBKT7, were digested with EcoRI and PstI, and treated with 
phosphatase (see below method), and the DNA concentration were determined. 
 
Phosphatase treatment  
 Combine the following reaction mixture: 
 19 µL vector (sub cloning vector) 
 1 µL SAP 
 3 µL Buffer  
 7 µL H2O 
 Incubate the reaction mixture for 10 min at 37°C, followed by an additional incubation 
for 10min at 65°C    
 
 
EcoRI 
PstI 
PstI 
EcoRI 
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6. Ligations of the following reactions were performed: esxA and esxB inserts into pGBKT7 
to obtain bait contructs. Transform ligation mixtures into E. coli. 
a. The ligation reaction were set up using the equation described below and the T4 
DNA ligase kit 
 
         
                
   kb size of insert   
 
 
                       
 
7. Restriction digest product of ESAT-6 and CFP-10 were cloned in frame using the enzyme 
sites. See multiple cloning sites (MCS) below: 
  
 
8. The insert-containing plasmids were identified by restriction enzyme analysis, PCR, and 
sequencing  
 
9. Resulting clones to be used in the two-hybrid analyses. 
 
List of additional constructs made during this study 
1. proline-glutamic (PE) family related protein (PE35; Rv3872) 
2. proline-proline-glutamic (PPE) family related protein (PPE68; Rv3873) 
3. PPE family, MPTR subfamily (PPE-MPTR62; Rv1917c) 
4. PE family, PGRS subfamily (PE-PGRS33; Rv1818c) 
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Growth curves of recombinant pGBKT7-PE35, -PPE68, -MPTR62 and –PGRS33 
 
 
Figure 3.8: Growth curves of recombinant pGBKT7-PE35, -PPE68, -MPTR62 and –PGRS33 versus empty 
pGBKT7 vector to test the toxic effects of the recombinant constructs in the Y187 yeast strain. These constructs did 
not produce any toxic effects, as measured by growth curves compared the empty pGBKT7 vector (BK) 
 
Table: Testing recombinant baits for transcriptional activation. Bait constructs were plated on SD/-Trp/-His and 
SD/-Trp/-Ade to test for transcriptional activation of reporter genes. Bait constructs PE35 and PPE68 were 
active on SD/-Trp/-His and grew on TDO plates. No growth was observed on QDO selection plates. 
Background growth on –His media was eliminated by adding 10mM 3-AT to TDO selection media 
    
mating with empty 
pGADT7:AH109 
 
pGBKT7 Trp/His Trp/Ade TDO QDO 
Y187 
PE35 + - + - 
PPE68 + - + - 
PGRS33 - - - - 
MPTR62 - - - - 
 
leaky HIS3 expression suppressed with 10mM 3-AT 
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Appendix 9 
Transform into yeast 
Reagents and materials 
 
Appropriate recombinant vectors for transformation into yeast cell 
 
Appropriate SD agar plates 
 
YPDA 
 50 g YPD  
 20 g Bacto Agar 
 15 ml of 0.2% stock solution  L-adenine hemisulphate   
 Dissolve into 900 mL dH2O. 
 Adjust pH to 6.5 if necessary. 
 Adjust volume to 1 L with dH2O.  
 Sterilise by autoclaving.  
 
2 mg/mL Herring Testes Carrier DNA (Clontech Laboratories Inc., Palo Alto, CA) 
 
1M LiAc (10X) 
 Dissolve 5.1 g of LiAc into 50 mL dH2O 
 Filter-sterilise. 
 Store at room temperature 
 
50% PEG 
 Dissolve 25g of polyethyleneglycol 4000 into 50 mL dH2O by stirring 
 Sterilise by autoclaving 
 Store at 4°C 
 
Protocol 
1. Inoculate a large yeast colony into 10 mL appropriate medium in 50mL sterile tube  
 
2. Grow overnight at 30C shaking at ~250 rpm 
 
3. Centrifuge at 3000rpm for 10 min, decant the supernatant and re-suspend the pellet into 10 
mL YPDA liquid media, vortex and allow to grow for 5 hrs 
 
4. Centrifuge the cell suspension, if the yeast cell volume is estimated to be between 20-50 L, 
proceed with the next steps. 
 
5. Re-suspend the pellet of 20-50 L yeast cells into 1 mL sterile dH2O, vortex and pellet the 
cells for 30sec at 1500 rpm 
 
6. Remove supernatant and re-suspend the pellet into 1 mL of 100mM LiAc solution 
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7. Incubate at 30C for 5 min, without shaking and pipette the 20-50 L yeast suspension into a 
2 mL eppendorf tube 
 
8. Pellet cells (top speed for 20sec) and remove all LiAc supernatant   
 
9. Add the following in order: 
 240 L 50% PEG 
 36 L 1M LiAc 
 25 L of a 2 mg/mL Herring Testes Carrier DNA 
 10-20 L plasmid prep (100 ng – 5 g) together with sterile dH2O up to volume of 
50 L 
 
10.  Vortex for 1 min and incubate in water bath at 42C for 30min 
 
11. Plate transformed suspension onto appropriate SD agar plates 
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Appendix 10 
Testing of DNA-BD Fusions 
 
Reagents and materials 
 
2 mg/mL Herring Testes Carrier DNA (Clontech Laboratories Inc., Palo Alto, CA) 
 
DMSO (Sigma, St. Louis, MO) 
 
YPD Plus Medium (Clontech Laboratories Inc., Palo Alto, CA) 
 
NaCl 
 Dissolve 58.44 g of NaCl into 1 L of dH2O 
 Sterilise by autoclaving 
 
1 g/mL X-α-gal 
 Dissolve 10 g of X-α-gal into 10 mL DMSO.   
 Store at -20°C for long term storage. Protect from light. 
 
Appropriate SD agar plates 
 
1M 3-Amino-1,2,4-triazole (Sigma, St. Louis, MO) 
 Dissolve 8.41 g of 3-AT into 100 mL dH2O 
 Do not autoclave, but filter sterilise the solution.  
 Store at 4°C for up to 1 year 
 
Kanamycin 
 Dissolve 0.5 g of kanamycin into 10 mL of dH2O.  
 Filter-sterilise and store at -20°C  
 
AH109 and Y187 yeast strains 
 
 
Protocol 
 
Test the DNA-BD Fusion for Transcriptional Activation 
 
1. Transfer ~50 µL of Herring Testes DNA to a micro-centrifuge tube and heat at 100°C for 
5 min. Immediately chill the DNA by placing the tube in an ice bath. Repeat once more 
before using the DNA in the transformation reaction described below. 
 
2. Transform AH109 and Y187 with the constructs by setting up twelve 1.5 mL micro-
centrifuge tubes and adding components using the volumes indicated in the table: 
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Component 1 2 3 4 5 6 7 8 9 10 11 12 
pGBKT7esxA (500 ng/μL) 0.5 0.5 - - - - - - - - - - 
pGBKT7esxB (500 ng/μL) - - 0.5 0.5 - - - - - - - - 
pGBKT7 (500 ng/μL) - - - - - - - - 0.5 0.5 - - 
pBridge (500 ng/μL) - - - - - - - - - - 0.5 0.5 
Herring Testes Carrier DNA  
(10 mg/mL), denatured* 
5 5 5 5 5 5 5 5 5 5 5 5 
AH109 competent yeast 50 - 50 - 50 - 50 - 50 - 50 - 
Y187 competent yeast  - 50 - 50 - 50 - 50 - 50 - 50 
PEG/LiAc Solution 500 500 500 500 500 500 500 500 500 500 500 500 
 
3. Mix thoroughly by gently vortexing, and incubate at 30°C for 30 min. Vortex gently every 
10 min. 
 
4. Add 20 μL of DMSO to each tube, mix, and then place the tube in a 42°C waterbath for15 
min. Vortex gently every 5 min. 
 
5. Centrifuge at high speed in a micro-centrifuge for 15 sec. 
 
6. Remove supernatant and re-suspend in 1 mL of YPD Plus Liquid Medium. 
 
7. Incubate at 30°C for 90 min, centrifuge at high speed for 15 sec. 
 
8. Discard the supernatant and re-suspend in 1 mL of NaCl Solution by gently pipetting up 
and down. 
 
9. Spread 100 μL of a 1:10, 1:100, and 1:1000 dilution onto 100mm plates containing  
SD/–Trp/X--Gal 
SD/–His/–Trp/X--Gal 
SD/–Ade/–Trp/X--Gal 
 
10. Incubate the plates at 30°C (face down) for 2–4 days, until colonies appear. 
 
11. Bait protein is inactive if the transformant colonies are white and grow on SD/–Trp/X--
Gal, but do not grow on SD/–His/–Trp or SD/–Ade/–Trp.  
 
12. Bait protein is active if the transformant colonies are blue and grow on SD/–His/–Trp or 
SD/–Ade/–Trp. 
 
13. If a bait strain exhibits background growth on –His medium, you may be able to eliminate 
(or reduce) the leaky His3 background expression by adding 3-AT to the selection 
medium (see below). Alternatively, use –Ade/–His/–Leu/–Trp medium for the library 
screening. 
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14. If a bait strain exhibits background growth on –Ade and –His medium, it will be difficult 
to use this bait protein in a two-hybrid library screening.  
 
15. To test for transcriptional activation induced by the 3rd protein in the pBridge vectors, 
spread 100 μL of a 1:10, 1:100, and 1:1000 dilution of only the AH109 transformations 
(the Y187 is a methionine auxotroph and will not grow on –Met medium) onto 100mm 
plates containing: 
SD/–Met/–Trp/X--Gal 
SD/–His/–Met/–Trp/X--Gal 
 
16. Incubate the plates at 30°C (face down) for 2–4 days, until colonies appear. 
 
17. 3rd protein is inactive if the transformant colonies are white and grow on SD/–Met/–
Trp/X--Gal, but do not grow on SD/–His/–Met –Trp.  
 
18. 3rd protein is active if the transformant colonies are blue and grow on SD/–His/–Met/–Trp. 
See below for eliminating leaky HIS3 expression. 
 
Leaky HIS3 expression – optimisation of the 3-AT concentration in the selection medium 
 
1. Plate AH109 yeast transformants on a series of SD/–His/–Trp (or SD/–His/–Met/–Trp, if 
applicable) plates containing different concentrations of 3-AT. 
 
2. start by testing [3-AT] in the range 0 to 15 mM (e.g. 0, 2.5, 5, 7.5, 10, 12.5, and 15 mM). 
 
3. Use the lowest concentration of 3-AT that, after one week, allows only small (<1 mm) 
colonies to grow. Too much 3-AT in the medium can kill freshly transformed cells. 
 
Testing the DNA-BD Fusion for Toxicity 
 
1. Compare the growth rate in liquid culture of Y187 and AH109 cells transformed with the 
"empty" DNA-BD vector and cells transformed with the DNA-BD/bait plasmid. If the 
bait strain grows noticeably slower, your DNA-BD/bait protein may be toxic. 
 
2. Select transformants from the SD/–Trp transformation plates above, then prepare an 
overnight culture as follows: 
 
3. Inoculate 50 ml of SD/–Trp/Kan (20 μg/mL) with one large (2–3 mm) colony. 
 
4. Incubate at 30°C overnight (16–24 hrs) with shaking at 250–270 rpm. 
 
5. Check the OD600 of the culture; it should be ≥0.8. If the OD600 is much less than 0.8, the 
DNA-BD fusion may be toxic. If the fusion does not appear to hamper yeast growth—i.e. 
is nontoxic, carry on. 
 
Preparation of DNA-BD transformants for Mating with the cDNA library-containing 
AH109  
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1. Centrifuge transformed Y187 culture at 600 x g for 5 min. 
 
2. Remove supernatant. 
 
3. Re-suspend in ~5 mL SD/–Trp liquid medium. Count cells using a hemacytometer. The 
cell density should be ≥ 1 x 109 cells/mL. 
 
4. Mate this bait strain with your AD fusion library host strain. 
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Appendix 11 
 
Yeast Two-Hybrid Assays 
 
Reagents and Materials 
 
Appropriate SD plates and recombinant vectors 
 
2X YPDA Liquid  
 
0.5 X YPDA Liquid  
 
Kanamycin 
 
X-α-gal 
 
Protocol 
 
Mate the library host strain with your bait strain. 
(NB: Controls should be done in parallel with experimental work) 
 
1. Thaw a 1ml aliquot (≥ 2 x 107 cells) of the AH109[library] in a room temperature 
waterbath. 
 
2. Combine the 5 mL Y187 [bait] culture (≥ 1 x 109 cells/mL) and the 1 mL aliquot of 
AH109 [library] cells (≥ 2 x107 cells/mL) in a sterile 2 L flask. 
 
3. Add 45 mL 2X YPDA/Kan (50 μg/mL). Swirl gently. 
 
4. Rinse cells from library vial with two 1 mL aliquots of 2X YPDA/Kan (50 μg/mL). 
 
5. Incubate at 30°C for 20–24 hrs with gentle swirling (30–50 rpm). Low-speed swirling is 
necessary to keep cells from settling to the bottom of the flask. However, shaking the 
culture at speeds > 50 rpm will significantly reduce mating efficiency.   
 
6. After 20 hrs of mating, check a drop of the mating culture under a light microscope (40X). 
If zygotes (a zygote typically has a three-lobed shape, the lobes representing the two 
haploid (parental) cells and the budding diploid cell) are present, allow mating to continue 
for four more hours. Otherwise, continue. 
 
7. Transfer the mating mixture to a sterile 100 mL centrifuge bottle. Centrifuge at 1000 x g 
for 10 min. Meanwhile, rinse the mating flask twice (50ml each rinse) with 0.5X 
YPDA/Kan (50 μg/mL). Combine the rinses and use them to re-suspend the pellet. 
 
8. Centrifuge at 1000 x g for 10 min. Re-suspend the cell pellet in 10 mL of 0.5X 
YPDA/Kan (50 μg/mL) and measure the total volume of cells + medium. 
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Select for yeast diploids expressing interacting proteins 
 
1. To determine the mating efficiency (see below), spread 100 μL of a 1:10 000, 1:1 000, 
1:100, and 1:10 dilution of the mating mixture on three media (100mm plates): 
SD/–Leu 
SD/–Trp 
SD/–Leu/–Trp 
 
2. Spread remaining mating mixture on Triple Dropout Medium (TDO) or Quadruple 
Dropout Medium (QDO) plates (200 μL cells / 150mm plate): 
For pGBKT7 
TDO: SD/–His/–Leu/–Trp  
QDO: SD/–Ade/–His/–Leu/–Trp 
  
3. Incubate at 30°C until colonies appear. After 2–3 days, some colonies will be visible, but 
plates should be incubated for at least 5 days to allow slower growing colonies (i.e., weak 
positives) to appear. Ignore the small, pale colonies that may appear after 2 days but never 
grow to > 1 mm in diameter. True Ade+, His+ colonies are robust and can grow to > 2 
mm. Also, Ade+ colonies are white or light pink, whereas Ade– colonies will slowly turn 
red on adenine-limited medium. 
 
4. Score for growth on SD/–Leu, SD/–Trp, and SD/–Leu/–Trp. Calculate Mating Efficiency 
and Number of Colonies Screened (see below). 
 
5. For colonies growing on TDO medium: Replica plate colonies onto QDO medium. 
Incubate at 30°C for 3–8 days. 
 
6. Choose Ade+, His+ colonies for further analysis. 
 
7. Streak out Ade+/His+ colonies on fresh SD/–Ade/–His/–Leu/–Trp/X--Gal master plates 
and grow for 2–4 days at 30°C. This enables the testing of the Ade+/His+ colonies for the 
activation of a third reporter: MEL1, which encodes -galactosidase, a secreted enzyme 
that hydrolyzes X--Gal to produce a blue end product. 
 
8. Seal the master plates with Parafilm and store at 4°C. If desired, prepare glycerol stock 
cultures of interesting clones and freeze at –70°C for long-term storage.   
 
Control Matings 
 
1. Pick one colony of each type prepared in Section 12 - i.e., AH109 [pGBKT7-RecT], Y187 
[pGBKT7-53], and Y187 [pGBKT7-Lam] - to use in the mating. Use only large (2–3 
mm), fresh (< 2 weeks old) colonies from the master plates. 
 
2. Place both colonies in one 1.5 mL micro-centrifuge tube containing 0.5 mL of 2X YPDA 
medium. Vortex the tube for 1 min to completely re-suspend the cells. 
 
3. Incubate at 30°C overnight (20–24 hrs) with shaking. Use the lowest shaking speed 
possible to prevent cells from settling. Vigorous shaking can reduce the mating efficiency 
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4. Plate cells on SD minimal media (see Table below; 100 μL cells/100mm plate). Use 
sterile 5mm glass beads to promote even spreading of the cells 
 
Cross Plate on SD Minimal Media
a
 
(100mm plates) 
Phenotype 
Mel1                      His/Ade 
Positive Control 
AH109[pGADT7-RecT] x 
Y187[pGBKT7-53] 
–Leub 
–Trpb 
–Leu/–Trpb 
–Ade/–His/–Leu/–Trp/X--
Gal  
Blue + 
Negative Control 
AH109[pGADT7-RecT] x 
Y187[pGBKT7-Lam] 
–Leub 
–Trpb 
–Leu/–Trpb 
–Ade/–His/–Leu/–Trp/X--
Gal 
no colonies – 
a Spread 100 μL aliquots of 1:10 and 1:100 dilutions of the mating culture. 
b Use these plates to calculate the mating efficiency. 
 
5. Incubate plates (colony side down) at 30°C for 3–5 days to allow diploid cells to form 
visible colonies. 
 
6. Score for growth. Calculate the mating efficiency 
 
7. Confirm nutritional and reporter phenotypes of diploids. Pick representative colonies from 
selection plates. Streak onto fresh medium. 
 
8. After colonies have grown, seal plates with Parafilm and store at 4°C. For long term 
storage (> 2 weeks), prepare glycerol stock cultures and freeze at –70°C. These diploids 
are useful as reference strains when you wish to check a new batch of SD selection 
medium 
 
Calculate Mating Efficiency & Number of Clones Screened 
 
1. Count the colonies (cfu) growing on the SD/–Leu, SD/–Trp, and SD/–Leu/–Trp dilution 
plates that have 30–300 cfu 
 
2. Calculate the viable cfu/ml on each type of SD medium:  
                       cfu                         = # viable cfu/mL 
Vol. plated (mL) x dilution factor 
 
# cfu/mL on SD/–Leu = viability of Y187 partner 
# cfu/mL on SD/–Trp = viability of AH109 partner 
# cfu/mL on SD/–Leu/–Trp = viability of diploids 
 
 
3. Compare the viable cfu/mL of the two mating partners. The strain with the lower viability 
is the ―limiting‖ partner. In this library screening protocol, the AH109[library] strain 
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should be the limiting partner to ensure that the maximum number of library cells find a 
mating partner. In a control cross, either strain could be limiting.  
 
4. Calculate the mating efficiency (i.e., % Diploid): 
    # cfu/mL of diploids        x 100 = % Diploid 
# cfu/mL of limiting partner 
 
5. Estimate the number of clones screened: 
# cfu/mL of diploids x re-suspension volume (mL) = # of clones screened 
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Appendix 12 
 
Verification and Analyses of Positive Interactions 
 
Reagents and Materials 
 
BD Matchmaker GAL4 AD LD-Insert Screening Amplimer Set (9103-1) 
Appropriate SD plates 
 
Protocol 
 
Retest the Phenotype 
 
Library transformants may contain more than one AD/library plasmid, which can complicate the 
analysis of putative positive clones. Thus, it is a good idea to restreak the positive colonies on SD 
dropout plates 2–3 times to segregate the AD/library plasmids.  
 
1. Restreak positive two-hybrid clones on TDO medium.  
TDO = SD/–Ade/–Leu/–Trp or SD/–His/–Leu/–Trp 
 
2. Incubate plates at 30°C for 4–6 days. 
 
3. Replica plate or transfer well-isolated colonies to SD/–Ade/–His/– Leu/–Trp plates 
containing X--Gal to verify that they maintain the correct phenotype and to test for the 
expression of MEL1 
 
4. Collect the re-streaked and retested positive colonies in a grid fashion on fresh master 
plates 
 
5. Incubate plates at 30°C for 4–6 days. 
 
6. After colonies have grown, seal plates with Parafilm, and store at 4°C for up to 4 weeks. 
 
Rescue the Library cDNA Insert by Plasmid Isolation 
 
1. Isolate plasmid DNA from yeast using method described in Appendix 7. 
 
2. Because the plasmid DNA isolated from each yeast colony will be a mixture of the bait 
plasmid and at least one type of AD/library plasmid, you will need to separate the 
plasmids by selection in E. coli. 
 
3. Transform the isolated plasmid extract from yeast into E. coli  
 
4. For matings with pGBKT7 (Kanamycin-resistance), plate the transformants on LB 
medium containing ampicillin to select for the AD/library plasmid only. 
 
5. Purify the AD/library plasmid using any suitable method 
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6. Amplify the cDNA insert by PCR using the BD Matchmaker AD LD-Insert Screening 
Amplimer Set (#9103-1) and the BD Advantage 2 PCR Kit (#K1910-1).  
 
7. Analyze the cDNA Insert by Agarose/EtBr Gel Electrophoresis (see below) 
 
Rescue the Library cDNA Insert by PCR Colony Screening 
 
1. Preheat a PCR thermal cycler to 94°C 
 
2. Place the BD Advantage 2 PCR Kit components and GAL4 AD LD-Insert Screening 
Amplimers on ice and allow them to thaw completely. Mix each component thoroughly 
before use 
 
3. Prepare a Master Mix by combining the components as specified in the Table below: 
 
Reagent 1 rxn 
PCR-grade deionised H2O 41 mL 
10X Advantage 2 PCR Buffer 5 μL 
5' LD Amplimer (20 μM) 1 μL 
3' LD Amplimer (20 μM) 1 μL 
50X dNTP Mix (10 mM ea.) 1 μL 
50 X Advantage 2 Polymerase 
Mix 
1 μL 
Total 50 μL 
 
4. Using a sterile pipette tip, scrape a few cells from a colony that you wish to analyze. Place 
the cells in the bottom of a clean 250 μL PCR tube 
 
5. Add 50 μL of Master Mix to the tube. Gently pipette up and down to disperse the cells, 
and PCR as follows: 
94°C 3 min 
25–30 cycles: 
94°C 30 sec 
68°C 3 min 
68°C 3 min 
Soak at 15°C 
 
6. Analyze the PCR product by Agarose/EtBr Gel Electrophoresis (see below) 
 
Analyze the cDNA Insert by Agarose/EtBr Gel Electrophoresis 
 
1. Analyze a 5 μL aliquot of the PCR product alongside DNA size markers on a 0.8% 1X 
TAE agarose/EtBr gel 
 
2. To distinguish the PCR product from similar size inserts in other AD/library plasmids, 
digest the PCR product with a frequent-cutter restriction enzyme such as Alu I or Hae III. 
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3. Run a small sample on a 2% agarose/EtBr gel. Compare the digestion pattern with that of 
other inserts 
 
4. If a high percentage of the colonies appear to contain the same AD/library insert, expand 
the PCR analysis to another batch of 50 colonies. 
 
5. If the PCR product consists of more than one band, segregate the library plasmids by 
isolating the plasmids from yeast using any standard method, transforming it into E. coli 
and selecting on LB/amp plates. Pick individual colonies.. 
 
6. If the PCR product consists of a single band, prepare a new master plate with a 
representative clone from each group. 
 
7. Prepare a glycerol stock of each unique type of clone. Store at –80°C 
 
8. Purify the PCR product with the Wizard SV PCR purification kit and sequence using the 
BD Matchmaker AD LD-Insert Screening Amplimer Set (#9103-1) or T7 Sequencing 
Primer 
 
Retesting the Interaction 
 
Protein-protein interactions can be retested in yeast (by either co-transformation or yeast mating), 
in vitro (by co-immunoprecipitation - Co-IP), and/or in mammalian cells.   
Stellenbosch University  http://scholar.sun.ac.za
   
199 
 
Appendix 13 
 
Protocol for Immunofluorescence-Labelling of Cultured Cells 
 
Reagents and materials 
 
RPMI 1640 media (Sigma, St. Louis, MO) 
 
Methanol (Sigma, St. Louis, MO) 
 
1X PBS 
 Dissolve the following in 800 mL dH2O. 
 8g of NaCl 
 0.2g of KCl 
 1.44g of Na2HPO4 
 0.24g of KH2PO4 
 Adjust pH to 7.4. 
 Adjust volume to 1L with additional dH2O. 
 Sterilise by autoclaving 
 
4% Paraformaldehyde in PBS 
 Take 1.25 mL of 32% w/v paraformaldehyde solution to a final volume of 10 ml in 1X 
PBS 
 
1% Bovine serum albumin (BSA) 
 Dissolve 1 g of BSA into 100 mL 1X PBS 
 Filter-sterilise. 
 Store at 4°C 
 
Appropriate primary and secondary (labelled) antibodies 
 
DAPI nuclear stain (Invitrogen) 
 Dissolve the content of one vial (10 mg) in 2 mL deionised H2O 
 Aliquot and store at -20°C for long term storage 
 
Mowiol mounting medium with anti-fade (Calbiochem) 
 
Protocol 
 
NOTE: General protocol that can be modified to give optimal results  
Coverslip fixation of cultures of cells 
1. Briefly rinse cell cultures in pre-warmed culture medium. 
 
2. Alcohol permeabilisation: immerse coverslips carrying cells in absolute Methanol (5 min, -
20°C). 
 
Stellenbosch University  http://scholar.sun.ac.za
   
200 
 
3. Fix cells in 4% Paraformaldehyde in PBS (5 min, RT). 
 
4. Wash cultures in PBS (3 x 10 min), then continue with Step 1 below: 
 
Coverslip staining of cultures of cells 
1. Incubate sections/cells in Blocking Solution: 1% bovine serum albumin (BSA) in PBS 
(optional and depending on antigen to be labelled: add 0.1% Triton X-100) (1 h, RT; 
blocking step to reduce non-specific staining). 
 
2. Incubate sections/cells with appropriate pair of Primary Antibodies diluted in Blocking 
Solution (dilutions are antibody-specific and have to be established. As a rule of thumb, a 
good starting concentration for polyclonal ABs is 2 micrograms/ml; for monoclonals 20 
micrograms/ml).  
 
3. Seal in a humidified chamber and incubate overnight at 4oC. Free-floating sections should 
be placed on a nutator for gentle agitation – but avoid this for mounted sections or cells on 
coverslips, as they may dislodge. 
 
4. Wash sections/cells in PBS (3 x 10 min, RT) 
 
5. Incubate sections/cells in Secondary Antibodies (e.g. donkey-anti-rabbit Cy3 and goat-
anti-mouse ALEXA 488, both 1:500, diluted together in Blocking Solution). 
Incubate (90 min, RT) in a humidified chamber in the dark. 
 
6. Wash sections/cells in PBS (3 x 10 min, RT) 
 
7. Counterstain with DAPI Nuclear Stain (0.5 µg/ml in PBS) for 10min 
 
8. Wash sections/cells in PBS (1 x 10 min, RT) 
 
9. Mount sections/cells with Mowiol mounting medium with anti-fade (Calbiochem) (retards 
fading of fluorescence) 
 
10. Store sections in the dark at 4°C until viewing 
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Appendix 14 
 
SDS polyacrylamide gel electrophoresis  
 
Reagent and materials 
 
SDS PAGE BUFFERS:  
 
1.5M Tris, pH8.8 
 Dissolve 181.65 g of Tris base with 700 ml of dH2O by stirring. 
 Adjust the pH by adding the concentrated HCl. 
 Adjust the final volume to 1 L with dH2O. 
 Autoclave to sterilise. 
 
1 M Tris, pH 6.8 
 Dissolve 121.4 g of Tris base with 700 ml of dH2O by stirring. 
 Adjust the pH by adding the concentrated HCl. 
 Adjust the final volume to 1 L with dH2O. 
 Autoclave to sterilise. 
 
10% SDS 
 Dissolve 10 g of SDS (ultra-pure grade SDS) in 90 mL of ddH2O. 
 Bring up to final volume of 100 mL 
 
20% SDS 
 Dissolve 20 g of SDS (ultra-pure grade SDS) in 90 mL of ddH2O. 
 Bring up to final volume of 100 mL 
 
2X reducing SDS sample buffer 
 Combine the following 
 Tris (1M, pH 6.8)   3.4 mL 
 Glycerol    2 mL 
 SDS (20%)    3 mL 
 Bromophenol blue (0.75%)  500 μL 
 EDTA (0.5 M)   200 μL 
 β-Mercaptoethanol (BME)  1 mL 
 
Store at -20°C or 4°C 
 
Running bufferfor SDS-PAGE gels 
 Combine the following 
2 litres:  4 litres: 
 25mM Tris          6 g             12 g 
 192mM Glvcine    28.8 g    57.6 g 
 0.1% SDS (10%)    20 mL    40 mL 
 H2O       to 2 L     to 4 L  
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 DO NOT adjust pH. Store at 4°C or RT. 
 
Acrylamide-BIS (30% w/v)  
 Combine the following 
 Acrylamide     30 g  
 BIS      0.8 g 
 ddH20     to 100mL 
 
 Store at 4°C in dark container. 
 
 
Ammonium persulphate (APS) (10% w/v)  
 Dissolve 1 g of ammonium persulphate into 10 mL sterile dH2O  
 Store at 4°C. 
 
Protocol 
 
Preparation of the sample 
 
1. Add an equal volume of 2 x SDS Sample Buffer to the protein sample (5-10 μg).  
 
2. Mix and place in boiling water bath for 5 min.  
 
3. If reduced and unreduced samples are to be run on same slab the reduced samples must be 
alkylated with iodoacetimide (l0 μL of a 1M solution per sample well, i.e. per 25 μL 
reducing sample buffer).  
 
4. IAA added to samples after boiling, just prior to loading. 
 
Preparation of the gel 
 
1. Assemble gel apparatus as per manufacturer‘s instructions, and prepare separating and 
stacking gels as follows: 
 
(a) Separating gel (for 2 x 0.75 mm mini-slab gels): 
Component 7.5% 10% 12% 15% 18% 
Acrylamide/bisacrylamide 
30:0.8 (% w/v) 
2.5 mL 
3.33 mL 
(2.5ml of a 40% stock) 
4.0 mL 5.0 mL 6.0 mL 
1.5M Tris-HCI pH 8.8 2.5 mL 2.5 mL 2.5 mL 2.5 mL 2.5 mL 
10% SDS 0.1 μL 0.1 μL 0.1 μL 0.1 μL 0.1 μL 
H20 4.85 mL 4.0 mL 3.35 m 2.35 mL 1.35 m 
TEMED 10 μL 10 μL l0 μL l0 μL l0 μL 
10% ammonium persulphate 50 μL 50 μL 50 μL 50 μL 50 μL 
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2. Add water to the top of the gel to help separating gel set.  After setting, pour off water and 
pour on stacking gel.   
 
(b) 3% Stacking gel: (enough for 4) :  
Components Volumes 
Acrylamide/bisacrylamide 
30:0.8 (% w/v) 
1.3 mL 
(0.8 ml of a 40% stock) 
1M Tris-HCI pH 6.8 1.25 mL 
10% SDS 0.1 μL 
H20 7.4 mL 
TEMED 20 μL 
10% ammonium persulphate 50 μL 
 
Running of the samples 
 
1. Pour running buffer into upper and lower chambers of apparatus so that top and bottom of 
gel and both electrodes are covered. 
 
2. Load samples into the wells (approximately 15 - 20 uL), including a molecular weight 
marker in one lane.  
 
3. Electrophorese at 200V (constant voltage) until the dye front reaches the end of the gel 
(45 min - 1 hr).   
 
4. After electrophoresis the gel may be stained or used for Western Blotting. 
 
 
Western Blotting  
 
Reagent and materials 
 
TBS-T wash buffer (0.1 % Tween) 
 Combine the following 
 20mM Tris (1M 111 7.6) 50 mL 20 mL 
 137mM NaCl (5M) 137 mL / 40.03 g 16.01 g 
 Tween 5 mL 2 mL 
 H2O to 5 L to 2 L 
 
Blocking buffer 
 Combine the following 
 200 mL TBS-T wash buffer   
 20 g fat free milk powder 
 2 g of BSA  
 
Stripping buffer (for Western membranes)   
 β-Mercaptoethanol   100mM (21 mL 1.433M) 
 SDS     2% (6 mL 10%) 
 Tris (pH 6.7)     62.5mM (18.75 mL lM) 
 ddH20     Make up to 300 mL 
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Protocol 
 
Transfer of protein to nitrocellulose membrane: 
 
1. The transfer stack is assembled as follows in Figure 1 and placed in the iBlot blotting 
system (Figure 2) 
 
 
Figure 1.  How iBlot® dry blotting works.   
 
  
  
Figure 2. iBlot® dry blotting system (Invitrogen, Carlsbad, CA; http://www.Invitrogen, 
Carlsbad, CA.com) 
 
2. After the transfer, the membrane is blocked overnight in 20 mL Blocking buffer (0.1% 
Tween). 
 
Western detection 
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1. After overnight blocking step, the blocked membrane is rinsed with TBS-T buffer (0.1% 
Tween) 
 
2. Incubate the blocked membrane with primary Ab diluted in TBS-T buffer at appropriate 
dilution for 60 min at RT 
 
3. Wash step: rinse membrane 2x in TBS-T buffer, then wash 3x 10 min in TBS-T buffer 
with shaking 
 
4. Incubate with dilution of secondary antibodies 60 min at RT. 
 
5. Repeat the Wash step 
 
6. Incubate in ECL detection fluid (5 mL of solution A with 5 mL of solution B)for 5 min 
 
7. Wrap membrane in plastic wrap, stick to piece of Whatmann paper that fits into cassette  
 
8. Detect 10 sec - 10 min with auto-radiographic film and develop autorads 
 
Stripping and reprobing of blot (Safe to do once) 
 
1. Incubate membrane in preheated Stripping buffer at 50°C in shaking water bath for 30' 
(70°C for high affinity antibodies) 
 
2. Wash membrane 2x in TBS-T buffer at RT 
 
3. Continue with blocking in Block buffer and proceed with Western Blot detection as 
outlined above. 
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Appendix 15 
  
Sandwich ELISA protocol 
 
Reagents and materials 
 
96-Well Microtiter Nunc Maxisorb plates 
 
3,3',5,5'-tetramethyl-benzidine (Sigma, St. Louis, MO T-2885) 
 
Hydrogen peroxide 30% solution (Sigma, St. Louis, MO H-1009) 
 
Dimethyl sulfoxide (DMSO), minimum 99.5% GC (Sigma, St. Louis, MO D5879-100ml) 
  
Sulphuric acid 96% H2SO4 
 
Sodium azide NaN3 
 
Adhesive plastic 
 
2X anti-human C1qA primary antibodies (capture and detection) (two different epitopes) 
 
1x secondary 
 
Standard C1qA 
 
Carbonate Buffer pH 9.5, 1L – store at 4°C 
 Combine the following 
 1.59 g of Na2CO3 
 29.3 g of NaHCO3 
 2 mL of 10% NaN3 
 Adjust the volume 1 L with dH2O.  
 Store at 4°C. 
 
Blocking buffer 0.05% Tween-20, 5% BSA, PBS – store at 4°C   
 Dissolve 100 mg of BSA into 10 mL PBS-Tween 
 Filter-sterilise and store at 4°C  
 
TMB solution for 1mL– store at 4°C  
 Dissolve 10 mg of TMB into 1 mL DMSO 
 Filter-sterilise and store at 4°C 
 
TMB buffer pH 5.5, 1L, 0.1M Na-acetate 
 Dissolve 13.6 g of CH3COONa*3H2O into 900 mL dH2O 
 Adjust pH to 5.5 with Acetic acid 
 Adjust volume to 1 L with dH2O 
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4M H2SO4 1L 
 Carefully pour 392 mL H2SO4  stock solution in 608ml dH2O (always pour acid into 
water) 
 
2M H2SO4 100mL 
 Combine 50 mL of the 4M H2SO4 solution with 50 mL dH2O  
 
Protocol 
  
Day One 
Antibody coating (capture) 
  
1.  Coat wells (Nunc Maxisorb plates) with capture antibody @ [1-10 μg/mL] 
carbonate/bicarbonate buffer pH 7.4 overnight at 4C. 
 
2. Remove coating solution and wash plate 3X 200 μL PBS/Tween 
 
Day Two 
Blocking  
 
3. Block remaining protein binding sites in coated wells by adding 200-300 μL blocking 
buffer. 
 
4. Incubate covered overnight at 4C. 
 
Day Three 
Adding samples (duplicates) 
 
5. Wash plate 3X 200-300μL PBS/Tween 
 
6. Adding samples: 
a. Add 100 μL of diluted sample (blocking buffer) to each well. 
b. Set up standard curve (load 100 μL of each) 
 4000, 2000, 1000, 500, 250, 125, 62.5, 31.25 pg/mL (blocking buffer) 
 
7. Incubate for 90 min (or overnight) at 37C 
 
8. Remove samples and wash 3X with 200-300 μL PBS/Tween 
 
Incubation with detection antibody and secondary antibody 
 
9. Add 100 μL of diluted detection antibody to each well 
 
10. Cover plates and incubate for 2hrs at room temperature 
 
11. Wash plate 4X 200-300 μL PBS/Tween 
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12. Add 100 μ of secondary antibody conjugated with HRP, diluted in blocking buffer 
 
13. Cover plates and incubate for 1-2 hrs at room temperature 
 
14. Wash plate 4X 200-300 μL PBS/Tween 
 
Detection 
  
15. Add 100 μL TMB developing solution to wells 
a. 1 ELISA plate mix: 
 11 mL TMB buffer 
 110 μL TMB solution 
 22 μL H2O2 
b. Incubate for 15-30min 
 
16. Add 100 μL 2M H2SO4 to stop the reaction 
 
17. Read absorbance at 450nm 
a. Positive wells will change to a blue color depending on signal intensity 
b. The blue will change to yellow when the reaction is stopped 
c. Read multiple plates in the order the color development was stopped 
 reaction is stopped after 5 min 
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Appendix 16 
 
Haplotype frequencies 
 
rs.172378-rs12033074 
TB Frequency OR of TB, adjusted for age and 
gender 
Haplotype: Control case OR 95% CI 
A-G 0.02 0.02 0.84 0.38 1.87 
A-C 0.34 0.33 1.06 0.86 1.30 
G-C 0.21 0.26 1.39 1.09 1.77 
G-G 0.43 0.39 1   
 
rs12033074-rs631090 
TB Frequency OR of TB, adjusted for 
age and gender 
Haplotype: Control case OR 95% CI 
C-C 0.19 0.25 1.37 1.02 1.83 
G-C 0.15 0.13 0.99 0.73 1.34 
G-T 0.30 0.27 0.91 0.71 1.18 
C-T 0.37 0.35 1.00 1.00 1.00 
 
rs587585-rs665691-rs.172378 
TB Frequency OR of TB, adjusted for 
age and gender 
Haplotype: Control case OR 95% CI 
A-C-A 0.31 0.28 0.99 0.79 1.22 
A-C-G 0.03 0.03 0.94 0.55 1.60 
A-G-A 0.01 0.01 1.83 0.50 6.75 
G-G-A 0.05 0.06 1.41 0.92 2.15 
G-G-G 0.19 0.24 1.48 1.16 1.89 
A-G-G 0.41 0.38 1.00 1.00 1.00 
 
rs665691-rs.172378-rs12033074 
TB Frequency OR of TB, adjusted for 
age and gender 
Haplotype: Control case OR 95% CI 
C-A-C 0.29 0.27 1.00 0.80 1.24 
C-A-G 0.02 0.01 0.68 0.29 1.59 
C-G-G 0.03 0.03 0.94 0.55 1.61 
Stellenbosch University  http://scholar.sun.ac.za
   
210 
 
G-A-C 0.06 0.07 1.35 0.89 2.02 
G-G-C 0.21 0.26 1.40 1.09 1.78 
G-G-G 0.39 0.36 1.00 1.00 1.00 
 
rs587585-rs665691-rs.172378-rs12033074 
TB Frequency OR of TB, adjusted for 
age and gender 
Haplotype: Control Case OR 95% CI 
A-C-A-C 0.29 0.26 0.99 0.80 1.24 
A-C-A-G 0.02 0.02 0.84 0.40 1.79 
A-C-G-G 0.03 0.04 0.98 0.58 1.67 
A-G-G-C 0.02 0.03 1.38 0.73 2.62 
G-G-A-C 0.05 0.06 1.44 0.94 2.21 
G-G-G-C 0.19 0.24 1.45 1.13 1.86 
A-G-G-G 0.39 0.35 1.00 1.00 1.00 
 
rs12033074-rs631090 
TBM Frequency OR of TB, adjusted for 
age and gender 
Haplotype: Control Case OR 95% CI 
C-C 0.19 0.27 0.20 0.02 2.34 
G-C 0.15 0.14 9.48 1.09 82.67 
G-T 0.30 0.25 2.04 0.34 12.24 
C-T 0.37 0.34 1.00 1.00 1.00 
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